posts tagged:


lifescience


(search for keywords instead, or create an alert on this tag)

Wednesday, August 27, 2014

Neurosigma Files For IPO

Los Angeles-based NeuroSigma, a developer of medical devices aimed at treating epilepsy and depression, has filed for an IPO, saying that it is looking to raise up to $50M on the public markets. The company said it has applied to list on th...

READ MORE...
Wednesday, August 27, 2014

TigerText Sees Messaging Surge

Santa Monica-based TigerText, the secure messaging service provider for the enterprise market, reports that it has seen a spike of 750 percent in its message volume in the first half of the year. The company said the growth comes due to rec...

READ MORE...
Thursday, August 14, 2014

Geneva Healthcare Gets $1.8M

San Diego-based Geneva Healthcare has raised $1.8M in a funding round, the company said this morning, to go towards the development of its platform for managing data from cardiac devices. The company said the funding came from high net wort...

READ MORE...
Thursday, August 14, 2014

Amgen Sees Clinical Trial Failure, Recall

Thousand Oaks-based Amgen reported Wednesday that its Phase 3 clinical trial for its compound Kyprolis--which was being targeted for treatment of multiple myeloma--has failed, and that the study has been discontinued. Separately, in more ba...

READ MORE...
Wednesday, August 13, 2014

Otonomy Up In IPO

San Diego-based biopharmaceuticals firm Otonomy was up today in early trading, after pricing 6.25 million shares of its common stock at $16.00 per share last night. The company was trading around $17.52 today after its debut on the NASDAQ G...

READ MORE...
Monday, August 11, 2014

ViaCyte Raises $5.4M

San Diego-based ViaCyte, a biopharmaceuticals startup developing stem-cell based treatments for diabetes, said late Friday that it has raised $5.4M in a Series C-1 funding round. The company said the funding came from an un-named, nonprofit...

READ MORE...
Tuesday, August 5, 2014

Cynvenio, CollabRx Team On Cancer Therapy Tool

Westlake Village-based Cynvenio, a developer of cancer diagnostics and biomarker monitoring technology, and cloud-based expert system maker CollabRx have teamed up with a new, web-based cancer decision support application, according to the ...

READ MORE...
Tuesday, August 5, 2014

San Diego's Mapp Bio Behind Experimental Ebola Drug

A San Diego-based biopharmaceuticals startup, Mapp Biopharmaceuticals, is the source of the experimental Ebola treatment that has been given to the two Americans who are being treated for the dreaded disease, according to CNN. Mapp Pharmace...

READ MORE...
Monday, August 4, 2014

Otonomy Sets Estimated IPO Pricing Range

San Diego-based Otonomy, which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. The company indicated in a filing that it now expects its IPO at between $14.00 and $16.00 per sha...

READ MORE...
Friday, August 1, 2014

Cold Genesys Gets $13.57M For Bladder Cancer Treatment

Newport Beach-based Cold Genesys, a biopharmaceuticals company which is developing treatment for bladder cancer, said this week that it has raised $13.57M in a Series A funding. The funding came from Ally Bridge Group. According to the comp...

READ MORE...
Wednesday, July 30, 2014

Epic Sciences Raises $30M For Cancer Diagnostics

San Diego-based Epic Sciences, a biotech startup focusing on diagnostics for treatment and management of cancer, has raised $30M in a Series C funding. The funding came from RusnanoMedInvest (RMI) and Arcus Ventures, plus Domain Associates,...

READ MORE...
Tuesday, July 29, 2014

Amgen To Cut Nearly 3,000

Thousand Oaks-based biotechnology giant Amgen said Tuesday that it plans to cut 2,400 to 2,900 staff, including at its headquarters location, and will also close facilities in both Washington and Colorado. According to Amgen, the move is pa...

READ MORE...
Tuesday, July 29, 2014

PaxVax Finds $62M For Vaccine Efforts

PaxVax, a biopharmaceuticals company developing vaccines for infectious disease, has raised $62M in a funding round. The funding included $50M in secured debt from Pharmakon Advisors, and $12M in a Series B extension round. The company is b...

READ MORE...
Monday, July 28, 2014

Ceres Gets Funding From Brazil

Thousand Oaks-based agricultural biotech developer Ceres said this morning that its product development programs in Brazil are now being funded in part by that country. Ceres said it is expanding its product development programs in the coun...

READ MORE...
Friday, July 25, 2014

TigerText Lands Community Health System Operator

Santa Monica-based TigerText, the developer of secure, real-time messaging apps and software aimed at the healthcare and enterprise markets, reported a win with a community health system which operates 58 hospitals across 20 states. TigerTe...

READ MORE...
Monday, July 14, 2014

Otonomy Files For IPO

San Diego-based Otonomy, the biopharmaceuticals firm which is developing treatment of diseases and disorders of the ear, has filed for an IPO, saying in a filing that it is looking to raised $86.25M in an offering on the NASDAQ Global Marke...

READ MORE...
Thursday, July 3, 2014

Cytori Therapeutics Adds To Board

San Diego-based biopharmaceuticals developer Cytori said Wednesday that it has named Gail K. Naughton as a new, independent director at the company. Naughton was the co-founder of Advanced Tissue Sciences, where she also served as Presiden...

READ MORE...
Tuesday, July 1, 2014

Ambrx Withdraws IPO

La Jolla-based biotechnology developer Ambrx has withdrawn its IPO, citing "current public market conditions" in a regulatory filing this morning. Ambrx was venture backed by Tavistock, Maverick Capital, Apposite Healthcare, Versant Venture...

READ MORE...
Monday, June 30, 2014

Cidara Therapeutics Gets $32M

San Diego-based Cidara Therapeutics, a new, startup biopharmaceuticals firm working on treatments for severe fungal infections, has raised $32M in a Series A funding. The funding was led by 5AM Ventures, Aisling Capital, Frazier Healthcare ...

READ MORE...
Thursday, June 26, 2014

Amphastar Pharmaceuticals Debuts In IPO

Rancho Cucamonga-based Amphastar Pharmaceuticals, a specialty pharmaceuticals company focused on generic and proprietary injectable and inhalable drugs, priced its IPO Wednesday at $7 per share. The company is selling 8 million shares of it...

READ MORE...
Friday, June 20, 2014

Kite Pharma Surges In IPO

Los Angeles-based Kite Pharma, a biopharmaceuticals firm developing treatments for cancer, surged in its IPO this morning on the NASDAQ Global Market, trading as high as $29.22 in morning trading. The company had priced last night at $17.00...

READ MORE...
Friday, June 20, 2014

Genzum Raises $20M For Generic Pharmaceuticals Effort

Los Angeles-based biopharmaceuticals firm Genzum has raised $20M in a funding round, according to backer SG LLC. According to SG, its Alternative Investments Division invested $20M in Genzum, to go towards that company's expansion of its pi...

READ MORE...
Tuesday, June 17, 2014

TigerText Wins Boston Children's Hospital

Santa Monica-based secure messaging services provider TigerText, which is led by Brad Brooks, announced a big win this morning with Boston Children's Hospital. TigerText said that the pediatric center has selected TIgerText as its secure me...

READ MORE...
Tuesday, June 17, 2014

Isis Pharmaceuticals Gets $10M From Biogen Idec

Carlsbad-based Isis Pharmaceuticals, which is developing antisense technology for a wide range of conditions, said it has earned $10M in a milestone payment from Biogen Idec today. Isis Pharmaceuticals said the payment is associated with th...

READ MORE...
Wednesday, June 11, 2014

Ambrx Sets IPO Pricing Range

La Jolla-based biopharmaceuticals developer Ambrx has set its initial estimated pricing range for its IPO, saying in a filing this morning that it expects to price its IPO at between $12.00 and $14.00 per share. The offering will raise arou...

READ MORE...
Wednesday, June 11, 2014

Kite Pharma Sets IPO Range

Los Angeles-based biopharmaceuticals developer Kite Pharma has set an initial offering range for its IPO, saying in a filing this morning that it expects to sell 6 million shares of its common stock at between $12.00 and $14.00 per share. T...

READ MORE...
Wednesday, June 11, 2014

RuiYi Gets $4M In Venture Loan

La Jolla- and Shanghai-based RuiYi, a biopharmaceuticals firm developing treatments for rheumatoid arthritis and cancer, said yesterday that it has raised $4M in a venture debt funding, from Silicon Valley Bank. The company said it will use...

READ MORE...
Thursday, June 5, 2014

NantHealth Applies Supercomputers To Cancer Treatment

Los Angeles-based healthcare IT company NantHealth, which is led by billionaire Dr. Patrick Soon-Shiong, said this week that it has rolled out a new, super computer-based system aimed at improving treatments for cancer. NantHealth said it h...

READ MORE...
Wednesday, June 4, 2014

Ambit Biosciences Shuffles Board

San Diego-based biopharmaceuticals company Ambit Biosciences has shuffled its board this morning, saying it has added Jeffrey S. Hatfield as a member of its board of directors, as current board member Steven Elms resigns. Hatfield is the CE...

READ MORE...
Monday, June 2, 2014

Sente Secures $5M For Skincare Aesthetics

San Diego-based Sente, an aesthetics medicine company focused on skincare, said this morning that it has raised $5M in a Series C financing round. The funding was led by PharmaBio Investments, and also included existing and new, individual ...

READ MORE...
Monday, June 2, 2014

Kite Pharma Names New R&D Head

Santa Monica-based biopharmaceuticals firm Kite Pharma, which is developing products for the treatment of cancer, said today that it has named David D. Chang, M.D., Ph.D., as its new Executive Vice President, Research and Development, and C...

READ MORE...
Wednesday, May 28, 2014

California Technology Ventures Gets Exit An AngioScore

Pasadena-based venture capital firm California Technology Ventures has scored an exit at one of its portfolio firms, selling cardiac catheter maker AngioScore, to medical device firm Spectranetics. Spectranetics said it would pay $230M plus...

READ MORE...
Monday, May 19, 2014

Sophiris Raises $2M In PIPE

San Diego-based Sophiris Bio said this morning that it has raised $2M in funding from Aspire Capital Fund, and received commitments of up to $13M more, to help fund its efforts to develop a treatment for localized prostate cancer. Publicly ...

READ MORE...
Wednesday, May 14, 2014

UCI School of Medicine Adopts Google Glass

In what the school says is the first move by a medical school to adopt Google Glass into its curriculum, the UC Irvine School of Medicine said Wednesday that it will integrate use of Google Glass into its four year curriculum, using the hig...

READ MORE...
Tuesday, May 13, 2014

Dermtech Files For IPO

La Jolla-based Dermtech, a developer of non-invasive, gene expression tests for helping to diagnose skin cancer, has filed for an IPO. According to the company, it is looking to raised $25.0M in its IPO, and has applied to list on the NASDA...

READ MORE...
Monday, May 12, 2014

Lumena Pharmaceuticals Acquired By Shire

San Diego-based biopharmaceuticals developer Lumena Pharmaceuticals has been acquired by UK-based Shire plc, in a deal worth $260M plus earn out, the companies said this morning. Shire said the buy would help add to its rare diseases portfo...

READ MORE...
Friday, May 9, 2014

ImaginAb Raises $21M

Los Angeles-based ImagineAb, a developer of biotechnology used for molecular imaging, said Thursday that it has raised $21M in a Series B financing round. The funding was led by Merieux Developpement, and also included Novartis Venture Fund...

READ MORE...
Monday, May 5, 2014

Millennium Laboratories Names Three Executives

San Diego-based Millennium Laboratories, which is developing technology around medication monitoring and pharmacogenetics, said today that it has named three new executives. The company named Nikhil A. Nayak as chief marketing officer; Stev...

READ MORE...
Friday, May 2, 2014

Domain Associates Portfolio Firm ProteinSimple Files For IPO

San Diego-based life sciences investor Domain Associates has yet another company that has filed for an IPO, after the S-1 yesterday of protein analysis tools developer Protein Simple. Protein Simple said in its IPO filing that it is looking...

READ MORE...
Wednesday, April 30, 2014

Otonomy Gets $49M In New Funding

San Diego-based biopharmaceuticals developer Otonomy--which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. The Series D funding came from Jennison Associate...

READ MORE...
Monday, April 28, 2014

Alignment Healthcare Raises $125M

Irvine-based Alignment Healthcare, a startup providing continuous care programs that handle clinical care coordination, risk management capabilities, and information technology for healthcare providers, has raised $125M in a funding round. ...

READ MORE...
Monday, April 28, 2014

Kite Pharma Scores $50M For Cancer Immunotherapy

Santa Monica-based Kite Pharma said this morning that it has raised $50M, in a mezzanine, private financing, made up of convertible notes. According to Kite Pharma, the funding came from an un-named syndicate of healthcare-dedicated investo...

READ MORE...
Friday, April 25, 2014

Domain Elite Invests In SMART Medical Systems

Domain Elite, the joint venture between San Diego investor Domain Associates and China's Elite Consulting, said today that it has made an investment in SMART Medical Systems, a developer of endoscopy and colonoscopy products. Domain Elite s...

READ MORE...
Wednesday, April 23, 2014

Allergan Adopts Poison Pill

Irvine-based Allergan said late Tuesday evening that it has adopted a one-year, stockholder rights plan--better known to investors as a "poison pill"--after the receipt of an unsolicited bid by Valeant Pharmaceuticals to acquire the company...

READ MORE...
Tuesday, April 22, 2014

Allergan Gets Hostile Bid From Valeant

Irvine-based healthcare firm Allergan has received a hostile bid from Valeant Pharmaceuticals, in a deal worth around $152.89 per share. Valeant offered to pay $48.30 in cash plus 0.83 percent in Valeant stock for each share of Allergan's s...

READ MORE...
Thursday, April 10, 2014

Xencor Gets Milestone Payment From Merck

Monrovia-based biopharmaceuticals developer Xencor reports this morning that it has received a milestone payment from Merck, for the initiation of a Phase 1 clinical trail which uses its antibody engineering technology. Size of that milesto...

READ MORE...
Tuesday, April 8, 2014

Sequent Medical Snags $20M

Aliso Viejo-based Sequent Medical, which is developing medical devices for treating aneurysms, said Tuesday that it has raised $20M in a Series D funding. The funding was led by Delphi Ventures, and also included Domain Associates, US Ventu...

READ MORE...
Tuesday, April 8, 2014

Questcor Acquired For $5.6 Billion

Publicly held pharmaceuticals firm Questcor has been acquired for $5.6 billion by fellow pharmaceuticals maker Mallinckrodt Pharmaceuticals, the two said late Monday. Mallinckrodt will pay $30.00 in cash and 0.897 of its shares for each sha...

READ MORE...
Tuesday, April 8, 2014

Atara Biotherapeutics Bolsters Board, Executives

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. Fust was most ...

READ MORE...
Friday, April 4, 2014

Lumena Pharmaceuticals Files For IPO

San Diego-based Lumena Pharmaceuticals has filed for an IPO, saying in a filing with the SEC that it is looking to raise up to $75.0M in a public offering. Lumena said that it has applied to list on the NASDAQ Global Market as LIVR. Lumena'...

READ MORE...
Wednesday, April 2, 2014

Illumina Targets Cancer Research With New Tools

San Diego-based life sciences equipment maker Illumina said this morning that it has launched a new set of products aimed specifically at the oncology market. According to Illumina, it has launched a new set of products aimed at discovery a...

READ MORE...
Thursday, March 27, 2014

RuiYi Raises $15M For Monoclonal Antibody Research

La Jolla-based RuiYi, a company developing therapeutic monoclonal antibodies, said today that it has raised $15M in a Series B financing. The funding came from 5AM Ventures, Versant Ventures, Apposite Capital, SR One, Merck Serono Ventures,...

READ MORE...
Tuesday, March 25, 2014

Sorrento Therapeutics Spins Off Animal Health Company

San Diego-based Sorrento Therapeutics, which develops treatments for cancer and treatment of pain, is spinning off a new company focused on animal health, the company announced this morning. Sorrento Therapeutics said it has created a wholl...

READ MORE...
Friday, March 21, 2014

Presbia Files For IPO

Irvine-based Presbia, a medical device company developing optical lens implants, has filed for an IPO. According to the company's S-1, it is looking to riase up to $90M on the NASDAQ Global Market as LENS. The IPO is being underwritten by J...

READ MORE...
Friday, March 21, 2014

Otonomy Appoints New Board Member

San Diego-based Otonomy, a biopharmaceuticals company developing treatments for disorders of the inner and middle ear, said Thursday that it has added Vickie Capps to its board of directors. Capps was previously EVP, CFO, and treasure for D...

READ MORE...
Tuesday, March 18, 2014

CorTechs Labs Snags Series B

San Diego-based CorTechs Labs, a developer of medical software, said this morning that it has raised a Series B funding round. Size of the funding round was not disclosed, however, a regulatory filing indicates the round was worth $1.2M. Co...

READ MORE...
Monday, March 17, 2014

C3 Jian Raises $60.5M To End Cavities

Los Angeles-based C3 Jian, which is developing biopharmaceuticals aimed at improving oral healthcare, said Monday that it has raised $60.5M in a Series D financing. The funding was led by Renaissance Holding Company, and also included affil...

READ MORE...
Monday, March 17, 2014

AMN Healthcare invests In PipelineRx

San Diego-based healthcare staffing firm AMN Healthcare Services said this morning that it has made a strategic investment in PipelineRx, a developer of clinical, telepharmacy medication management services. AMN said it is investing $5M in ...

READ MORE...
Monday, March 17, 2014

Ligand Gets $1M From Merck

San Diego-based Ligand Pharmaceuticals reported this morning that it has earned a $1M, milestone payment related to the licensing of its technology to Merck. Ligand said that the payment game due to the U.S. Food and Drug Administration's a...

READ MORE...
Friday, March 14, 2014

Ignyta Prices IPO

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 a share. The IPO will raised $48.0M for the company. Ignyta will trade on the NAS...

READ MORE...
Thursday, March 13, 2014

AnaptysBio Gets $17M in Licensing Deal

San Diego-based AnaptysBio, a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. According to AnaptysBio, it will receive an upfront license fee of $17M from TESARO, plus receiv...

READ MORE...
Wednesday, March 12, 2014

Domain Associates, Versant Get Another IPO Exit

Two, Southern California venture investors have scored another paired exit today, after South San Francisco-based Achaogen debuted on the NASDAQ Global Market as AKAO. Both Domain Associates and Versant Ventures had an exit via another, bio...

READ MORE...
Tuesday, March 11, 2014

Lumena Pharmaceuticals Gets $45M

San Diego-based Lumena Pharmaceuticals, a biopharmaceuticals firm developing treatments for liver disease, said today that it has raised $45M in a Series B funding. The funding was led by New Enterprise Associates, and also included Adage C...

READ MORE...
Tuesday, March 4, 2014

Cardium Gets Strategic Funding From China

San Diego-based Cardium Therapeutics said Monday that it has scored a strategic funding from Shanxi Taxus Pharmaceuticals Co., Ltd., to help support development of its regenerative medicine therapeutics products. According to Cardium, the d...

READ MORE...
Friday, February 28, 2014

Mast Therapeutics Completes Acquisition of Aires Pharmaceuticals

San Diego-based Mast Therapeutics said yesterday that it has completed its acquisition of Aires Pharmaceuticals, the company developing treatments for pulmonary arterial hypertension. The deal is worth around $5.2M, and was announced earlie...

READ MORE...
Wednesday, February 26, 2014

Bruin Biometrics Finds $10M For Medical Sensors

Los Angeles-based medical device startup Bruin Biometrics said this morning that it has raised $10.0M in a new fundign round, to go towards its biometric sensing products. The startup develops a sensor which can be used to detect inflammato...

READ MORE...
Tuesday, February 25, 2014

Thesan Pharmaceuticals Adds $49M

San Diego-based Thesan Pharmaceuticals, which is developing treatments for acne and atopic dermatitis, said today that it has raised $49M in a Series B financing round. The funding round was led by Novo Ventures, and also included SV Life S...

READ MORE...
Thursday, February 13, 2014

Lithera Ups Series C To $35.6M

San Diego-based pharmaceuticals firm Lithera, which is developing aesthetic medicine products aimed at reducing fat, said this week that it has completed a final close of its Series C funding at $35.6M. The final tranche of the round added ...

READ MORE...
Thursday, February 13, 2014

Domain Associates Re-Ups On Miramar Labs

San Diego-based biotech investor Domain Associates has re-upped its investment in medical device manufacturer Miramar Labs. Miramar Labs said Wednesday that it has raised $10M in a Series D funding, from Aisling Capital, Cross Creek Capital...

READ MORE...
Wednesday, February 12, 2014

Trio Of SoCal Investors Back Welltok

Three, local venture capital investors -- Miramar Venture Partners, Okapi Venture Capital, and Qualcomm Ventures -- are part of a group investing $22.1M in healthcare software developer Welltok, which announced a big funding round this morn...

READ MORE...
Wednesday, February 12, 2014

Illumina Launches Genomics Accelerator Program, But Not In San Diego

San Diego-based life sciences equipment maker Illumina has tossed its hat into the accelerator market, saying this morning that it has launched a brand new, genomics-focused startup accelerator program. Illumina said its new Illumina Accele...

READ MORE...
Tuesday, February 11, 2014

Cadence Pharmaceuticals Acquired For $1.3 Billion

San Diego-based Cadence Pharmaceuticals, a biopharmaceuticals firm developing an intravenous formulation of acetominophen for treating pain, has been acquired by Irish biopharmaceuticals firm Mallinckrodt, in a deal worth $1.3 billion. Mall...

READ MORE...
Tuesday, February 11, 2014

NeuroSigma Names VP

Los Angeles-based NeuroSigma, a life sciences firm developing systems for the treatment of epilepsy and major depressive disorder, said today that it has named Carl Adams as Vice President and Controller. Adams was previously at advisory fi...

READ MORE...
Monday, February 10, 2014

Mast Therapeutics Buys Aires Pharmaceuticals

San Diego-based biopharmaceuticals developer Mast Therapeutics announced this morning that it has acquired AIres Pharmaceuticals, a company developing therapies to treat pulmonary vascular disorders. Mast Therapeutics said the deal is an al...

READ MORE...
Friday, February 7, 2014

Pathway Genomics Names Chief Strategy Officer

San Diego-based Pathway Genomics, which offers genetic testing lab services, said Thursday that it has named Ardy Arianpour as its Chief Strategy Officer. According to Pathway Genomics, Arianpour was most recently at Ambryx Genetics, and al...

READ MORE...
Thursday, February 6, 2014

Sonrgy Licenses Technology From UC San Diego

San Diego-based biotechnology startup Sonrgy said Wednesday that it has license core, ultrasound-sensitive drug delivery nanotechnology for the company from UC San Diego. According to Sonrgy, it has begun commercializing the technology, whi...

READ MORE...
Wednesday, February 5, 2014

Inogen Sets IPO Range

Goleta-based medical equipment maker Inogen has set the pricing range for its IPO, saying in a filing with the SEC that it expects its stock to price at between $16.00 and $18.00 per share. The company is offering up 3,529,411 shares of its...

READ MORE...
Wednesday, February 5, 2014

Auspex Prices IPO

La Jolla-based biopharmaceuticals developer Auspex Pharmaceuticals has priced its IPO, saying it will offer up 7,000,000 shares of its common stock at $12.00 per share. The company will begin trading this morning as ASPX on the NASDAQ Globa...

READ MORE...
Wednesday, February 5, 2014

Amgen, Merck In Collaboration Over Melanoma Treatments

Thousand Oaks-based Amgen and fellow biopharmaceuticals firm Merck said this morning that they are in an agreement to create a combination treatment for advanced melanoma. The two said they are looking to evaluate the safety and efficacy of...

READ MORE...
Tuesday, February 4, 2014

Pelican Products Buys UK Company

Torrance-based Pelican Products, which is best known for its protective cases and flashlights and other lighting systems, said late Monday that it has acquired UK-based Cool Logistics, a developer of temperature controlled packaging product...

READ MORE...
Monday, February 3, 2014

Sorrento Therapeutics Names New Board Member

San Diego-based clinical oncology firm Sorrento Therapeutics said today that it has named a new board director. Sorrento Therapeutics said it named Daniel Levitt, the current Executive Vice President and Chief Medical Officer of CytRx, to i...

READ MORE...
Thursday, January 23, 2014

LA Billionaire Soon-Shiong: World Needs Medical Manhattan Project

Los Angeles-based biotech billionaire Dr. Patrick Soon-Shiong said Thursday that the world needs a "medical Manhattan Project" to tackle the issues of health, surrounding issues around a divide in health treatment between the rich and the p...

READ MORE...
Friday, January 17, 2014

Kite Pharma Names Regulatory VP

Los Angeles-based Kite Pharma announced this morning that it has named a new VP. The biotechnology company--which is developing treatments for cancer--said it has named Rizwana F. Sproule, Ph.D. as Vice President, Regulatory Affairs. Sproul...

READ MORE...
Thursday, January 16, 2014

AqueSys Raises $43.6M For Glaucoma Treatments

Aliso Viejo-based AqueSys, a medical device firm developing stent-based treatments for glaucoma, said this morning that it has raised $43.6M in a Series D funding. ACcording to the company, the round came from Accuitive Medical Ventures, Th...

READ MORE...
Thursday, January 16, 2014

Amgen, Illumina In Diagnostic Test Deal

Thousand Oaks-based Amgen and San Diego-based Illumina are in an agreement to develop and commercialize a test for metastatic colorectal cancer, Illumina said late Wednesday. Illumina said the test will use its MiSeqDx instrument to develop...

READ MORE...
Tuesday, January 14, 2014

Isis Pharmaceuticals Gets $7.5M From Alnylam

Carlsbad-based Isis Pharmaceuticals said late Monday that it has received $7.5M in a payment from Alnylam Pharmaceuticals, as part of a recent alliance between Genzyme and Alnylam. According to the biotech marker, the deal also has the pote...

READ MORE...
Monday, January 13, 2014

Ivantis Raises $46.5M For Glaucoma Treatments

Irvine-based Ivantis, a developer of stents used to lower eye pressure for glaucoma patients, said this morning that it has now raised $46.5M in its Series B funding round, with the addition of an additional $14.0M close in the funding. Acc...

READ MORE...
Friday, January 10, 2014

Atara Biotherapeutics Raises $52M

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M. According to Atari Biotherapeutics, the investors in the round in...

READ MORE...
Friday, January 10, 2014

Suneva Medical Gets $35 Million For Aesthetic Medicine

San Diego-based Suneva Medical, which is developing aesthetic medicine products, said late Thursday that it has raised $35M in a funding round. The funding included both debt and equity, and included $20M in a Series B equity financing. Tha...

READ MORE...
Friday, January 10, 2014

Amgen Loses CFO

Thousand Oaks-based biotech giant Amgen said late Thursday that its Executive Vice President and Chief Financial Officer, Jonathan M. Peacock, is leaving the company. According to Amgen, Peacock is leaving to pursue "broader career opportun...

READ MORE...
Friday, January 10, 2014

Sorrento Therapeutics Names New Chairman

San Diego-based Sorrento Therapeutics has named William Marth, the former President and CEO of Teva - Americas, as the company's new Chairman, the company said Thursday. The company, which is developing treatments for cancer, said Marth was...

READ MORE...
Thursday, January 9, 2014

Avelas Biosciences Raises $6.85M

San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company's technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included ...

READ MORE...
Wednesday, January 8, 2014

Auspex Pharmaceuticals Raises $35M

La Jolla-based Auspex Pharmaceuticals, a biopharmaceuticals firm aiming at treating hyperkinetic movement disorders, announced this morning that it has raised $35M in two separate financings. According to the company, it raised $20M in a Se...

READ MORE...
Wednesday, January 8, 2014

Kite Pharma Names CFO

Los Angeles-based biotechnology developer Kite Pharma said today that it has named a new Chief Financial Officer. According to Kite Pharma, it has named Cynthia M. Butitta as its new EVP and CFO. Buttita was most recently at NextWave Pharma...

READ MORE...
Tuesday, January 7, 2014

Halozyme Gets $20M In Term Loan

San Diego-based biopharmaceuticals firm Halozyme Therapeutics announced Monday that it has received $20M in a term loan, from Oxford Finance and Silicon Valley Bank. Terms of the new loan were not announced. According to Halozyme, the proce...

READ MORE...
Tuesday, January 7, 2014

Cibus Buys Nucelis

San Diego-based Cibus, a developer of gene-based, crop breeding techniques, said today that it has acquired Nucelis, a biotechnology firm focused on technology for developing bio-chemicals based on harnessing plants, yeast, and bacteria. Fi...

READ MORE...
Monday, January 6, 2014

Ignyta Gets $10M In Term Loan

San Diego-based Ignyta, a developer of biotechnology for the oncology market, said this morning that it has received a $10M, expanded capital term loan from Silicon Valley Bank. Financial terms of that new term loan were not announced. Igny...

READ MORE...
Thursday, January 2, 2014

CareFusion Completes Vital Signs Buy

San Diego-based medical technology firm CareFusion said this week that it has completed its acquisition of the Vital Signs division of GE Healthcare in the U.S., China, and other geographies. The deal was worth $500M, and was funded through...

READ MORE...
Friday, December 20, 2013

Sorrento Therapeutics Completes Concortis Biosystems Buy

San Diego-based Sorrento Therapeutics has completed its acquisition of Concortis Biosystems, the company announced late Thursday. The deal was worth $11.3M. Sorrento said that the buy provides it with comprehensive antibody drug conjugate ...

READ MORE...
Tuesday, December 17, 2013

Atara Biotherapeutics Gets $38.5M

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease. The funding ...

READ MORE...
Tuesday, December 10, 2013

Indi Molecular Picks Up $300K More In $1.8M Seed Funding

Culver City-based Indi Molecular, a developer of synthetic replacements for antibodies, announced Tuesday that it has raised $300,000 more in its seed funding, bringing the total raised in the round to $1.8M. The new funding was led by Inte...

READ MORE...
Monday, December 9, 2013

Accelrys Buys QUMAS

San Diego-based life sciences software maker Accelrys said Monday that it has acquired QUMAS, an Irish developer of cloud-based and on-premise enterprise compliance software for the life sciences industry. Accelrys said it paid approximatel...

READ MORE...
Monday, December 9, 2013

CareFusion Invests $100M In Israeli Company

San Diego-based medical device maker CareFusion said this morning that it has invested $100M in an Israeli medical device company, Caesarea Medical Electronics (CME). Caesarea makes infusion pump systems. CareFusion said the investment will...

READ MORE...
Tuesday, December 3, 2013

Xencor Prices IPO

Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the ...

READ MORE...
Monday, December 2, 2013

Inogen Files For IPO

Goleta-based medical equipment manufacturer Inogen filed for an IPO over the weekend, saying that it plans to list on the NASDAQ Global Market under the symbol INGN. The developer of portable oxygen concentrators -- used as an alternative t...

READ MORE...
Monday, December 2, 2013

Isis Pharmaceuticals Earns $2M From GlaxoSmithKline

Carlsbad-based biopharmaceuticals developer Isis Pharmaceuticals said this morning that it has earned $2M from GlaxoSmithKline, related to advancement of a compound in Phase 2/3 studies. The company said the milestone payment from GSK was r...

READ MORE...
Friday, November 22, 2013

Sitari Pharmaceuticals Raises $10M To Tackle Celiac Disease

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals, with $10M in a Series A financing. Avalon said new startup is focused on the development of novel treatments for celiac disea...

READ MORE...
Tuesday, November 19, 2013

Cal-X Stars Accelerator Seeks $15M

Santa Monica-based life sciences accelerator Cal-X Stars Business Accelerator said this morning that it is in an effort to raised $15M in funding for the accelerator, via a number of crowdsourcing sites. The accelerator--backed by Leonhardt...

READ MORE...
Monday, November 18, 2013

CareFusion Acquires GE Healthcare Division For $500M

San Diego-based CareFusion announced this morning that it is spending $500M to acquire the Vital Signs division of GE Healthcare. GE's Vital Signs division manufactures single-patient-use consumables for respiratory care and anesthesiology....

READ MORE...
Thursday, November 14, 2013

Sorrento Therapeutics Buys Concortis Biosystems

San Diego-based Sorrento Therapeutics announced this morning that it is acquiring fellow, San Diego biotech Concortis Biosystems, to bolster its library of antibodies. According to Sorrento Therapeutics, it will issue 1,331,978 shares of it...

READ MORE...
Tuesday, November 12, 2013

NantHealth Partners With ALERT Life Sciences

Los Angeles-based NantHealth, the developer of next generation diagnostics and therapeutics tools for the healthcare industry which is backed by billionaire Dr. Patrick Soon-Shiong, said it has partnered with ALERT Life Sciences Computing. ...

READ MORE...
Friday, November 8, 2013

Amgen Foundation Commits $2.5 Million To Science Education Efforts

The Amgen Foundation, the nonprofit arm of biopharmaceuticals giant Amgen, has committed $2.5 million in new grants to help bolster scientific education. Amgen said the new funding will go to provide real-world biotech lab experience to mi...

READ MORE...
Thursday, November 7, 2013

Pathway Genomics Names Sales VP

San Diego-based genetic testing laboratory Pathway Genomics Corporation said this morning that it has named Robert C. Verfurth as its new Vice President of Sales. Verfuth has served at such companies as Innovus Pharmaceuticals, Dianon Syste...

READ MORE...
Friday, November 1, 2013

Ignyta Hits Public Markets In Reverse Merger

Venture-backed biotechnology startup Ignyta, which is backed by Colt Ventures and City Hill Ventures, has gone public in a reverse merger. According to the company, it completed a reverse merger with Infinity Oil & Gas Company, which trades...

READ MORE...
Wednesday, October 30, 2013

Domain, Versant Portfolio Firm Veracyte Hits IPO Market

Southern California venture capital investors Domain Associates and Versant Venture saw a public exit of one of their portfolio companies this morning, molecular diagnostics equipment maker Veracyte. Veracyte debuted on the NASDAQ Global Ma...

READ MORE...
Tuesday, October 29, 2013

Critical Diagnostics Names Board Member

San Diego-based Critical Diagnostics, a developer of cardiac biomarkers, said today that it has named Richard Dee to its board of directors. Dee is a board director and Senior Vice President at Unilab, and also serves on the boards of Assi...

READ MORE...
Monday, October 28, 2013

llumina Buys NextBio

San Diego-based life sciences equipment manufacturer Illumina said today that it has agreed to acquire NextBio, a developer of big-data based, clinical and genomic informatics software. Financial details of the acquisition were not disclose...

READ MORE...
Friday, October 25, 2013

Aerie Pharmaceuticals Prices IPO

Aerie Pharmaceuticals, which develops therapies for treating glaucoma and other eye diseases, has priced its IPO, saying this morning that it is offering up 6,720,000 share os its common stock at $10.00 per share. The company said it will b...

READ MORE...
Monday, October 21, 2013

Insightra Medical Gets Funding For Medical Devices

Irvine-based Insightra Medical, the developer of a medical device used for treating hernias, has raised a Series C financing round, the company announced this morning. Size of the round was not announced. The funding was co-led by Baird Cap...

READ MORE...
Monday, October 21, 2013

Arcturus Therapeutics Gets $5M

San Diego-based Arcturus Therapeutics, a developer of RNAi technology, said it has raised $5M in a Series A funding round. According to Arcturus, the funding came from multiple private capital,, high net worth investors from Canada, Japan, ...

READ MORE...
Monday, October 21, 2013

ChromaDex Gets Strategic Investment

Irvine-based ChromaDex, a publicly held developer of phytochemical ingredients, said it received a strategic investment from DSM Venturing, the venture capital arm of Royal DSM. Size of the investment was not announced. Royal DSM is a major...

READ MORE...
Thursday, October 17, 2013

Inari Medical Gets $4.7M For Medical Device Startup

Aliso Viejo-based Inari Medical, a medical device developer incubated out of Inceptus Medical, said Wednesday that it has raised $4.7M in a Series A funding round. The funding came from Versant Venturs and U.S. Venture Partners. Inceptus sa...

READ MORE...
Thursday, October 17, 2013

Amgen Names New Board Member

Thousand Oaks-based biopharmaceuticals developer Amgen said yesterday that it has named Greg C. Garland to its board of directors. Garland is Chairman, President, and CEO of Phillips 66. The company said that Garland will also serve on its ...

READ MORE...
Tuesday, October 15, 2013

Sofie Biosciences Lands $5M In Series A

Culver City-based molecular imaging products maker Sofie Biosciences said Tuesday that it has raised $5M in a Series A funding round. The funding was led by Tata Industries, and also included MRM Capital and the Cycad Group. Sofie Bioscienc...

READ MORE...
Tuesday, October 15, 2013

Prolacta Opens New Facility For Human Milk Processing

Prolacta Bioscience, the venture-backed startup which is developing human milk-based products for treating premature infants, said this morning that it has opened up a new, 67,000 square foot facility in the City of Industry. The company sa...

READ MORE...
Monday, October 14, 2013

Vital Therapies Seeks $86.52M In IPO

San Diego-based Vital Therapies has filed for an IPO, saying in a filing late Friday that it is looking to raised $86.25M in an IPO effort on the NASDAQ Global Market. The company is looking to trade as VTL. The company, which develops cell...

READ MORE...
Monday, October 14, 2013

Celladon Files For IPO

San Diego-based Celladon, a clinical stage biopharmaceuticals firm which is developing enzymes to address calcium regulation, has filed for an IPO. The company said it is looking to raise up to $86.25M in an offering on the NASDAQ Global Ma...

READ MORE...
Monday, October 14, 2013

Arrowhead Research Raises $60M In PIPE

Pasadena-based Arrowhead Research said this morning that it has raised $60M in a private offering, from RA Capital Management, LLC, plus its other existing institutional investors. The biopharmaceuticals firm, which is developing targeted R...

READ MORE...
Friday, October 11, 2013

Sorrento Therapeutics Buys Sherrington Pharmaceuticals

San Diego-based Sorrento Therapeutics said Thursday that it has acquired Sherrington Pharmaceuticals, a company developing chronic pain treatments for end-stage cancer patients and other severe pain indications. Financial terms of the buy w...

READ MORE...
Thursday, October 10, 2013

Sotera Wireless Gets FDA Clearance For Wireless Patient Monitoring

San Diego-based Sotera Wireless reports today that it has received FDA clearance for its continuous, patient blood pressure monitoring system. The venture backed startup said the U.S. Food and Drug Administration has cleared its ViSi Mobil...

READ MORE...
Thursday, October 10, 2013

KFx Medical Wins $29M In Patent Infringement Case

San Diego-based KFX Medical, the venture-backed developer of bone implant products, has scored a big win in a patent infringement case. The company said that it was awarded $29 million by a jury in the United States District Court for the S...

READ MORE...
Wednesday, October 9, 2013

Factual Enhances Healthcare Data

Los Angeles-based data startup Factual has just made a big update to the healthcare data in its giant database-in-the-sky, saying Tuesday that it has released a new set of Healthcare Providers data. Factual says it has added 830,000 new hea...

READ MORE...
Tuesday, October 8, 2013

PharmAkea Raises $45M For Small Molecule Drugs

San Diego-based biopharmaceuticals developer PharmAkea Therapeutics has raised $45M in funding for development of its small molecule drugs, aimed at trating cancer and fibrotic diseases. The funding included $35M from Celgene Corporation in...

READ MORE...
Friday, October 4, 2013

SOFIE BIO Gets $1.8M In SBIR

Culver City-based SOFIE BIOSCIENCES, a developer of imaging diagnostics products, reported earlier this week that it has received $1.8M in a Small Business Innovation Research (SBIR) grant. The company said the grant will go towards the dev...

READ MORE...
Friday, October 4, 2013

Evolus Acquired By Strathspey Crown

Santa Barbara-based Evolus, a company producing clinical neurotoxins, has been acquired by private equity investor Strathspey Crown. Financial details of the acquisition were not disclosed. Evolus had been partnered with Korean pharmaceutic...

READ MORE...
Thursday, October 3, 2013

Cynvenio Debuts New Cancer Diagnostics Product

Westlake Village-based Cynvenio, a developer of molecular analysis technology being used for cancer treatment and management, has launched a new product for cancer diagnostics. The company said it has launched the ClearID Breast Cancer moni...

READ MORE...
Wednesday, October 2, 2013

BioNano Genomics Finds $10M For Human Genome Analysis

San Diego-based BioNano Genomics announced this morning that it has raised $10M in a funding round, to commercialize its system for human genome analysis. The funding came from Batelle Ventures, Domain Associates, and Gund Investment Corpor...

READ MORE...
Tuesday, October 1, 2013

Fate Therapeutics Up In IPO

San Diego-bsaed Fate Therapeutics, which is developing biopharmaceuticals base don adult stem cells to treat a number of orphan diseases, is up slightly in trading after its initial public offering this morning. Fate Therapeutics priced at ...

READ MORE...
Tuesday, October 1, 2013

Amgen Completes Onyx Pharmaceuticals Tender Offer

Thousand Oaks-based Amgen reported this morning that it has completed its tender offer for Onyx Pharmaceuticals, and now expects its acquisition to complete today. Amgen said the deal is worth $9.7 billion net of estimated cash at Onyx. Amg...

READ MORE...
Monday, September 30, 2013

GenomeDX Gets New Funding

San Diego-based GenomeDX Biosciences said this morning that it has raised a Series B financing round, for the company's genomic tests for prostate cancer. The funding was led by Merck Global Health Innovation Fund (GHIF), and also included ...

READ MORE...
Wednesday, September 25, 2013

Evoke Pharma Raises $25M In IPO, But Sees Price Drop After Debut

San Diego-based Evoke Pharma, a biopharmaceuticals firm focused on gastrointestinal disease, raised $25M in an IPO this morning, but is trading down from its IPO debut. The company, which is now trading as EVOK on the Nasdaq Global Market, ...

READ MORE...
Wednesday, September 25, 2013

Amgen To Open R&D Center In Shanghai

Thousand Oaks-based biotech Amgen has linked with a university in Shanghai, China, to open up a new R&D center. According to Amgen, it has entered into a strategic partnership with ShanghaiTech University, to open up a research and developm...

READ MORE...
Tuesday, September 24, 2013

Sequenom Looks To Sell Off Genetic Analysis Business

San Diego-based life sciences products company Sequenom reported late Monday that it has engaged Jefferies LLC as a financial advisor, to review potential "strategic alternatives" for its Genetic Analysis business segment. Sequenom said it ...

READ MORE...
Monday, September 23, 2013

Indi Molecular Raises $1.5M For Antibody Startup

Culver City- and Seattle-based Indi Molecular, a startup developing a synthetic replacement for antibodies, has raised $1.5M in a seed funding round. The funding was led by InterWest Partners, and also included a number of un-named angel in...

READ MORE...
Monday, September 23, 2013

Domain, Versant Portfolio Firm Plans IPO

Veracyte, a portfolio firm of two, Southern California venture capital investors--Domain Associates and Versant Ventures--has filed for an IPO, saying that it is looking to raised up to $74.7M in an IPO on the NASDAQ Global Market. Versant ...

READ MORE...
Thursday, September 19, 2013

Amgen, Onyx Pharmaceuticals Get Approval On Acquisition

Thousand Oaks-based Amgen and Onyx Pharmaceuticals said late Wednesday that the two have received early termination of the Hart-Scott-Rodino Antitrust waiting period for Amgen's acquisition of Onyx. Amgen announced on August 24th that it wi...

READ MORE...
Tuesday, September 17, 2013

Ocera Cuts Site, Jobs In Quebec

San Diego-based biopharmaceuticals developer Ocera Therapeutics said today that it has closed its operations site in Sherbrooke, Quebec, as part of a restructuring. The closure means the loss of 17 employees in that location. The location w...

READ MORE...
Wednesday, September 4, 2013

Triton Algae Innovations Snags $5M

San Diego-based Triton Algae Innovations, a new startup whose founders include the co-founders of Sapphire Energy, Dr. Steve Mayfield and Dr. Jason Pyle, is announcing today that it has raised $5M in a Series A funding round. The funding ca...

READ MORE...
Wednesday, September 4, 2013

Otonomy Lands $45.9M

San Diego-based biopharmaceuticals firm Otonomy announced this morning that it has raised $45.9M in a Series C, equity funding. According to the company, the funding was led by OrbiMed Advisors, and also included Aperture Venture Partners, ...

READ MORE...
Wednesday, September 4, 2013

IIllumina Wins Genetic Testing Company

San Diego-based life sciences equipment provier Illumina said this morning that it has entered into an agreement with Natera, a provider of genetic testing services, to supply sequencing instruments and consumables. Financial details of the...

READ MORE...
Tuesday, September 3, 2013

Fate Therapeutics Sets IPO Range

San Diego-based Fate Therapeutics, which develops stem cell technology, said today in a regulatory filing that it is looking to sell 4,000,000 shares of its common stock at between $14.00 and $16.00 per share. The firm said it hopes to trad...

READ MORE...
Tuesday, September 3, 2013

Sonendo Gets FDA Clearance

Laguna Hills-based ultrasonic cleaning device developer Sonendo announced this morning that it has received clearance from the FDA, for use of its products in root canal therapy. Sonendo, which is venture backed by OrbiMed Advisors LLC, The...

READ MORE...
Tuesday, September 3, 2013

Teledyne Completes CETAC Technologies Buy

Thousand Oaks-based Teledyne Technologies said late Friday that it has completed its acquisition of CETAC Technologies, a developer of sample handling and sample introduction equipment for laboratory instrumentation. Financial terms of the ...

READ MORE...
Friday, August 30, 2013

Accumetrics Acquired By ITC

San Diego-based Accumetrics, a developer of life sciences testing equipment, has been acquired by ITC Nexus Holding Company, ITC said this morning. Financial terms of the buy were not announced. Accumetrics develops equipment to assess pati...

READ MORE...
Friday, August 30, 2013

Solulink Names New Board Member

San Diego-based Solulink, a developer of life sciences tools, has named a new board member, the company said this week. According to Solulink, it has added John L. "Kip" Miller to its board. Miller was most recently President of Genetic Sys...

READ MORE...
Wednesday, August 28, 2013

Imprimis Pharmaceuticals In Intellectual Property Deal

San Diego-based biopharmaceuticals developer Imprimis Pharmaceuticals announced this morning that it has acquired intellectual property from Novel Drug Solutions and Eye Care Northwest. Imprimis said the IP includes a provisional patent app...

READ MORE...
Tuesday, August 27, 2013

Ceregene Acquired By Sangamo BioSciences

San Diego-based Ceregene, a startup developing gene-therapy based products for treating Parkinson's and Alzheimer's disease, has been acquired by Richmond, California-based Sangamo BioSciences. Sangamo said it will issue 100,000 shares of i...

READ MORE...
Friday, August 23, 2013

XIFIN Buys PathCentral

San Diego-based XIFIN, which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral, a developer of software for the pathology community, the company announced Thursday afternoon. Financia...

READ MORE...
Friday, August 23, 2013

Applied Proteomics Gets $28M For Molecular Diagnostics Tools

San Diego-based Applied Proteomics, which develops molecular diagnostics technology, said earlier this week that it has raised $28.0M in a Series C funding round. The company said the financing was led by Genting Berhad, and also included D...

READ MORE...
Friday, August 23, 2013

TigerText Claims Record Growth In First Half

Santa Monica-based TigerText, the developer of the enterprise, secure messaging apps, claims it had "record growth" in the first half of the year. The company did not disclose any financials, but said it quadrupled the number of paid users ...

READ MORE...
Friday, August 23, 2013

Vantage Oncology Buys Radiation Oncology Services of America

Manhattan Beach-based Vantage Oncology, which operates a network of radiation oncology centers, said this morning that it has acquired Radiation Oncology Services of America (ROSA). Financial terms of the deal were not announced. Vantage On...

READ MORE...
Tuesday, August 20, 2013

Acutus Medical Closes Out Series B At $28M

San Diego-based minimally invasive, cardiac catheter developer Acutus Medical reported Tuesday that it has closed out its Series B funding at $28M. According to the company, the round was led by OrbiMed Advisors and GE Ventures, and also in...

READ MORE...
Tuesday, August 20, 2013

Ivantis Adds $5M In Series B Funding

Irvine-based Ivantis, a developer of medical devices used to treat glaucoma, has raised $5M more in its Series B funding, the company said this morning. The company said the second close on its funding was led by EDBI of Singapore, and brin...

READ MORE...
Tuesday, August 20, 2013

Teledyne Technologies Acquires CETAC

Thousand Oaks-based Teledyne Technologies has acquired laboratory automation and instrument developer CETAC Technologies, the company annoucned this morning. Financial details of the buy were not announced. CETA, which was headquartered in ...

READ MORE...
Tuesday, August 20, 2013

DermTech Adds $5.6M For Skin Cancer Detection

San Diego-based DermTech, a biotechnology company which is developing technology for detecting skin cancer, has raised $5.6M in a Series B funding. The funding was led by Jacobs Investment COmpany, and also included other, un-named investor...

READ MORE...
Friday, August 16, 2013

Pathway Genomics Names New Executive

San Diego-based Pathway Genomics announced Thursday that it has appointed Karl Odquist as Executive Director of Managed Care. The company, which provides genetic testing services, said Odquist will head up managed care contracting, reimburs...

READ MORE...
Thursday, August 15, 2013

BioIQ Targets New Health Regulations

Santa Barbara-based BioIQ, which develops technology for corporate health and wellness programs, said yesterday that it is helping employers to comply with regulations that are part of the Patient Protection and Affordable Care Act (ACA). T...

READ MORE...
Wednesday, August 14, 2013

TrueVision Systems Gets Debt Funding

Goleta-based TrueVision Systems has raised a debt funding round, according to funder Agility Capital. Size and terms of the senior secured growth capital loan were not announced. TrueVision develops 3D visualization and guidance systems for...

READ MORE...
Tuesday, August 13, 2013

Amgen Gets Clearance On Product Collaboration

Thousand Oaks-based biotech giant Amgen said late Monday that it has received clearance on a product collaboration with Servier. According to Amgen, it received an early termination of the waiting period under the Hart–Scott–Rodino Antitrus...

READ MORE...
Thursday, August 8, 2013

SetPoint Medical Raises $27.0M

Valencia-based SetPoint Medical, a developer of biomedical products for treating inflammatory disease, announced today that it has raised $27M in a financing round. The new funding came from Covidien Ventures, Action Potential Venture Capit...

READ MORE...
Tuesday, August 6, 2013

Freedom Meditech Raises $7M For Diabetes Monitoring

San Diego-based Freedom-Meditech, which is developing a medical device which measures blood sugar by monitoring a user's eyes, has raised $7M in a Series B funding round. The company said the funding comes from both new and returning invest...

READ MORE...
Friday, August 2, 2013

Life Technologies Opens Lab In India

Carlsbad-based biotechnology provider Life Technologies said Thursday that it has opened up a new lab in India. According to the company, it has opened up a new, DNA forensics laboratory in Gurgaon, India, to provide high-throughput DNA pro...

READ MORE...
Thursday, August 1, 2013

Cytori Divests Product Line

San Diego-based biopharmaceuticals firm Cytori Therapeutics said yesterday that it is in a deal to divest pieces of the company, with Bimini Technologies and two affiliates, Puregraft Technologies and Kerastem Technologies. Cytori said it h...

READ MORE...
Wednesday, July 31, 2013

Trius Therapeutics Acquired By Cubist Pharmaceuticals

San Diego-based Trius Therapeutics is in a deal to be acquired for approximately $707M by Cubist Pharmaceuticals, a fellow biopharmaceuticals firm, the companies said Tuesday. According to the two, Cubist will acquired Trius for $13.50 per ...

READ MORE...
Wednesday, July 31, 2013

Trovagene Raises $15M In PIPE

San Diego-based molecular diagnostics developer Trovagene announced this morning that it has raised $15M in a registered direct offering of its common stock. The publicly held company, which trades on the NASDAQ as TROV, said the shares wer...

READ MORE...
Monday, July 29, 2013

ReVision Optics Gets $55M For Vision Treatments

Lake Forest-based Revision Optics announced this morning that it has raised $55M in a new equity funding, for the company's implantable corneal inlay treatment for presbyopia. The company said the funding included Canaan Partners, ProQuest ...

READ MORE...
Monday, July 29, 2013

aTyr Pharma Gets $10M In Venture Debt

San Diego-based aTyr Pharma, a developer of protein-based therapeutics, said today that it has raised $10M in a debt financing round. The funding came from Silicon Valley Bank. According to the company, the new funding will go towards clini...

READ MORE...
Friday, July 26, 2013

Meditope Biosciences Gets $3.6M For Cancer Treatments

Los Angeles-based Meditope Biosciences announced this morning that it has raised $3.6M in a Series A financing, to accelerate development of its antibody-based cancer products. The startup said the investment came from angel investors. Medi...

READ MORE...
Thursday, July 25, 2013

Kareo Buys Medical Billing Company

Irvine-based Kareo, which develops cloud-based software for medical office practice management, has acquired a provider of medical billing services. According to Kareo, it acquired ECCO Health, which it says has been providing medical billi...

READ MORE...
Wednesday, July 24, 2013

Illumina Buys Liquid Logic

San Diego-based biotech equipment provider Illumina has acquired Advanced Liquid Logic, a provider of liquid handling solutions, the firm said yesterday. Financial terms of the buy were not disclosed. Advanced Liquid Logic (ALL) develops mi...

READ MORE...
Monday, July 22, 2013

Illumina Wins Testing Lab

San Diego-based life sciences equipment provider Illumina reports this morning that it has bene selected by HistoGenics, a provider of high resolution, sequence-based human leukocyte antigen (HLA) testing services. According to Illumina, Hi...

READ MORE...
Thursday, July 18, 2013

Lithera Brings New Funding To $27.3M

San Diego-based pharmaceuticals firm Lithera announced this morning that it has had a second close on a $27.3M, Series C funding round. According to the company, the second close adds $6.7M to the round. The funding came from RusnanoMedInve...

READ MORE...
Monday, July 15, 2013

Abbott Medical Optics Acquires Optimedica

Santa Ana-based Abbott Medical Optics, which developer intraocular lenses and other products for ocular surgery, plus refractive and eye care products, has acquired a Silicon Valley developer of opthalmic surgery devices. Abbott said that A...

READ MORE...
Wednesday, July 10, 2013

ViaCyte Snags $10.6M For Diabetes Treatments

San Diego-based ViaCyte, a developer of stem-cell based treaments for diabetes, has raised $10.6M. According to ViaCyte, the Series C-1 funding round came from existing investors Johnson & Johnson Development Corporation, Sanderling Venture...

READ MORE...
Tuesday, July 9, 2013

Organovo Moving To NYSE

San Diego-based biotechnology developer Organovo Holdings, which is developing 3D, bioprinting technology, said today that it is moving from the OTC markets to the New York Stock Exchange. Organovo said it will move trading of its stock, un...

READ MORE...
Tuesday, July 2, 2013

Xencor In Licensing Deal With Merck

Monrovia-based Xencor announced today that it is in a technology license and option agreement with biotech giant Merck. Xencor said that the deal provides Merck with access to one of its patents for therapeutic monoclonal antibodies. Xencor...

READ MORE...
Monday, July 1, 2013

MannKind Gets $160M In Debt Funding

Valancia-based MannKind, which provides discovery, development, and commercialization of therapeutics products, said Monday that it has received $160M in a debt financing round. The publicly traded firm said the funding came from affiliates...

READ MORE...
Monday, July 1, 2013

Incubating LA's Biotech Future, With Richard Koffler, Greenwings Biomedical

A couple of weeks ago, a brand new, startup incubator launched in town--with a slightly different focus, on biomedical technology. The incubator--Greenwings Biomedical (www.greenwingsbiomedical.com), is led by Richard Koffler, a serial en...

READ MORE...
Monday, July 1, 2013

Cytori Gets $27M In Loan

San Diego-based Cytori Therapeutics announced this morning that it has entered into a $27M, term loan, from Oxford Finance Corporation and Silicon Valley Bank. The biotechnology developer, which is developing treatments for cardiovascular d...

READ MORE...
Tuesday, June 25, 2013

Acutus Medical Gets $21M For 3D Medical Imaging

San Diego-based Acutus Medical, a developer of medical devices used for 3D, cardiac chamber imaging, has raised $21M as part of a Series B financing, the firm announced this morning. The firm said the funding was led by OrbiMed, and also in...

READ MORE...
Monday, June 24, 2013

Sonendo Finds $18M For Dental Technology

Laguna Hills-based Sonendo said Monday that it has raised $18M in a funding round, the second tranche of an equity financing announced last year. The firm, which develops technology used in root canal therapy, said the funding was led by Or...

READ MORE...
Monday, June 24, 2013

SOA Software Targets Life Sciences Industry

Los Angeles-based SOA Software, which provides application middleware used to manage enterprise services and APIs, reported today that it has started delivering products for use in the life sciences and biopharma industry. The firm said tha...

READ MORE...
Friday, June 21, 2013

Aviir Finds $10M In Financing For Heart Risk Testing

Irvine-based Aviir has raised $10M more as part of a financing round, as part of a third tranche of funding. The firm develops heart risk testing technology, to help prevent cardiovascular disease. The firm said the funding came from Partne...

READ MORE...
Thursday, June 20, 2013

Banyan Biomarkers Gets $6M For Detecting Traumatic Brain Injury

Carlsbad, California- and Alachua, Florida-based Banyan Biomarkers has raised $6M in a Series A funding, to go towards development of a diagnostic test for traumatic brain injury (TBI). Source of the funding was not disclosed. Banyan Biomar...

READ MORE...
Wednesday, June 19, 2013

Vertos Medical Gets $23M for Spinal Treatments

Aliso Viejo-based Vertos Medical said today that it has raised $23M in a Series E financing round, to fund the company's expansion in the U.S. and launch in European markets. The firm, which develops a outpatient procedure for helping lumar...

READ MORE...
Monday, June 17, 2013

PathCentral Adds Penn Medicine

Irvine-based PathCentral said today that it has added Penn Medicine to its online information exchange and consultation forums. PathCentral said that Penn will participate in its PathCentral Pathology Network, which lets physicians upload c...

READ MORE...
Monday, June 17, 2013

Imprimis Pharmaceuticals Licenses IP

San Diego-based Imprimis Pharmaceuticals said this morning that it has licensed a set of intellectual property assets, from Buderer Drug Company. Financial details of the licensing deal were not announced. Imprimis said it is developing inn...

READ MORE...
Friday, June 14, 2013

Greenwings Biomedical Launches Incubator

A new, Los Angeles startup incubator, Greenwings Biomedical, announced its launch Friday, saying that it will be the first incubator of biomedical ventures in Los Angeles. The new startup, headed by startup veteran Richard Koffler, said it ...

READ MORE...
Friday, June 14, 2013

ClearLight Partners Sells Portfolio Firm

Newport Beach-based private equity firm ClearLight Partners said earlier this week that it has agreed to sell The Outsource Group, one of its portfolio companies, to Parallon Business Solutions, a subsidiary of HCA Holdings. Financial terms...

READ MORE...
Friday, June 14, 2013

Conatus Pharmaceuticals Files For IPO

San Diego-based Conatus Pharmaceuticals, which is developing treatments for liver disease, has filed for an IPO, saying this morning that it is looking to raised $69.0M on the public markets. The firm said plans to trade on the NASDAQ Globa...

READ MORE...
Thursday, June 13, 2013

Life Technologies Buys Korean Firm

Carlsbad-based life sciences equipment maker Life Technologies announced this morning that it has acquired Life Science Korea (LSK), a distributor of instruments based in Seoil, South Korea. Financial terms of the buy were not disclosed. Li...

READ MORE...
Wednesday, June 12, 2013

Colorescience Lands $10M For Cosmetics

Carlsbad-based Colorescience, the aesthetic medicines business spun out of SkinMedica when that company was acquired by Allergan, has raised $10M in a Series A funding round today. The company said the funding came from its existing investo...

READ MORE...
Monday, June 10, 2013

How RxVantage's IT Software Aims To Automate A $20B Market

Pharmaceutical companies spent $20 billion a year marketing their products to medical offices. However, the whole business of those companies working with medical offices is one sorely in need of technology. RxVantage (www.rxvantage.com),...

READ MORE...
Thursday, June 6, 2013

RxVantage Buys RepAccess

Los Angeles-based software-as-service provider RxVantage, which develops software to help manage the relationship between medical offices and pharmaceutical and medical sales representatives, has acquired RepAccess, one of its competitors. ...

READ MORE...
Thursday, June 6, 2013

Zogenix Chops Staff

San Diego-based pharmaceutical firm Zogenix has made some big cuts, the firm said yesterday, after the FDA delayed approval for the company's lead product. Zogenix, which is commercializing products for treating central nervous system disor...

READ MORE...
Monday, June 3, 2013

Arcturus Therapeutics Gets $1.3M

San Diego-based Arcturus Therapeutics, which is developing RNAi therapeutics to treat disease, said this morning that it has raised $1.3M in a seed fudning round. The company said the round came from multiple, high net-worth private investo...

READ MORE...
Wednesday, May 29, 2013

SnapMD Adds Green Dot Investor To Advisory Board

Los Angeles-based telemedicine startup SnapMD, which is looking to allow doctors and other healthcare providers to help patients via the web, has tapped a local investor for its advisory board. SnapMD said that Brian C. Smith was a founding...

READ MORE...
Wednesday, May 29, 2013

Amgen Ties With Astellas To Tackle Japan

Thousand Oaks-based biotech Amgen announced today that it has linked with Astellas Pharma, in a deal to reach the Japanese market with new medicines. According to the two, they are in a strategic alliance where they will provide new medicin...

READ MORE...
Tuesday, May 21, 2013

Ignyta Buys Actagene Oncology

San Diego-based biotechnology developer Ignyta has acquired fellow, San Diego biotechnology developer Actagene, a developer of personalized medicines based on cancer genome mining and sequencing. Financial details of the acquisition were no...

READ MORE...
Monday, May 20, 2013

eFFECTOR Therapeutics Gets $45M For Cancer Treatments

San Diego-based eFFECTOR Therapeutics said today that it has raised $45M to go towards the development and invention of small molecule drugs, specifically aimed at treating cancer. According to the firm, the Series A investment included U.S...

READ MORE...
Friday, May 17, 2013

TigerText Links With Mobile Device Security Firm

Santa Monica-based healthcare messaging provider TigerText has linked up with a provider of mobile security, AirWatch, the firms said this week. According to the companies, the move will allow healthcare customers to secure both their mobil...

READ MORE...
Thursday, May 16, 2013

SnapMD Looks To Connect Health Care Providers, Patients Via Tablet, Smartphone

What's the best way to connect physicians with their patients? A new, Glendale-based startup, SnapMD, is hoping to do that through a smart phone, tablet, or your home PC, via a new service. The firm has just raised $175,000 in a seed fundin...

READ MORE...
Thursday, May 16, 2013

Active Life Scientific Snags $500K

Santa Barbara-based Active Life Scientific, a developer of life sciences research and diagnostics tools, said this morning that it has raised $500K in a Series A follow on investment. The funding came from members of the Tech Coast Angels. ...

READ MORE...
Thursday, May 16, 2013

Ambit Biosciences Prices IPO

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 per share. The company will start trading today on the NASDAQ Global Market as AMBI. Ambit priced well below i...

READ MORE...
Thursday, May 16, 2013

Ambit Biosciences Prices IPO

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 per share. The company will start trading today on the NASDAQ Global Market as AMBI. Ambit priced well below i...

READ MORE...
Wednesday, May 15, 2013

Kite Pharma Raises $35M

Los Angeles-based Kite Pharma, a biotechnology company developing immunotherapies for cancer, said today that it has raised $35M in its Series A funding round. The firm said that the funding came from Alta Partners, David Bonderman, Pontifa...

READ MORE...
Friday, May 10, 2013

Amgen In Chinese Joint Venture

Thousand Oaks-based biotech giant Amgen said Thursday that it is in a joint venture with Chinese company Zhejiang Beta Pharma, to commercialize the firm's Vectibix (panitumumab) product in the Chinese market. Financial arrangements of the j...

READ MORE...
Friday, May 10, 2013

Isis Pharmaceuticals Gets $3.5M From Biogen Idec

Carlsbad-based biopharmaceuticals developer Isis Pharmaceuticals reported Thursday that it has received $3.5M in a milestone payment, from Biogen Idec. The company said the payment was received as part of a Phase 2 study milestone of a trea...

READ MORE...
Thursday, May 9, 2013

Receptos Flat In IPO

San Diego-based biopharmaceuticals developer Receptos is trading flat after its initial public offering, after pricing last night at $14.00 per share. The developer of biopharmaceuticals for treating immune and metabolic diseases priced at ...

READ MORE...
Wednesday, May 8, 2013

Lumena Pharmaceuticals Gets $23M

San Diego-based Lumena Pharmaceuticals announce today that it has raised $23M in a Series A funding round, to go towards developing oral therapeutics for rare liver diseases. The funding came from Pappas Ventures, RiverVest Venture Partners...

READ MORE...
Monday, May 6, 2013

InstaMed Gets More Funding

Newport Beach- and Philadelphia-based InstaMed, which operates an online electronic payment clearinghouse for the healthcare industry, said today that it has raised an internal round of funding. Size of the round was not announced. The firm...

READ MORE...
Monday, May 6, 2013

Arrowhead Gets $36M In PIPE

Publicly held biotherapeutics developer Arrowhead Research said this morning that it has raised $36M in a private offering. The Pasadena-based company said the new financing was led by RA Capital, and included new investors Camber Capital, ...

READ MORE...
Thursday, May 2, 2013

Ambit Biosciences Sets Estimated IPO Range

San Diego-based Ambit Biosciences has set the estimated range for its IPO, saying in a filing today that it is expecting to offer 4,645,000 shares of its stock at between $13.00 and $15.00 per share. The firm has applied to list on the NASD...

READ MORE...
Tuesday, April 30, 2013

Ligand Buys Rights To Programs From Selexis

San Diego-based biopharmaceuticals firm Ligand said today that it has acquired a portfolio of potential future milestone and royalty payments for more than 15 biologic development programs from Selexis SA. Financial details of the buy were ...

READ MORE...
Monday, April 29, 2013

PathCentral Lands Johns Hopkins

Irvine-based PathCentral, which operates an online community for pathologists, said today that the Johns Hopkins University School of Medicine has joined its online information exchange and consultation forum. Financial impact of the win wa...

READ MORE...
Thursday, April 25, 2013

Receptos Sets Estimated IPO Pricing Range

San Diego-based biopharmaceuticals developer Receptos has set the initial, estimated pricing range for its IPO, saying in a filing Thursday that it now expects its IPO pricing to be between $14.00 and $16.00 a share. THe firm, which has app...

READ MORE...
Thursday, April 25, 2013

Topera Takes $25M More For Medical 3D Analysis System

In a bid to help bring its products to market, San Diego-based Topera Medical said Thursday that it has raised $25M in a Series C financing, which will go towards its 3D analysis and mapping system for treating atrial fibrillation. The new ...

READ MORE...
Tuesday, April 23, 2013

Illumina Hires New General Counsel

San Diego-based life sciences equipment firm Illumina said Monday that it has appointed Charles Dadswell as its new Senior Vice President and General Counsel. Dadswell was most recently VP, GEnreal COunsel for North and Latin America, and C...

READ MORE...
Monday, April 22, 2013

Seechangehealth Gets $15.0M For Healthcare Plans and Technology

Studio City-based Seechangehealth has raised a $15.0M funding round, from Psilos Group and Maverick Capital for its health plans and technology geared around preventative care. The Series C investment was actually disclosed in January, but ...

READ MORE...
Wednesday, April 17, 2013

Xencor Licenses Technology To Australian Firm

Monrovia, California-based biotherapeutics technology developer Xencor said Tuesday that it has licensed its Xtend technology to an Australian firm. Xencor and CSL Limited said they are in a technology license agreement, which will provide ...

READ MORE...
Monday, April 15, 2013

Ambit Biosciences Names Venture Partner To Board

San Diego-based biopharmaceuticals firm Ambit Biosciences announced this morning that it has tapped a venture partner from New Enterprise Associates for a new board member. Ambit said it has named David R. Parkinson, M.D. to its board of di...

READ MORE...
Friday, April 5, 2013

Receptos Files For IPO

San Diego-based biopharmaceuticals firm Receptos has filed for an IPO, saying in a filing that it is looking to raise up to $86.3M in an offering on the NASDAQ Global Market. The firm said it intends to list as "RCPT". The firm's IPO is bei...

READ MORE...
Wednesday, April 3, 2013

Obagi, Valeant Raise Price As Bidding War Breaks Out

Long Beach-based aesthetic medicine developer Obagi Medical Products, and would-be acquirer Valeant Pharmaceuticals, which is based in Aliso Viejo, said this morning that Valeant has raised its offer to acquire Obagi to $24.00 per share in ...

READ MORE...
Tuesday, April 2, 2013

Algenetix Scores $2M For Renewable Fuels Technology

San Diego-based Algenetix, a startup, industrial biotechnology firm, announced this morning that it has raised $2.0M in a Series A-1 funding. The firm said it is developing technology which improves the oil productivity in microbes, for the...

READ MORE...
Friday, March 15, 2013

Illumina Ordered To Pay $96M In Patent Suit

San Diego-based life sciences equipment maker Illumina has been ordered to pay $96M to Syntrix Biosystems, in a patent litigation suite, the company said Thursday. Illumina said a federal jury in Tacoma, Washington found that its BeadChip a...

READ MORE...
Wednesday, March 13, 2013

KYTHERA Names Chief Medical Officer

Los Angeles-based aesthetic medicine developer KYTHERA Biopharmaceuticals announced today that it has named Frederick Beddingfield, III, as its Chief Medical Officer. Dr. Beddingfield is a dermatologist, who was most recently at Allergan, w...

READ MORE...
Tuesday, March 12, 2013

Avanir Pharmaceuticals Adds Director

Aliso Viejo-based Avanir Pharmaceuticals, which is developing treatments for central nervous system disorders, said today that it has added Ms. Corinne Nevinny to its board of directors. Nevinny is General Partner at venture capital firm LM...

READ MORE...
Monday, March 11, 2013

ADVENTRX Becomes Mast Therapeutics

San Diego-based ADVENTRX Pharmaceuticals announced this morning that it has renamed itself Mast Therapeutics. The firm also said it has swapped its ticker symbol to MSTX on the NYSE market. The firm, which is developing treatments for sickl...

READ MORE...
Thursday, March 7, 2013

Sorrento Therapeutics To Buy IGDRASOL

San Diego-based biopharmaceuticals developer Sorrento Therapeutics announced today that it has signed an exclusive option to acquired Fountain Valley-based IGDRASOL, a company developing oncologic agents for treating metastatic breast cance...

READ MORE...
Wednesday, March 6, 2013

Althea Technologies Acquired By Japanese Company

San Diego-based pharmaceuticals contract manufacturer Althea Technologies said today that it has been acquired by Japanese company Ajinomoto Co.. Financial terms of the buy were not disclosed. Althea Technologies provides biopharmaceutical ...

READ MORE...
Tuesday, March 5, 2013

Carolus Therapeutics Gets $2.25M In Debt Funding

San Diego-based Carolus Therapeutics, a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the n...

READ MORE...
Monday, March 4, 2013

Amgen's Kevin Sharer Joins Healthcare Venture Capital Firm

Is Amgen the next source of the healthcare industry's venture capital deals? It might be, on news that Kevin Sharer, the former CEO of Thousand Oaks-based Amgen, has joined venture capital investment firm Foundation Medical Partners. Accor...

READ MORE...
Monday, March 4, 2013

The Gores Group Buys GE Healthcare Strategic Sourcing

Los Angeles-based private equity investor The Gores Group announced this morning that it has completed the acquisition of GE Healthcare STrategic Sourcing, from GE Healthcare. Financial terms of the buy were not disclosed. GE Healthcare Str...

READ MORE...
Monday, March 4, 2013

Qualcomm Life Ties With WebMD

San Diego-based Qualcomm said this morning that its subsidiary, Qualcomm Life, has joined with health information site WebMD. According to the companies, the two have linked to enable consumers to access and manage their wireless health dat...

READ MORE...
Thursday, February 28, 2013

Ignyta Raises $1M In Venture Debt

San Diego-based personalized medicine developer Ignyta has raised $1M in funding, via a capital term loan from Silicon Valley Bank, the company disclosed this morning. The firm--which is focusing on treating rheumatoid arthritis (RA), lupus...

READ MORE...
Friday, February 22, 2013

Sanguine BioSciences Finds Seed Funding

Valencia-based Sanguine Biosciences, a startup developing a service around blood sample collection for research and development, said Thursday that it has closed on a seed financing round. Size of the round was not announced. The funding wa...

READ MORE...
Wednesday, February 20, 2013

Ambit Biosciences Files For IPO

San Diego-based Ambit Biosciences has filed for an IPO, saying in an S-1 with the SEC that it is looking to raised $57.5M in a funding round. The firm said it intends to list as AMBI on the Nasdaq Global Market. The IPO is being underwrit...

READ MORE...
Wednesday, February 20, 2013

Hycor Biomedical Sells Unit To Private Equity Firms

Garden Grove-based Hybor Biomedical, which manufactures and markets in vitro diagnostic products for the autoimmune and allergy market, has sold its urinalysis business to an affiliate of One Rock Capital Partners, Laurel Crown Partners, an...

READ MORE...
Wednesday, February 20, 2013

Masimo Wins U.Va.

Irvine-based health monitoring products developer Masimo announced a win at the University of Virginia Medical Center, the firm announced this morning. Masimo said that the center is using its Hemoglobin (SpHb) and Acoustic Respiration Rate...

READ MORE...
Tuesday, February 19, 2013

Aviir In Middle Eastern Distribution Deal

Irvine-based Aviir, a life sciences startup developing laboratory tests for cardiovascular disease, said today that it has signed a distribution and expansion pact covering 19 Middle Eastern and North African countries. Aviir said it has in...

READ MORE...
Friday, February 15, 2013

BAROnova Gets $27.3M For Weight Loss Device

Goleta-based medical device developer BAROnova announced this morning that it has raised a big, $27.3M funding round to fund clinical trails for its weight loss device. The firm said the Series C funding was led by Sante Ventures and Boston...

READ MORE...
Friday, February 15, 2013

Ixia Extends Wi-Fi Testing Product

Calabasas-based network testing equipment and software firm Ixia announced this week that it has launched a new effort with its Wi-Fi testing product, specifically aimed at the health care market. The firm said it has expand its Wi-Fi testi...

READ MORE...
Friday, February 15, 2013

PURE Bioscience Expands Board

San Diego-based PURE Bioscience, which develops antimicrobial products, said earlier this week that it has named Dave Pfanzelter to its board of directors. Pfanzelter was previously a Senior Vice President at Kellogg Company, and also serve...

READ MORE...
Friday, February 15, 2013

Receptos Names CFO

San Diego-based Receptos, a developer of treatments for immune and metabolic disease, said this week that it has named Graham Cooper as its Chief Financial Officer. Cooper has previously served as CFO of Geron Corporation and Orexigen Thera...

READ MORE...
Thursday, February 14, 2013

Elcelyx Therapeutics Gets $20M

San Diego-based Elcelyx Therapeutics, a developer of treatments for weight management and obesity-related disorders, said this morning that it has raised $20M in a Series C funding round. The financing was led by GSM Fund LLC, and also incl...

READ MORE...
Tuesday, February 12, 2013

Aviir Snags $10M In Second Tranche Financing

Irvine-based Aviir, a developer of cardiovascular disease testing technology, said today that it has raised $10M in a second financing tranche, after meeting a revenue milestone. According to Aviir, the round was led by Merck Global Health ...

READ MORE...
Friday, February 8, 2013

Glaukos Gets $30M For Glaucoma Treatments

Laguna Hills-based Glaukos, which is developing a medical device for treating glaucoma, said this week that it has raised $30M in a funding round. The Series F funding was led by Meritech Capital Partners, and also included Versant Ventures...

READ MORE...
Thursday, February 7, 2013

Health Data Vision Lands $2.8M For Medical Records Software

Health Data Vision, a new startup based in Burbank, said this week that it has raised a Series A funding round, to go towards its software-as-a-service platform for medical records analysis. Size of the funding was not announced, however,...

READ MORE...
Wednesday, February 6, 2013

Sotera Wireless Finds $14.8M For Wireless Medical Monitoring

Sotera Wireless, the developer of medical devices for wirelessly monitoring patients, has raised $14.8M in a funding round, the firm said this morning. The funding round came from Safeguard Scientifics, and also included Delphi Ventures, Sa...

READ MORE...
Thursday, January 31, 2013

Ivantis Gets $27M For Glaucoma Treatments

Ivantis, an Irvine-based developer of treatments for glaucoma, said today that it has raised $27.0M in a Series B funding round. According to Ivantis, the round was led by Ascension Health Ventures, and also included prior investors New Ent...

READ MORE...
Wednesday, January 23, 2013

DRX Acquired By Connecture

DRX, a provider of web-based shopping and enrollment software for Medicare health plans, which was based in Los Angeles, has been acquired by Wisconsin-based Connecture, the companies said today. Connecture develops sales automation technol...

READ MORE...
Wednesday, January 23, 2013

Allergan Buys MAP Pharmaceuticals

Irvine-based Allergan and MAP Pharmaceuticals said this morning that Allergan has agreed to acquire MAP Pharmaceuticals, in a deal worth approximately $958M. Allergan said it will pay $25.00 per share for publicly held MAP Pharmaceuticals. ...

READ MORE...
Tuesday, January 22, 2013

Life Technologies Buys BAC BV

Carlsbad-based scientific instruments manufacturer Life Technologies said this morning that it has acquired BAC BV, a Netherlands-based firm focused on the discovery, development and manufacture of protein purification products. Financial t...

READ MORE...
Friday, January 18, 2013

Life Technologies Hires Investment Bankers, Looks For Buyer

Carlsbad-based Life Technologies said this morning that it has hired two investment banking firms, Deutsche Bank Securities Inc. and Moelis & Company LLC, to assist it in what it called an "annual strategic review". However, according to a ...

READ MORE...
Thursday, January 17, 2013

Amgen To Invest $200M In Singapore Facility

Thousand Oaks-based biotech giant Amgen said this week that it is planning to build a new manufacturing facility in Singapore, and will invest approximately $200M in the new plant. Amgen said the new facility will be located in the Tuas Bio...

READ MORE...
Monday, January 14, 2013

NantHealth Raises $6.1M

NantHealth, the advanced, next-generation healthcare services startup which is part of NantWorks, the startup incubation effort of billionaire Dr. Patrick Soon-Shiong, has raised $6.1M in a funding round, according to a regulatory filing by...

READ MORE...
Monday, January 14, 2013

Pelican Products Buys Minnesota Thermal Science

Torrance-based Pelican Products, the manufacturer of protective cases, flashlights and portable lighting systems, and other products, has acquired Minnesota Thermal Science (MTS), a developer of temperature controlled packaging solutions. F...

READ MORE...
Thursday, January 10, 2013

Independa Rolls Out On Samsung Galaxy Tablets

San Diego-based Independa, the developer of software tools to help seniors live longer on their own, said Wednesday that it has rolled out its Independa Angela social engagement product on the Samsung Mobile Galaxy Tab 2. The firm, which is...

READ MORE...
Tuesday, January 8, 2013

Ceres Claims Milestone

Thousand Oaks-based biotech seed developer Ceres said today that it has hit a milestone in its field evaluations, showing that its technology has been demonstrated to provide double-digit percentage increases in yield under drought conditio...

READ MORE...
Monday, January 7, 2013

Biotech Startup Licenses Technology From UCSD, Raises $18M

A new, biotech startup focused on delivery of nucleic acid therapeutics, Solstice Biologics, said last week that it has licensed technology developed at UC San Diego, and received $18M in a Series A funding. Solstice, which is based in San ...

READ MORE...
Monday, January 7, 2013

PatientSafe Solutions Lands $20M

San Diego-based PatientSafe Solutions, a developer of mobile platforms used for running healthcare operations and accessing patient data, said today that it has raised $20M in a Series C funding round. The round was led by Merck Global Heal...

READ MORE...
Monday, January 7, 2013

Illumina Buys Verinata Health

San Diego-based life sciences equipment firm Illumina said over the weekend that it is in an agreement to acquire Verinata Health, a provider of non-invasive testing for fetal chromosomal abnormalities. Illumnina said it would pay $350M plu...

READ MORE...
Monday, January 7, 2013

Ambryx Names New CEO

San Diego-based Ambrx, a biopharmaceuticals company developing antibodies and proteins, including a Phase 2b growth hormone compound, said today that it has named Lawson Macartney as President and CEO of the company. Macartney also joins th...

READ MORE...
Friday, January 4, 2013

ADVENTRX Sets New CFO

San Diego-based ADVENTRX Pharmaceuticals announced this morning that it has named Brandi L. Roberts as its Chief Financial Officer and Senior Vice President. Roberts has been VP, Finance at the company since March of 2011, and also has serv...

READ MORE...
Thursday, January 3, 2013

BioSurplus Gets $1.75M In Debt Financing

San Diego-based BioSurplus, a supplier of pre-owned scientific instruments and equipment, has raised $1.75M in a debt financing. The debt financing was announced over the holidays, and came from Square 1 Bank. Terms of the debt were not ann...

READ MORE...
Thursday, January 3, 2013

Questcor Pharmaceuticals Buys BioVectra

QuestCor Pharmaceuticals, the Anaheim-based biopharmaceuticals firm providing treatments for autoimmune and inflammatory disorders, said yetserday that it has acquired BioVectra, a supplier of contract manufacturing services to the pharmace...

READ MORE...
Wednesday, January 2, 2013

Ignyta Lands $6M For Personalized Medicine

San Diego-based Ignyta has raised $6M in a Series B funding, the firm said over the holidays. The firm said the funding included $5.5M in a Series B equity funding and $500,000 in a capital term loan from Silicon Valley Bank. The first clos...

READ MORE...
Wednesday, January 2, 2013

Independa Raises $5M In Series A

San Diego-based Independa, the developer of electronics products and software to help seniors live independently longer, has raised $5M in its Series A funding round, the firm announced this morning. The firm said the funding came from City...

READ MORE...
Thursday, December 27, 2012

Qualcomm Backs goBalto For Clinical Trials Software

San Diego-based Qualcomm Ventures, the venture capital arm of Qualcomm, has backed goBalto, a developer of clinical trial workflow software. goBalto said it raised $12M in a Series B funding, which was led by Singapore Economic Development ...

READ MORE...
Thursday, December 27, 2012

AwarePoint Receives $4.0M In Funding

San Diego-based AwarePoint has raised $4.0M, part of an ongoing, $10.4M funding round, according to a regulatory filing by the firm. The filing indicates the round is a convertible round for the company, and includes JAFCO Technology Partne...

READ MORE...
Friday, December 21, 2012

Cal-X Stars To Present Startup Class

Cal-X Stars Business Accelerator, a startup accelerator group which has been ramping up in Santa Monica, said Friday that it is planning to present its class of medtech companies in San Francisco as part of the Founder Club DEMO day. The ac...

READ MORE...
Friday, December 21, 2012

PathCentral Sells Diagnostics Lab Business

Irvine-based PathCentral, the provider of tools and technology to the pathology community, said today that it sold its diagnostic laboratory business to Ascend Clinical, a provider of end-stage renal disease laboratory testing. Financial te...

READ MORE...
Thursday, December 20, 2012

MEI Pharma Gets $27.5M In PIPE

San Diego-based MEI Pharma, a publicly traded developer of oncology drugs, said today that it has completed a $27.5M private placement. The new funding was led by Vivo Ventures and New Leaf Venture Partners. MEI Pharma said the new funding ...

READ MORE...
Thursday, December 20, 2012

ACADIA Pharmaceuticals Get Research Funding

ACADIA Pharmaceuticals, which is developing treatments for central nervous system and neurological disease, said this morning that it has received funding from Fast Forward LLC, a nonprofit established by the National Multiple Sclerosis Soc...

READ MORE...
Wednesday, December 19, 2012

Domain Associates, Rusnano Boost Three Firms By $93M

San Diego-based venture capital firm Domain Associates and its Russian partner, Rusnano, have put part of their $760M, late stage investment fund to work, investing a total of $93M in funding in three portfolio companies of Domain. The two ...

READ MORE...
Wednesday, December 19, 2012

Allergan Completes SkinMedica Buy

Irvine-based Allergan said today that it has completed its $350M acquisition of Carlsbad-based SkinMedica, the developer of aesthetic skin care products. The acquisition had been announced on November 12th. As part of the acquisition, SkinM...

READ MORE...
Tuesday, December 18, 2012

AtheroNova Sets Chief Medical Officer

Irvine-based AtheroNova, the biotech working on treating atherosclerotic plaque, reported this morning that it has named Dr. Mark K. Wedel as its Senior Vice President of Clinical Affairs, and Chief Medical Officer. Wedel has previously ser...

READ MORE...
Thursday, December 13, 2012

Masimo Debuts Pulse Oximeter For iPhone, iPad

Irvine-based Masimo, the developer of pulse oximeters used for measuring oxygen levels in patients, has connected its devices to the iPhone, iPad, and iPod touch. The company said its iSpO2 pulse oximeter cable and sensors connect to the de...

READ MORE...
Wednesday, December 12, 2012

ACADIA Pharmaceuticals Gets $86.4M In PIPE

San Diego-based biopharmaceuticals firm ACADIA Pharmaceuticals said today that it has raised $86.4M in a private placement. Source of the new funding was not announced. The firm said the new funds will go towards completing its Phase III pr...

READ MORE...
Wednesday, December 12, 2012

Cadence Pharmaceuticals Terminates Buyout Option For Incline Therapeutics

San Diego-based Cadence Pharmaceuticals said this morning that it has entered into an agreement to terminate an option it has to acquire Incline Therapeutics. Cadence said it will receive approximately $13M from The Medicines Company to ter...

READ MORE...
Tuesday, December 11, 2012

Somaxon Pharmaceuticals Acquired For $25M

San Diego-based Somaxon, a developer of treatments for insomnia, has been acquired by Pernix Therapeutics Holdings, in a deal worth $25M. According to the two companies, Pernix will acquire Somaxon in a stock-for-stock transaction worth a t...

READ MORE...
Monday, December 10, 2012

Amgen Buys deCODE Genetics

Thousand Oaks-based biotech Amgen is acquiring Iceland-based deCODE Genetics, in a deal worth $415M in cash, the two companies announced this morning. deCODE Genetics is a provider of human genetic research which was founded in 1996. deCODE...

READ MORE...
Thursday, December 6, 2012

Avelas Biosciences Gains $7.65M For Tumor Visualization

San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. Avelas is developi...

READ MORE...
Thursday, December 6, 2012

Biomatrica Raises $5M

San Diego-based Biomatrica, a developer of technology for stabilizing DNA, RNA, and protein samples, has raised $5M in a funding round, the firm said today. Source of the new funding was not announced. Biomatrica develops ambient temperatur...

READ MORE...
Thursday, November 29, 2012

ArmaGen Technologies Gets $17M For Protein Therapeutics

Santa Monica-based biopharmaceuticals startup ArmaGen Technologies announced Thursday afternoon tha tit has raised $17M in a Series A financing round. The firm said it is developing brain-penetrating recombinant protein therapeutics, which ...

READ MORE...
Wednesday, November 28, 2012

Regulus Therapeutics Names VP

La Jolla-based Regulus Therapeutics', which is developing microRNA therapeutics in the oncology, fibrosis, hepatitis C and metabolic diseases areas, said yesterday that it has named Victor Knopov as its Vice President, Pharmaceutical Develo...

READ MORE...
Monday, November 26, 2012

Volcano Corporation Buys Sync-Rx

San Diego-based Volcano Corporation, a developer of diagnostic tools for treating coronary and peripheral vascular disease, said Friday that it has acquired Sync-Rx Ltd., an Israeli software firm developing image processing products.Financi...

READ MORE...
Tuesday, November 20, 2012

MabVax Raises $5.25M

San Diego-based MabVax Therapeutics, a developer of immunotherapies aimed at preventing recurrent cancer, said today that it has raised $5.25M in a funding round. The round was led by Numoda Capital Innovation, and also included Burrill Cap...

READ MORE...
Friday, November 16, 2012

SkinMedica Acquired By Allergan For $375M

Carlsbad-based SkinMedica, the developer of aesthetic medicine products, is being acquired by Irvine-based Allergan in a $350M deal, the two said today. Allergan said it will buy SkinMedica $350M up front, plus up to $25M based on future sa...

READ MORE...
Tuesday, November 13, 2012

Biosynthetic Technologies Gets $7M

Irvine-based Biosynthetic Technologies, a firm developing synthetic biomolecules from plant oils, has raised $7M in funding from Monsanto, in addition to other funding from BP Ventures and other investors, the firm said recently. The compan...

READ MORE...
Tuesday, November 13, 2012

Epic Sciences Gets $13M For Cancer Diagnostics

San Diego-based Epic Sciences, a firm developing cancer diagnostics technology, announced today that it has raised $13M in a Series B equity round. The round came from Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, a...

READ MORE...
Thursday, November 8, 2012

Vessix Vascular Acquired By Boston Scientific For $425M

Laguna Hills-based Vessix Vascular, a deveveloper of percutaneous radiofrequency (RF) balloon catheter technology being targeted at treating hypertension, has been acquired by Boston Scientific Corporation, the two said this morning. The de...

READ MORE...
Thursday, November 8, 2012

Auspex Pharmaceuticals Raises $25M For Phase 3 Trials

San Diego-based Auspex Pharmaceuticals announced this morning that it has raised $25M in a funding round, a Series D financing for the company. The round was led by Panorama Capital, and also included Thomas, McNerney & Partners, CMEA Capit...

READ MORE...
Tuesday, November 6, 2012

Ambit Biosciences Gets $25M Tranche

San Diego-based Ambit Biosciences announced this morning that it has raised $25M in the first tranche of a $50M preferred stock financing. The round will go towards supporting its lead drug candidate. The round was led by Orbimed Advisors, ...

READ MORE...
Monday, November 5, 2012

Genesis Digital Imaging Acquired By Carestream

Los Angeles-based Genesis Digital Imaging, a developer of imaging software for the diagnostic imaging systems market, has been acquired by CareStream, a manufacturer of healthcare imaging, X-ray systems, and other related products. Financia...

READ MORE...
Monday, November 5, 2012

Regulus Gets $80.9M In Financing Efforts

La Jolla-based biopharmaceuticals firm Regulus Therapeutics, which is developing microRNA-based biopharmaceuticals aimed at oncology, fibrosis, hepatitis C and metabolic diseases, said it has raised $80.9M in total proceeds from its IPO, a ...

READ MORE...
Monday, November 5, 2012

Life Technologies Buys Advanced Microscopy Group

Carlsbad-based life sciences equipment company Life Technologies announced today that it has acquired Advanced Microscopy Group, a developer of imaging systems for research microscopy. Financial terms of the buy were not disclosed. Life Tec...

READ MORE...
Thursday, November 1, 2012

Atara Biotherapeutics Gets Funding From Amgen, KPCB

Thousand Oaks-based Amgen and venture firm Kleiner Perkins Caufield & Byers have put their backing behind a new, Westlake Village based drug development firm, Atara Biotherapeutics, in an unusual spinout of technology from the biotech giant...

READ MORE...
Wednesday, October 31, 2012

Thesan Pharmaceuticals Raises $16M

San Diego-based Thesan Pharmaceuticals said today that it has raised $16M in a Series A round, for the firm's developing of treatments for dermatological disorders. The firm said the funding was co-led by Novo Ventures and Novartis Venture ...

READ MORE...
Tuesday, October 30, 2012

Reflexion Health Raises $4.25M

San Diego-based Reflexion Health, a new startup using Microsoft's Kinect for physical therapy products, has raised $4.25M in a funding round, the company said this morning. Reflexion Health said the funding came from West Health Investment ...

READ MORE...
Friday, October 26, 2012

TigerText Hits 250 Healthcare Customers

Santa Monica-based text messaging provider TigerText reported Thursday that it now has more than 250 healthcare facilities using its HIPAA compliant messaging platform. The firm, which provides secure text messaging for enterprise customers...

READ MORE...
Thursday, October 25, 2012

Aperio Acquisition Completes

The acquisition of Vista, California-based Aperio by German firm Leica Biosystems has completed, the firms said Thursday. Aperio, a maker of digital pathology and slide digitization systems, and Leica had announced the deal on August 21st. ...

READ MORE...
Wednesday, October 24, 2012

Health Essentials Gets Backing From Bessemer, SV Life Sciences

Santa Ana-based Health Essentials, a provider of post-acute care for the frail and elderly, has scored a round of growth capital from two Silicon Valley venture investors. Health Essentials said it raised a round of funding from SV Life Sci...

READ MORE...
Wednesday, October 24, 2012

NantHealth Gets Funding From Verizon

Los Angeles-based NanHealth, the subsidiary of NantWorks, the incubator of LA billionaire Dr. Patrick Soon-Shiong, has scored an investment from Verizon Investments, the investment arm of Verizon Communications. Size of the funding was not ...

READ MORE...
Wednesday, October 24, 2012

Isis Pharmaceuticals Earns $1.1M From Alnylam

Carlsbad-based pharmaceuticals developer Isis Pharmaceuticals said Tuesday afternoon that it will receive $1.1M from Alnylam Pharmaceuticals, as a resutl of upfront fees from Alnylam's collaboration with Genzyme. Isis said the additional pa...

READ MORE...
Tuesday, October 23, 2012

Independa Gets $1M In Angel Funding

San Diego-based Independa, the provider of technology which helps to connect and remotely monitor seniors, to help them live independently longer, has raised $1M in an angel funding round. The funding was first publicly disclosed in a regul...

READ MORE...
Tuesday, October 23, 2012

Accelrys Buys Software Firm

San Diego-based Accelrys, which develops software for the life sciences industry, has acquired a fellow software company, Aegis Analytical. Accelrys said it paid $30M for Colorado based Aegis, which it will use to bolster its products. Aegi...

READ MORE...
Thursday, October 18, 2012

Cebix Gains $30.9M For Diabetes Treatments

La Jolla-based Cebix, a biopharmaceutcials company that is developing treatments for complications due to diabetes, said this week that it has raised $30.9M in a Series B investment round. The funding came from its existing investors, which...

READ MORE...
Monday, October 15, 2012

Fate Therapeutics Names New CEO

San Diego-based Fate Therapeutics announced this morning that it has named Christian Weyer, M.D., M.A.S., as its new President and CEO. Weyer joins the firm from Amylin Pharmaceuticals. Weyer had been serving as SVP Research and Development...

READ MORE...
Thursday, October 11, 2012

RightCare Solutions Gets Funding From Domain Associates

San Diego-based healthcare investor Domain Associates has made an investment in a Philadelphia provider of hospital discharge planning and readmission management software this week, RightCare Solutions. RightCare said it has raised $1.72M ...

READ MORE...
Tuesday, October 9, 2012

LoneStar Heart Gets $20M For Heart Therapy

Laguna Hills-based LoneStar Heart, a firm developing cardiac restorative therapies for patients with heart failure, has raised $20M in a funding round, the firm revealed today, from Chinese investor Themes Investment Partners. The firm said...

READ MORE...
Tuesday, October 9, 2012

Life Technologies Buys Compendia Bioscience

Carlsbad-based life sciences equipment firm Life Technologies said Monday that it has acquired Compendia Bioscience, a developer of cancer bioinformatics products. Financial terms of the buy were not disclosed. Compendia's products are used...

READ MORE...
Thursday, October 4, 2012

Regulus Therapeutics Adjusts IPO Offering Terms

San Diego-based Regulus Therapeutics has adjusted its anticipated IPO terms, saying in a filing this morning that it now anticipates its initial public offering price of its stock to be $4.00 per share, and that it will offer up 11.25M shar...

READ MORE...
Friday, September 28, 2012

Vital Therapies Raises $16M

San Diego-based Vital Therapies, a biotechnology firm focused on treatments for acute liver failure, said Thursday that it has raised $16M, part of a $76M mult-stage commitment to the firm by its investors. The firm said the funding will go...

READ MORE...
Friday, September 28, 2012

Contour Energy Targets Use In Medical Devices

Azusa-based Contour Energy Systems, the venture backed developers of advanced battery systems, said today that it is targeting the medical device market with its products. The firm said its Li/CFx battery cells are particularly well-suited ...

READ MORE...
Friday, September 28, 2012

Cytori Gets $106M Contract Award

San Diego-based Cytori Therapeutics, a developer of cell therapy products aimed at treating cardiovascular disease and repairing soft tissue, said today that it has been awarded a contact worth up to $106M. The contract came from the U.S. ...

READ MORE...
Thursday, September 27, 2012

Freedom Meditech Gets $2M In Credit Line

San Diego-based Freedom Meditech, a developer of opthalmic medical devices being used to detect disease and measure patient health, said Thursday that it has secured a $2M line of credit. The credit line came from Silicon Valley Bank. Terms...

READ MORE...
Thursday, September 27, 2012

AutoGenomics Files For IPO

Vista-based AutoGenomics has filed for an IPO, saying that it is looking to raise up to $65M in a public offering on the NASDAQ Global Market. The maker of molecular diagnostics systems--used by reference laboratories, hospitals and special...

READ MORE...
Wednesday, September 26, 2012

KYTHERA Biopharmaceuticals Sets IPO Pricing Range

Calabasas-based KYTHERA Biopharmaceuticals, a venture-backed developer of aesthetic medicine products, has set its IPO pricing range, saying earlier this week that it is expectings its IPO price to be between $14.00 and $16.00 per share. KY...

READ MORE...
Tuesday, September 25, 2012

Paragon Biomedical Acquired By Clinipace

Irvine-based Paragon Biomedical, a contract research organization (CRO), has been acquired by Clinipace, the two announced today. Financial terms of the acquisition were not disclosed. The two companies said the acquisition will "significan...

READ MORE...
Wednesday, September 19, 2012

Skylight Healthcare Gets $5M For Interactive Healthcare

San Diego-based Skylight Healthcare Systems, a developer of interactive patient care systems, said today that it has raised $5.0M in a funding round. The Series D round came from Duchossois Capital Partners. Skylight said the funding will g...

READ MORE...
Wednesday, September 19, 2012

Aviir Diagnostic Laboratories Gets $8M In Debt Funding

Irvine-based Aviir, a developer of laboratory tests for detecting cardiovascular disease, said it has raised $8M in funding from Silicon Valley Bank. The firm said the round included $5M in growth debt, plus a $3M line of credit. The new fu...

READ MORE...
Wednesday, September 19, 2012

Illumina Buys BlueGnome

San Diego-based Illumina, the developer of life sciences tools, said this morning that it has acquired BlueGnome, a UK-based provider of in-vitro fertilization and cytogenetics screening products. Financial terms of the acquisition were not...

READ MORE...
Tuesday, September 18, 2012

Sense4Baby Gets Funding For Wireless Fetal Monitoring

San Diego-based Sense4Baby, a brand new starting spawned out of the West Health Institute, has licensed a wireless fetal monitoring system from West Health, and moved into that firm's new incubator. West Health Institute also said that Sens...

READ MORE...
Monday, September 17, 2012

Life Technologies In Deal With Bristol-Myers Squibb

Carlsbad-based Life Technologies, which develops genetic analysis and other scientific instruments, said today that it has entered into a partnership with Bristol-Myers Squibb. According to the company, the two will work on companion diagno...

READ MORE...
Thursday, September 13, 2012

Response Genetics Gets $8.8 Million in Private Placement

Los Angeles-based Response Genetics, a publicly held provider of molecular diagnostic testing services for cancer, announced this morning that it has raised $8.8M in a private placement of its stock. The new funding came from GlaxoSmithKli...

READ MORE...
Wednesday, September 12, 2012

GlySens Scores Funding For Glucose Monitoring Devices

San Diego-based GlySens, a startup developing implantable, long-term glucose monitoring sensors, has scored an investment round, according to investor West Health Investment Fund. Financial terms of the investment were not disclosed. La Jol...

READ MORE...
Tuesday, September 11, 2012

Exagen Diagnostics Finds $5.3M

Exagen Diagnostics, a venture-backed developer of molecular diagnostics testing which operates its main laboratory in Vista, California, said it has raised $5.3M. The funding was led by Tullis Health Invesotrs, and also included Sun Mountai...

READ MORE...
Monday, September 10, 2012

Health In Reach Launches Rewards Points Program

How would you like to receive "frequent flyer" points for visiting your doctor or dentist? That's just what Los Angeles-based Health In Reach announced this morning, saying that it has launched a reward program where users can earn free den...

READ MORE...
Tuesday, September 4, 2012

Sequenom Bolsters Board

San Diego-based Sequenom, the developer of life sciences and genetic testing equipment, said today that it has added Myla Lai-Goldman, M.D., to its board of directors. Lai-Goldman is Managing Partner at Personalized Science LLC, CEO of Gene...

READ MORE...
Thursday, August 30, 2012

Elevation Pharmaceuticals Acquired For $430M

San Diego-based Elevation Pharmaceuticals, the venture backed developer of treatment for patients with chronic obstructive pulmonary disease (COPD), has been acquired by Masachussets-based Sunovion Pharmaceuticals, in a deal worth up to $43...

READ MORE...
Tuesday, August 28, 2012

BioIQ Partners With Health Insurance Brokerage

Santa Barbara-based BioIQ, the developer of software and technology for the health and wellness industry, said today that it has partnered with privately held insurance brokerage and consulting firm Keenan. BioIQ said that its health screen...

READ MORE...
Tuesday, August 28, 2012

Isis Pharmaceuticals Gets $1.4M From Alnylam

Carlsbad-based biopharmaceuticals firm Isis Pharmaceuticals, which is developing treatments for Crohn's disease and other rare diseases, said this morning that it will receive $1.4M from Alnylam Pharmaceuticals. The payment comes as part of...

READ MORE...
Tuesday, August 21, 2012

Aperio Acquired By German Firm

Vista-based Aperio, the developer of digital pathology equipment, is being acquired by German company Leica Biosystems, the companies said today. Financial details of the buy were not announced by the companies. The two said the move will h...

READ MORE...
Tuesday, August 21, 2012

MediciNova Raises $20M

Publicly held biopharmaceuticals firm MediciNova, which is based in San Diego, said last night that it has raised $20M in funding in a deal with Aspire Capital Fund, LLC. Medicinova said that Aspire will purchase the $20M in common stock at...

READ MORE...
Monday, August 20, 2012

Regulus Therapeutics Files For IPO

San Diego-based Regulus Therapeutics has filed for an IPO, saying that it is looking to raised up to $57.5M in an IPO on the NASDAQ Global Market. The developer of microDNA-based biopharmaceuticals said it hopes to trade as RGLS. The IPO is...

READ MORE...
Friday, August 17, 2012

Obagi Medical Products Names VP

Long Beach-based Obagi Medical Products, a developer of aesthetic medicine products, said Thursday that it has named Mark T. Taylor as its Senior Vice President, Corporate Development and Investor Relations. Taylor joins the firm from Roth ...

READ MORE...
Wednesday, August 15, 2012

FitKit Launches Personalized Nutrition Service

A new, Los Angeles startup, FitKit--started by a team of doctors and computer science students at UCLA--is launching today, looking to help make nutrition advice personal for online users. The company, which was incubated in the StartEngine...

READ MORE...
Tuesday, August 14, 2012

ADVENTRX Names Chief Medical Officer

San Diego-based ADVENTRX Pharmaceuticals announced this morning that it has named Santosh J. Vetticaden, M.D., Ph.D., as its new Chief Medical Officer and Senior Vice President. The firm said Vetticaden was most recently at Cubist Pharmaceu...

READ MORE...
Monday, August 13, 2012

Elcelyx Therapeutics Adds $4M

San Diego-based Elcelyx Therapeutics, a developer of biopharmaceuticals aimed at both the weight loss and diabetes area, said this morning that it has raised $4M of a $7M extension of its Series B equity funding round. The new funding came ...

READ MORE...
Friday, August 10, 2012

Prolacta Tops $1M In Philanthoropic Donations

Monrovia, California-based Prolacta Bioscience, the venture-backed company which is turning donated breast milk into human milk fortifier for premature babies, reported this week that it has donated more than $1M to various charitable organ...

READ MORE...
Thursday, August 9, 2012

Amgen Terminates Drug Trial After Failure

Thousand Oaks-based Amgen said late Wednesday that it has terminated a Phase 3 study of a drug it is developing to treat metastatic pancreatic cancer, after a recommendation by the independent committee overseeing the trial. The firm said t...

READ MORE...
Thursday, August 2, 2012

Genomatica Drops IPO Plans, Raises $41.5M

San Diego-based renewable chemicals developer Genomatica has dropped its IPO plans, according to a regulatory filing by the company this morning. The firm, which had filed for a $100M IPO in August of 2011, said in a withdrawal of its regis...

READ MORE...
Wednesday, August 1, 2012

Independa Links With Wireless Health Monitoring Firm

San Diego-based Independa, the remote healthcare monitoring service aimed at helping the elderly live independently longer, is continuing to expand out its partnerships with equipment makers, saying today that it has linked with IDEAL LIFE,...

READ MORE...
Wednesday, July 25, 2012

Life Technologies Buys Pinpoint Genomics

Carslbad-based Life Technologies said today that it has acquired Pinpoint Genomics, a developer of an early-stage, non-small cell lung cancer test. Financial terms of the buy were not announced. Pinpoint's tests help identify early-stage pa...

READ MORE...
Wednesday, July 25, 2012

CoDa Therapeutics Lands $20M More

San Diego-based CoDa Therapeutics, which develops biopharmaceuticals aimed at wound care, said today that it has added $20M to its Series B financing round. The new funding, a second close, came from RusnanoMedInvest. CoDa Therapeutics said...

READ MORE...
Wednesday, July 25, 2012

NantPharma Gets $125M From Blackstone

Los angeles-based NantWorks, the technology thinktank of Los Angeles billionaire Dr. Patrick Soon-Shiong, said Tuesday that one of its companies, NantPharma, has received $125M in an investment by private equity firm Blackstone. NantPharma ...

READ MORE...
Tuesday, July 24, 2012

Life Technologies Signs On As First Competitor In Genomics X PRIZE

San Diego-based Life Technologies, the maker of life sciences equipment, has signed on as the first competitor in the Archon Genomics X PRIZE, the life sciences prize being administered by Marina Del Rey-based X Prize Foundation. The compet...

READ MORE...
Wednesday, July 18, 2012

Obalon Raises $16.5M For Weight Loss Technology

San Diego-based Obalon said Wednesday afternoon that it has raised $16.5M, in a Series C funding. The funding was led by InterWest Partners, and also included Domain Associates and Okapi Venture Capital. Obalon is a developer of gastric ba...

READ MORE...
Tuesday, July 17, 2012

BioSurplus Raises $2.4M

San Diego-based BioSurplus, a provider of equipment management services and pre-owned laboratory instruments, said this morning that it has closed its Series A financing round, bringing the total raised in the oversubscribed round to $2.4M....

READ MORE...
Tuesday, July 17, 2012

Life Technologies Buys Navigenics

Carlsbad-based life sciences equipment maker Life Technologies announced late Monday that it has acquired Navigenics, a venture-backed genetics diagnostic testing firm and lab. Navigenics was venture backed by Kleiner Perkins Caulfield and ...

READ MORE...
Tuesday, July 17, 2012

Gen-Probe Gets German Clearance On Hologic Buy

San Diego-based Gen-Probe, the developer of molecular diagnostics products, and Massachusetts-based Hologic announced this morning that the two firms have received clearance from Germany's Federal Cartel Office for the acquisition of Hologi...

READ MORE...
Wednesday, July 11, 2012

MiCardia Raises $4.4M, Spins Off Technology

Irvine-based Micardia, a developer of medical devices used for treating cardiovascular diseases, said Tuesday that it has raised a round of funding, which will provide it with $4.4M during 2012 and 2013. The firm said the round was an inter...

READ MORE...
Monday, July 9, 2012

UCLA Engineers Create World's Fastest Camera

Engineers at the University of California, Los Angeles have created the world's fatest camera, and are using it to help detect cancer cells and detecting disease, the school said last week. UCLA said that the team at the UCLA Henry Samueli...

READ MORE...
Friday, July 6, 2012

Amgen Completes KAI Pharmaceuticals Buy

Thousand Oaks-based biotech giant Amgen said Thursday that it has completed its acquisition of KAI Pharmaceuticals, the South San Francisco-based developer of treatments for treating secondary hyperparathyroidism in patients with chronic ki...

READ MORE...
Friday, June 29, 2012

Domain, Versant Re-Up On Spine Repair Startup

Two Southern California venture investors have re-upped their investment in a Northern California maker of spin repair devices, Benvenue Medical. Benvenue said it raised $25M in a Series D funding yesterday, led by its existing ivnestors, w...

READ MORE...
Friday, June 29, 2012

Sonendo Raising $20M

Laguna Hills-based Sonnendo, a firm developing medical devices for the use in root canals (endodontic therapy), said Thursday that it has raised $9.2M in an initial close of a $20M equity funding. e firm said the round was led by OrbiMed Ad...

READ MORE...
Thursday, June 28, 2012

Tech Coast Angels Backs Influenza Treatment Developer

The Tech Coast Angels, the largest angel investment group in Southern California, has backed a developer of treatments for the flu., According to Gemmus Pharma, it raised an angel funding round led by the Life Science Angels, and also inclu...

READ MORE...
Tuesday, June 26, 2012

Medsphere Names Sales Chief

Carlsbad-based Medsphere Systems, which develops open source, electronic health record (EHR) software, said this morning that it has named Mike Morotti as its Vice President of Sales. Morotti was previously at Validus Medical Systems, and a...

READ MORE...
Monday, June 25, 2012

Pathway Genomics In Brazilian Deal

San Diego-based Pathway Genomics, the venture backed provider of genetic testing services, reported a win this morning with a Brazilian medical diagnostics company. Pathway Genomics said it has tied with Diagnosticos da America, which it sa...

READ MORE...
Friday, June 22, 2012

Avanir Pharmaceuticals Gets $30M In Credit Facility

Aliso Viejo-based Avanir Pharmaceuticals, the biopharmaceuticals firm focused on treatments for central nervous system disorders, has received $30M in a debt funding round, according to lenders Oxford FInance and Silicon Valley Bank. Avanir...

READ MORE...
Monday, June 18, 2012

Ambrx in Collaboration Deal With Merck

San Diego-based Ambrx, a venture backed biopharmaceuticals firm, said this morning that it has entered into a deal with Merck. Ambrx said the deal with Merck is to design and develop rationally optimized biologic drug conjugates based on Am...

READ MORE...
Thursday, June 14, 2012

Life Technologies Sets Up Shop In Singapore

Carlsbad-based Life Technologies, the developer of molecular diagnostics and other tools for the life sciences industry, said today that it has set up shop in Singapore. The firm said it has opened a Global Instrument Center of Excellence i...

READ MORE...
Wednesday, June 13, 2012

Amgen Completes Mustafa Nevzat Pharmaceuticals Acquisition

Thousand Oaks-based biopharmaceuticals firm Amgen said Tuesday afternoon that it has completed its acquisition of Turkish biopharma Mustafa Nevzat Pharmaceuticals. The acquisition, which had originally been announced on April 25th, was wort...

READ MORE...
Monday, June 11, 2012

Qualcomm Re-Ups On AliveCor

San Diego-based Qualcomm has re-upped its investment in a maker of an electriocardiogram (ECG) device which connects into iPhone, iPad, and Android devices. According to AliveCor, which is based in San Francisco, it has raised $10.5M in a s...

READ MORE...
Monday, June 11, 2012

ReVision Optics Enters Phase 3 Clinical Trials

Lake Forest-based ReVision Optics, the venture backed developer of a implantable lens which reduces the need for reading glasses i patients with presbyopia, said it has advanced into its Phase 3, clinical trials with its corneal inlays. The...

READ MORE...
Thursday, June 7, 2012

Astute Medical Raises $40.4M

San Diego-based Astute Medical, a provider of biomarker-based medical diagnostics technology, reports this morning that it has raised $40.4M in a Series C funding round. The round was led by MPM Capital, and also included new investor Kaise...

READ MORE...
Tuesday, June 5, 2012

Medsphere Names CTO

Carlsbad-based Medsphere, the developer of electronic health records systems, said today that it has named Lily S. Chang as its Chief Technology Officer. Chang was most recently CTO at Advent Software, where she had run the firm's technolog...

READ MORE...
Tuesday, June 5, 2012

Optimer Pharmaceuticals Sets CFO

San Diego-based Optimer Pharmaceuticals said this morning that it has named Stephen Webster as the firm's new Chief Financial Officer. Webster was previously CFO of Adolar Corporation, and also served at Broadpoint Capital (formerly First A...

READ MORE...
Monday, June 4, 2012

Awarepoint Raises $14M More

San Diego-based Awarepoint, which develops real-time, location systems used for tracking patents and assets in a healthcare environment, said today that it has raised $14M in an additional financing round. The firm said the round was led by...

READ MORE...
Friday, May 25, 2012

Sangart Raises $50M

San Diego-based biopharmaceuticals firm Sangart has raised $50M in a Series G funding round, the company announced Thursday, bringing its total venture funds raised to $280M. Sangart, which is developing biopharmaceuticals to treat hemorrha...

READ MORE...
Monday, May 21, 2012

Makucell Names Pasadena Angels' Scanlon To Board

Makucell, a life sciences company developing anti-aging skin products, said this morning that it has appointed Kevin J. Scanlon, Ph.D., to its board of advisors. Scanlon is Chairman of the Pasadena Angels and also an active member of the Te...

READ MORE...
Wednesday, May 16, 2012

Verdezyne Hires DuPont Vet As Business Head

Biofuels and renewable chemical technology firm Verdezyne announced Wednesday that it has named a new Chief Business Officer. The firm said that Ray W. Miller, who was at DuPont from 1972 through 2011, has joined the firm to head up busines...

READ MORE...
Thursday, May 10, 2012

BioSurplus Gets $1.5M For Boston Expansion

San Diego-based BioSurplus, a provider of pre-owned, laboratory instruments for the life sciences industry, said today that it has raised $1.5M in a capital raise for an expansion into Boston. The firm said the funding came from KI Investme...

READ MORE...
Monday, May 7, 2012

Verdezyne Raises $10.6M More

Carlsbad-based Verdezyne, which is developing biotechnology used for biofuels production and chemicals manufacturing, has raised $10.6M in a new, debt funding round, according to a filing from the firm last week. Details on the funding have...

READ MORE...
Monday, May 7, 2012

Celladon Gets $53M In Funding

San Diego-based Celladon, a biopharmaceuticals firm developing a genetically targeted enzyme replacement therapy which helps in the treatment of late-stage, heart failure, has raised $53M in a second close of a funding round, the firm said ...

READ MORE...
Monday, April 30, 2012

Gen-Probe Acquired By Hologic For $3.7 Billion

San DIego-based molecular diagnostics equipment maker Gen-Probe, which is publicly held, is being acquired by Hologic in a $3.7 billion deal, the firms said this morning. The two said that Hologic will pay $82.75 per share in cash for Gen-P...

READ MORE...
Friday, April 27, 2012

Orexigen Therapeutics Shuffles Board

Three of the venture investors in publicly held Orexigen Therapeutics are departing the board of directors of the company, Orexigen said Friday, as the firm shuffled its board. Orexigen said that Joseph Lacob, Michael Powell, and Daniel Tur...

READ MORE...
Thursday, April 26, 2012

Tech Coast Angels Fund Cadence Biomedical

The Tech Coast Angels has backed the maker of a medical device to help people with severe disabilities to walk. According to Cadence Biomedical, the Tech Coast Angels are among a number of new investors in a $1.1M, Series A2 funding for the...

READ MORE...
Wednesday, April 25, 2012

Quality Systems Buys Matrix Management Solutions

Irvine-based Quality Systems, a provider of practice management and electronic health records software, said today that it has acquired Matrix Management Solutions, a reseller of revenue cycle management and electronic health records produc...

READ MORE...
Wednesday, April 25, 2012

RainTree Oncology Gets $11.1M

San Diego-based RainTree Oncology Services, a provider of systems which help oncologists to purchase oral drugs, manage inventories, track prescriptions, and monitor patients, has raised $11.1M, the firm said late Tuesday. The firm said the...

READ MORE...
Wednesday, April 25, 2012

Amgen Buys Turkish Pharmaceutical Company

Thousand Oaks-based Amgen said this morning that it has acquired Turkish pharmaceuticals firm Mustafa Nevzat Pharmaceuticals. Amgen said the deal is worth $700M in cash. Amgen said the acquisition will help to significantly expand its prese...

READ MORE...
Wednesday, April 25, 2012

Independa Raises $2.35M

San Diego-based Independa, which develops remote health management and monitoring systems for the elderly, said today that it has raised $2.35M in a convertible note funding. The firm said the round included Miramar Venture Partners and Cit...

READ MORE...
Monday, April 23, 2012

ReVision Optics Names Board Member

Lake Forest-based Revision Optics, which is developing implantable micro-lens technology for treating presbyopia, said today that it has named a new board member. The firm said it has added Stephen Slade, M.D., FACS, to its board. Slade is ...

READ MORE...
Thursday, April 12, 2012

Inogen Secures $20M For Oxygen Therapy Devices

Santa Barbara-based Inogen, a provider of oxygen therapy equipment and services, said Thursday that it has scored a $20M, equity funding round. The round was led by Novo A/S. Inogen, which is led by Raymond Huggenberger, said the new funds ...

READ MORE...
Thursday, April 12, 2012

Tioga Pharmaceuticals Gets $10M

San Diego-based Tioga Pharmaceuticals, a developer of biopharmaceuticals for treating irritable bowel syndrome, said today that it has raised $10M in a Series B funding round. The round was led by Thomas, McNerney & Partners, which also inc...

READ MORE...
Tuesday, April 10, 2012

Amgen Buys KAI Pharmaceuticals

Thousand Oaks-based biotech giant Amgen said this morning that it has agreed to buy KAI Pharmaceuticals, a developer of treatments for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis, f...

READ MORE...
Monday, April 9, 2012

WaveTec Vision Gets $16.5M For Cataract Surgery

Aliso Viejo-based WaveTec Vision, which is developing diagnostic devices for cataract surgery, said monday that it has raised $16.5M more in funding. The funding was led by Burrill & Company, and also included Versant Ventures, Accuitive Me...

READ MORE...
Monday, April 9, 2012

Optimer Pharmaceuticals In Executive Turmoil

Publicly held San Diego firm Optimer Pharmaceuticals, a developer of biopharmaceutical products, appears to be in the midst of a major executive overhaul. According to the firm this morning, its board has removed Dr. Michael Chang as Chairm...

READ MORE...
Wednesday, April 4, 2012

Microsoft's Xbox-using, Dancing Senior Citizens In LA

Computer software giant Microsoft has rolled out a video of a bunch of Xbox 360-playing, dancing senior citizens in Los Angeles, as part of an effort to promote a new program with the City of Los Angeles Department of Aging. Microsoft said ...

READ MORE...
Wednesday, April 4, 2012

Xencor Gets License Payment From Boehringer Ingelheim

Monrovia-based Xencor, the developer of antibody technology which is headed by Dr. Bassil Dahiyat, said today that it has received a second, milestone payment from Boehringer Ingelheim. Financial details and amount of the payment were not d...

READ MORE...
Monday, April 2, 2012

Illumina Rejects Latest Roche Offer

San Diego-based Illumina, the developer of genetics analysis and other life sciences tools, has again rejected an unsolicited bid from Roche to take over the company. Roche had upped its offer for Illumina to $51.00 last week, up from an ea...

READ MORE...
Friday, March 30, 2012

Genalyte Raises $11.8M

San Diego-based Genalyte, a developer of life sciences equipment which uses silicon chips for protein and nucleic acid testing. said this morning that it has raised $11.8M in a Series B financing round. The round came from Redmile Group, Cl...

READ MORE...
Thursday, March 29, 2012

GenMark In Patent Deal With PerkinElmer

Carlsbad-based GenMark Diagnostics, the developer of molecular diagnostics testing systems, reported this morning that it is in a licensing agreement with PerkinElemer. GenMark said it has been granted a non-exclusive license to PerkinElmer...

READ MORE...
Wednesday, March 28, 2012

Sientra Gains $65M

Santa Barbara-based Sientra, a developer of FDA-approved, silicone breast implants, said Wednesday that it has raised $65M in a Series C funding round. The funding was led by Abingworth, and also included Clarus Ventures, OrbiMed Advisors, ...

READ MORE...
Wednesday, March 28, 2012

Strand Diagnostics Raises $30 Million From NantWorks

Los Angeles-based NantWorks, the business investment and development firm run by billionaire Patrick Soon-Shiong, has invested $30M in Strand Diagnostics, a developer of a diagnostic and DNA testing service for diagnosing cancer. According ...

READ MORE...
Wednesday, March 28, 2012

Independa Powers Remote Care Service For LivHOME

San Diego-based Independa, the developer of remote monitoring products for seniors, is powering a new tablet computer-based remote care service from LivHOME, the two said this morning. LivHOME launched LivIndependa, a remote care and monito...

READ MORE...
Tuesday, March 27, 2012

ImaginAb Raises $12.5M

Los Angeles-based ImaginAb, a UCLA spinout which is developing antibody fragments for use in the diagnostic imaging market, said late last night that it has raised $12.5M in a Series A financing round. The round was led by Novartis Venture ...

READ MORE...
Tuesday, March 27, 2012

ISTA Pharmaceuticals Acquired For $500M

Irvine-based ISTA Pharmaceuticals, a manufacturer of products to treat ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis, has been acquired by Bausche + Lomb in a $500M d...

READ MORE...
Thursday, March 22, 2012

Anaphore Buys Chinese Firm, Gains $15M In Funding

La Jolla-based Anaphore, a startup biopharmaceuticals developer, said today that it has acquired a Chinese firm, RuiYi Inc., and closed on the second tranche of its Series A financing, worth $15M. Anaphore said it acquired RuiYi to gain acc...

READ MORE...
Thursday, March 15, 2012

Merck Invests $90M In San Diego Research Group

Biopharmaceuticals giant Merck said today that it is investing $90M in setting up a new, San Diego research organization, called Calibr. According to Merck, the new, independent not-for-profit will aim to accelerate translation of basic bio...

READ MORE...
Wednesday, March 14, 2012

KYTHERA Biopharmaceuticals Names Chief Commercial Officer

Los Angeles-based KYTHERA Biopharmaceuticals, which develops aesthetic medicine products, said this morning that it has named Elisabeth Sandoval as its Chief Commercial OFficer. Sandoval was previously at Bausch + Lomb Surgical, and also ha...

READ MORE...
Monday, March 12, 2012

Masimo Buys Spire Semiconductor

Irvine-based Masimo, the developer of pulse oximetry devices, said today that it is acquiring substantially all of the assets of Spire Semiconductor, a maker of light emitting diode (LED) and other components, which are used in biomedical a...

READ MORE...
Monday, March 12, 2012

HemaQuest Pharmaceuticals Gets $13M

San Diego-based HemaQuest Pharmaceuticals said today that it has raised $13M in a Series B funding. The firm, which is developing small molecule therapeutics for treating hemoglobin disorders such as sickle cell disease, said the funds come...

READ MORE...
Friday, March 9, 2012

Cameron Health Acquired By Boston Scientific

San Clemente-based Cameron Health, a maker of subcutaneous, implantable cardiac defibrillators, has been acquired by Boston Scientific, in a deal worth $150M in cash, plus up to $150M on FDA approval of Cameron Health's product, plus up to ...

READ MORE...
Wednesday, March 7, 2012

CareFusion Buys Pharmacy Automation Firm

San Diego-based CareFusion said yesterday that it has agreed a technology and consulting firm focused on pharmacy automation, PHACTS, LLC. Financial terms of the buy were not disclosed. PHACTS, which is based in Seattle, provides consulting...

READ MORE...
Wednesday, March 7, 2012

Sequent Medical Raises $26.0M

Aliso Viejo-based Sequent Medical, a developer of medical devices used to treat aneurysms, has raised $26.0M in a venture financing round. The firm said the Series C was led by Delphi Ventures, and also included Versant Ventures, US Venture...

READ MORE...
Tuesday, March 6, 2012

Aragon Pharmaceuticals Scores $42M

San Diego-based Aragon Pharmaceuticals reports this morning that the firm has raised $42M in a Series C, funding round. The firm, which is developing treatments targeting hormone-driven cancers, said the round was led by Topspin Fund, the i...

READ MORE...
Tuesday, February 28, 2012

NantWorks Buys Boston Life Labs

Los Angeles-based Nantworks, the new business incubator run by billionaire Dr. Patrick Soon-Shiong, said today that it has acquired another company, Boston Life Labs. Financial terms of the buy were not disclosed. NantWorks said it will ren...

READ MORE...
Tuesday, February 21, 2012

Qualcomm Life Invests In Wireless Healthcare Firm

San Diego-based Qualcomm Life, the wireless health-focused subsidiary of Qualcomm, reported today that it has made an investment in wireless healthcare startup AirStrip Technologies. Financial details of the investment were not disclosed. Q...

READ MORE...
Friday, February 17, 2012

OWL Biomedical Raises $3.0M

Santa Barbara-based OWL Biomedical, a developer of microchip-based disposable cell sorting technology for the biomedical industry, has raised $3.0M, part of an ongoing funding with a target of $16.8M, according to regulatory filings. OWL is...

READ MORE...
Thursday, February 16, 2012

Celladon Gets $43M For Heart Failure Treatments

La Jolla-based Celladon Corporation, a developer of biopharmaceuticals targeting cardiovascular disease, said Wednesday afternoon that it has raised $43M in a financing round. The round was led by Pfizer Venture Investments, and also includ...

READ MORE...
Tuesday, February 14, 2012

KFx Medical Gets Patent

Carlsbad-based KFX Medical, which is developing bone implant products for the orthopedic surgery market, reported today that it has received a third patent. The patent, U.S. Patent No. 8,109,969, covers its knotless double row soft tissue b...

READ MORE...
Friday, February 10, 2012

Cynvenio Spins Out BioMolded Products

Westlake Village-based Cynvenio Biosystems, the developer of molecular diagnostics systems for cancer, has spun out a new subsidiary, BioMolded Products, focused on blow molded plastic parts for the biopharmaceutical and life science indust...

READ MORE...
Wednesday, February 8, 2012

Ambit Biosciences Names Chief Medical Officer

San Diego-based Ambit Biosciences, the developer of biopharmaceuticals for the treatment of cancer, inflammatory disease and other conditions, said this morning that it has named a Chief Medical Officer. The company said it has appointed At...

READ MORE...
Tuesday, February 7, 2012

Applied Proteomics Raises $22.5M

San Diego-based Applied Proteomics, which is developing personalized medicine applications, said today that it has raised $22.5M in a Series B funding, and moved its headquarters to San Diego. The funding came from Domain Associates, Vulcan...

READ MORE...
Tuesday, February 7, 2012

Cynvenio Biosystems Raises $2.0M, Gets NCI Contracts

Westlake Village-based Cynvenio Biosystems, which is developing molecular diagnostics systems for cancer, announced this morning that it has received $2.0M in financing, plus scored two Small Business Innovative Research (SBIR) contracts fr...

READ MORE...
Thursday, February 2, 2012

TigerText Pounces On $8.2M

Santa Monica-based TigerText, a startup providing secure mobile messaging services for healthcare companies, announced today that it has raised $8.2M in a second round of funding. The round was led by Easton Capital and New Science Ventures...

READ MORE...
Thursday, February 2, 2012

Response Genetics Gets $7.8M In PIPE

Los Angeles-based Response Genetics, a developer of diagnostics test for cancer, said today that it has raised $7.8M in a private placement. The publicly traded firm did not disclose the name of its new investors. The firm said it sold appr...

READ MORE...
Friday, January 27, 2012

Illumina Board Ponders Takeover Offer

San Diego-based life sciences tools developer Illumina said today that its board of directors will be reviewing the usnolicited offer by Roche to acquire the firm, for $44.50 per share in cash. Roche made the offer--which is worth $5.7 bill...

READ MORE...
Thursday, January 26, 2012

Amgen to Acquire Micromet For $1.16B

Thousand Oaks-based Amgen announced today that it is acquiring Micromet, a biopharmaceuticals firm based in Germany and Rockville, Maryland, in a deal worth $1.16 billion. Amgen said it will pay $11 per share in cash for Micromet, which is ...

READ MORE...
Wednesday, January 25, 2012

KFx Medical Gets Patent

Carlsbad-based KFx Medical said Tuesday that it has scored a U.S. Patent, covering its knotless double row rotator cuff repair technology, which is used in its line of implant products. U.S. Patent No. 8,100,942 was granted by the US Patent...

READ MORE...
Tuesday, January 17, 2012

Verdezyne Gains Patent

Carlsbad-based Verdezyne, the venture backed developer of biofuels technology, said today that it has been granted a United States Patent. The firm said the patent, No. 8,093,037, covers its engineered microorganisms used to enable yest to ...

READ MORE...
Monday, January 9, 2012

SkinMedica Buys Makeup Firm

Carlsbad-based SkinMedica, a venture backed cosmaceuticals firm developing skin care products, said Monday that it has acquired Colorescience, a makeup company developing science-based mineral makeups. Financial terms of the buy were not di...

READ MORE...
Monday, January 9, 2012

Uptake Medical Raises Series C

Tustin-based Uptake Medical, the developer of treatments for emphysema led by R. King Nelson, announced today that it has raised a Series C funding round. Size of the round was not announced. The round was led by Crescent Point Group (Singa...

READ MORE...
Thursday, January 5, 2012

Yardi Buys Software Firm

Santa Barbara-based Yardi, which develops software for property management, said Thursday afternoon that it has acquired ALMSA Corporation, a provider of software for the assisted living industry. Financial terms of the buy were not disclos...

READ MORE...
Thursday, January 5, 2012

Arrowhead Research Inks Deal With Alnylam

Pasadena-based Arrowhead Research and RNAi therapeutics firm Alnylam Pharmaceuticals announced this morning that the two are in a collaboration and licensing agreement. Financial details of the agreement were not announced. THe two said tha...

READ MORE...
Wednesday, January 4, 2012

NeuroGenetic Pharmaceuticals Scores Investment

San Diego-based NeuroGentic Pharmaceuticals, a firm development treatments for Alzheimer's disease, said today that it has scored an investment round from Abbot Biotech Ventures. Size of the round was not announced. NeuroGenetic said the in...

READ MORE...
Thursday, December 29, 2011

Marshall Edwards Raises $2M In Private Placement

San Diego-based Marshall Edwards, a publicly held firm focused on development of oncology drugs, said Thursday that it has raised $2M in a private placement. The funding came from its majority shareholder, Novogen Limited. Marshall Edwards ...

READ MORE...
Friday, December 23, 2011

Meritage Pharma Gets $20M In Deal With ViroPharma

San Diego-based Metritage Pharma, which is developing drugs for treating chronic inflammatory diseases of the esophagus, is gaining up to $20M from ViroPharma, which is buying an exclusive option to acquire Meritage. ViroPharma said it paid...

READ MORE...
Monday, December 19, 2011

Aviir To Raise Up To $30M

Irvine-based Aviir, a venture-backed biotech firm targeting cardiac disease assessment, said late Monday that it has reached an agreement to raise up to $30M in a financing round. The firm said the round includes an initial $10M, plus up to...

READ MORE...
Monday, December 19, 2011

Amgen Inks $400M Deal With Generics Maker Watson Pharmaceuticls

Thousad Oaks-based Amgen said Monday that it has inked a $400M, co-development deal with Watson Pharmaceuticals, where they two will work together on oncology antibody biosimilar medicines. The two said that Amgen will assume primarily resp...

READ MORE...
Monday, December 19, 2011

Somaxon Cuts Staff, Looks for Buyer

San Diego-based Somaxon Pharmaceuticals, a developer of sleep medication, said today that it has cut 60 percent of its non-field based employees, and has hired a financial advisor to help sell the company. The firm said it has hired Stifel ...

READ MORE...
Thursday, December 8, 2011

Independa Ties Sensors Into Health Monitoring Service

San Diego-based Independa, the venture backed provider of health monitoring systems for the elderly, announced this week that it has launched a new set of health, safety, and activity sensors which connect into its services. The company--wh...

READ MORE...
Tuesday, December 6, 2011

Tribogenics Lands $2.5M For Portable X-ray Technology

Los Angeles-based Tribogenics, a startup working on technology to bring elements of Star Trek's "tricorder" to life, said this morning that it has raised $2.5M in a venture funding round. The firm, a spinoff of UCLA whose technology has bee...

READ MORE...
Monday, December 5, 2011

Qualcomm Launches Medical Devices Subsidiary, $100M Fund

San Diego-based Qualcomm announced this morning that it has created a new, wholly owned subsidiary called Qualcomm Life, which will focus on wireless solutions for the medical devices market. The new subsidiary will also backed by a new, ve...

READ MORE...
Wednesday, November 30, 2011

Harbor MedTech Raises $600K For Wound Healing Technology

Orange County-based Harbor MedTech, a developer of wound healing technology, has raised $600,000 in a funding round from private investors, the firm disclosed today, to help the firm grow and further develop its products. Harbor MedTech is ...

READ MORE...
Wednesday, November 30, 2011

eBioscience Acquired By Affymetrix

San Diego-based eBioscience, a developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics, is being acquired by Affymetrix, Affymetrix said Wednesday. Affymetrix said it is paying $330M in cash...

READ MORE...
Wednesday, November 30, 2011

Verdezyne Opens Pilot Plant

Carlsbad-based Verdezyne, a developer of biotechnology used to produce renewable chemicals and fuels, announced today that it has opened its first pilot plant. The company said the plant will produce adipic acid, a key component of nylon. T...

READ MORE...
Tuesday, November 29, 2011

AcuFocus Sees $65M

Irvine-based AcuFocus, a maker of corneal inlays for treating presbyopia, announced this morning that it has raised $65M in a funding round. The ronud was led by Cowen Healthcare Royalty Partners, and also included SV Life Sciences, Versant...

READ MORE...
Wednesday, November 23, 2011

Puma Biotechnology Raises $60M

Los Angeles-based Puma Biotechnology, a developer of biopharmaceuticals aimed at treating cancer, said this morning that it has completed a second tranche of a $60M private financing. The company said that Leerink Swann LLC was the lead pla...

READ MORE...
Tuesday, November 22, 2011

Excaliard Pharmaceuticals Acquired By Pfizer

San Diego-based Excaliard Pharmaceuticals, a developer of biopharmaceuticals for treating skin scarring, has been acquired by Pfizer. Financial terms of the buy were not disclosed. Excaliard was venture backed by RiverVest, Alta Partners, P...

READ MORE...
Friday, November 18, 2011

Scripps Institute, IBM Look To PCs to Cure Malaria With Jeopardy Winnings

La Jolla-based biomedical research nonprofit Scripps Research Institute and IBM said this morning that they are looking for the public's help, in volunteering to donate their computer time to help a new effort to cure malaria, funded by IBM...

READ MORE...
Wednesday, November 16, 2011

Domain, Versant Score Exit At Clovis Oncology

Two, Southern California venture investors have scored an exit this morning with the IPO of Clovis Oncology. San Diego's Domain Associates and Newport Beach-based Versant Ventures are both significant investors in Clovis, which priced its I...

READ MORE...
Wednesday, November 16, 2011

Ambit Biosciences Names CEO

San Diego-based Ambit Biosciences said today that it has named Michael A. Martino as its new President and CEO. Ambit, which is developing small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indicati...

READ MORE...
Tuesday, November 15, 2011

SoCal Investors Await Clovis Oncology IPO

Two Southern California venture firms are among the investors who are awaiting an expected IPO of Clovis Oncology, a developer of cancer drugs, this week. Clovis Oncology, based in Colorado, is expected to price its IPO this week, according...

READ MORE...
Monday, November 14, 2011

InTouch Health Names CFO

Santa Barbara-based InTouch Technologies, which develops telemedicine products, said this morning that it has named Stephen L. Wilson as Executive Vice President and Chief Financial Officer. Wilson was most recently Executive Vice President...

READ MORE...
Wednesday, November 9, 2011

Rempex Pharmaceuticals Snags $67.5M

San Diego-based Rempex Pharmaceuticals, a biopharmaceuticals firm addressing antibiotic resistance, announced this morning that it has raised $67.5M in an initial close of a Series B financing round. The round came from Frazier Healthcare V...

READ MORE...
Tuesday, November 8, 2011

Perminova Raises $7M For Surgical Software

La Jolla-based Perminova announced Tuesday that it has raised $7M in a funding round, which it will use to develop its web-based cardiovascular procedure software. Perminova's software provides scheduling, workflow, surgical data, and billi...

READ MORE...
Monday, November 7, 2011

ACADIA Pharmaceuticals Starts Phase I Studies

San Diego-based ACADIA Pharmaceuticals reported this morning that the U.S. Food and Drug Administration has completed its review of the firm's New Drug Application for AM-831, its small molecule for treatment of schizophrenia, and it is adv...

READ MORE...
Thursday, November 3, 2011

Prolacta Lands Series D

Monrovia, California-based Prolatca Bioscience, which supplies human milk-based fortifiers for premature infants, said today that it has closed a Series D funding round. The round came from Health Evolution Partners. Size of the round was n...

READ MORE...
Tuesday, November 1, 2011

ImaginAB Gets $2.3M

Los Angeles-based ImagineAb, a spinout of UCLA which is developing diagnostic imaging technology, reported Monday that it has been awarded $2.3M in funding, from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR...

READ MORE...
Thursday, October 27, 2011

Arrowhead Research Names COO

Pasadena-based Arrowhead Research, which develops biotherapeutics and other technology, announced today that it has named Bruce Given, M.D., as its Chief Operating Officer. Given was previously CEO of Leonardo Biosystems, and also has been ...

READ MORE...
Wednesday, October 26, 2011

Analytix On Demand Acquires Firm, Becomes CentraMed

Irvine-based Analytix On Demand, a developer of business intelligence software for the healthcare market, said Tuesday that it has acquired healthcare consulting and education firm Integrated Revenue Management, Inc.. Financial terms of the...

READ MORE...
Wednesday, October 26, 2011

Nantworks Buys Ziosoft

Los Angeles-based Nantworks, the business incubation and technology development firm headed by LA billionaire Patrick Soon-shiong, has acquired Ziosoft, a provider of medical imaging and visualization software. According to Ziosoft, which d...

READ MORE...
Tuesday, October 25, 2011

Patrick Soon-Shiong Aims At Pancreatic Cancer Treatments

The Chan Soon-Shiong Insitute for Advanced Health--one of the projects of that billionaire Patrick Soon-Shiong--said today, along with Soon-Shiong's incubator NantWorks, that Soon-Shiong has been working on a treatment for advanced metasta...

READ MORE...
Thursday, October 20, 2011

Verenium Gets $16M in Credit Line

San Diego-based biotechnology firm Verenium announced this morning that it has scored credit lines totaling $16M, for the development of its enzyme development efforts. The firm said it has entered into an agreement with Comerica Bank and t...

READ MORE...
Monday, October 17, 2011

Anadys Acquired By Roche

San Diego-based Anadys Pharmaceuticals, the developer of treatments for hepatitis C, said this morning that it has agreed to be acquired by Roche. The firm said it signed a definitive merger agreement where Roche will pay $3.70 per share fo...

READ MORE...
Friday, October 14, 2011

Amgen Expands Board

Thousand Oaks-based Amgen said Thursday evening that it has added Robert A. Bradway, the firm's current President and Chief Operating Officer, to the company's board. According to Amgen, the addition of Bradway brings its total board member...

READ MORE...
Tuesday, October 11, 2011

Caltech Engineers Use Legos, Google Smartphone For Smart Petri Dish

Researchers at the California Institute of Technology reported last week that they have created a "smart petri dish" which uses Google smart phones and Lego blocks, to automatically monitor cell growth in petri dishes. In a paper presented ...

READ MORE...
Tuesday, October 11, 2011

Inspiration Biopharmaceuticals Finds CEO

Laguna Niguel-based Inspiration Biopharmaceuticals, a developer of treatments for hemophilia, announced today that it has appointed John P. Butler as its new CEO. Butler replaces current CEO Michael Griffith, who becomes Chief Scientific Of...

READ MORE...
Tuesday, October 11, 2011

Medsphere Names Sales, Marketing VP

Carlsbad-based Medsphere Systems, which develops open source healthcare software, said today that it has named John Bright as Vice President of Sales and marketing. Bright joins the company from Henry Schein Medical Systems, and also has se...

READ MORE...
Thursday, October 6, 2011

CoDa Therapeutics Lands $6M Credit Facility

San Diego-based CoDa Therapeutics, a developer of biopharmaceuticals for wound care, has scored $6M in a credit facility, according to the firm's lender. Square 1 Bank said that it has provided CoDa Therapeutics with a $6M term loan. Terms ...

READ MORE...
Wednesday, October 5, 2011

ImThera Medical Snags $16M

San Diego-based ImThera Medical, a developer of medical devices to treat sleep apnea, has raised $16M in an initial funding round from publicly held Cyberonics, plus its other investors Cyberonics said Wednesday. ImThera is developing an im...

READ MORE...
Wednesday, October 5, 2011

JMI Equity Invests In Studer Group

San Diego-based private equity firm JMI Equity has invested in Studer Group, a provider of healthcare performance improvement services for hospitals and medical groups. Size of the investment was not disclosed. Financial details of the inve...

READ MORE...
Tuesday, October 4, 2011

ReShape Medical Names CEO

San Clemente-based ReShape Medical, a developer of a non-surgical weight loss device, said today that it has named Richard Thompson as the firm's president and CEO. Thompson was previously founder, president, and CEO of Luminous Medical, an...

READ MORE...
Friday, September 23, 2011

Prolacta Links With National Milk Bank

Monrovia-based Prolacta Bioscience, the venture-backed provider of human milk-based fortifiers for premature infants, said today that it has inked a deal with the National Milk Bank, where the firm will process all of the milk through the b...

READ MORE...
Thursday, September 22, 2011

Ambrx In Deal With Bristol-Myers Squibb

La Jolla-based Ambrx, the biopharmaceuticals developer, and Bristol-Myers Squibb said today that the two are in a collaboration. According to the companies, Bristol-Myer Squibb will receive exclusive, worldwide rights to research, develop, ...

READ MORE...
Thursday, September 22, 2011

Two Biotech Labs Set Up Shop In San Diego

In a demonstration of the amount of activity in San Diego's biotech industry, two, separate companies announced new biotech laboratories opened up in San Diego Wednesday. Both Isis Pharmaceuticals and the J. Craig Venter Institute said they...

READ MORE...
Wednesday, September 21, 2011

Independa Raises $1.6M

San Diego-based Independa, which operates a service to help family and professional caregivers monitor loved ones, has raised $1.6M in a seed funding round, the firm said today. The funding came from Miramar Venture Partners and CityHill Ve...

READ MORE...
Monday, September 19, 2011

KYTHERA Biopharmaceuticals Raises $37.4M

Los Angeles-based KYTHERA Biopharmaceuticals, a developer of aesthetic medicine products, said today that it has raised $37.4M in a series D funding round. The round included new investors Foley Ventures and Latham and Watkins, and also inc...

READ MORE...
Thursday, September 15, 2011

Celerus Diagnostics Ups Series C To $10M

Carpinteria-based Celerus Diagnostics, a developer of pathology analysis equipment, has now raised $10M in a Series C funding, according to a regulatory filing from the firm Thursday. Details on the funding have not been released by the com...

READ MORE...
Tuesday, September 13, 2011

RF Surgical Systems Gets $12M

RF Surgical Systems, a developer of systems used to keep track of surgical sponges during surgery procedures, announced Tuesday that it has raised $12M in funding. The firm--which has its R&D facilities in San Diego--said the round was led ...

READ MORE...
Monday, September 12, 2011

Zynx Health In Big Hiring Push

In good news for the LA jobs market, another Los Angeles company is reporting big hiring plans. Los Angeles-based Zynx Health, a developer of clincial decision support software for the healthcare market, said today that it has opened up ove...

READ MORE...
Thursday, September 8, 2011

Amgen Backs Therapeutic Antibody Firm

Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. According to Seattle-based Theraclone Sciences, Amgen Ventures was one of the investors in a $10.6M, Seri...

READ MORE...
Tuesday, September 6, 2011

Uptake Medical Hires European GM

Tustin-based Uptake Medical, the developer of a minimally invasive treatment for severe emphysema, announced today that it has named Lloyd Mencinger as its European General Manager. Mencinger most recently served at Tenent Healthcare, and a...

READ MORE...
Wednesday, August 31, 2011

Amgen Backs Small Molecule Drug Firm

Amgen Ventures, the venture capital arm of Thousand Oaks-based Amgen, has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes. According to Fremont, California-based Ardelyx, ...

READ MORE...
Tuesday, August 30, 2011

ConjuChem, Led By Dr. Patrick Soon-Shiong, Relaunches In LA

ConjuChem, a biotechnology firm focused on developing medicines based on therapeutics peptides, said today that it has relaunched the company, and is now based in Los Angeles under the management of Patrick Soon-Shiong, M.D. The firm, which...

READ MORE...
Wednesday, August 24, 2011

Inogen Gets Debt Financing

Santa Barbara-based Inogen, a manufacturer of oxygen therapy products for the home healthcare industry, has scored a $6M credit facility, according to Square 1 Bank. Terms of the credit facility were not announced. Inogen develops home oxyg...

READ MORE...
Wednesday, August 24, 2011

Awarepoint Pulls In $27M More

San Diego-based Awarepoint, the developer of real-time, location systems for the healthcare market, announced this morning that it has raised $27M in new financing, as part of a Series F round. The round was led by new investor Kleiner Perk...

READ MORE...
Wednesday, August 24, 2011

Zogenix Plans Follow-On Offering

San Diego-based Zogenix, the developer of delivery systems for administering pain medication, is planning a follow on offering of its stock. According to an S-1 filed by the firm today, it is selling 12M shares of its common stock, and is l...

READ MORE...
Tuesday, August 23, 2011

PBS Biotech Acquires Integrity CMI

Camarillo-based PBS Biotech, a developer of bioreactors for the biotech market, said Tuesday that it has acquired Camarillo-based Integrity CMI, a medical device design and manufacturing companies. Financial terms of the deal were not discl...

READ MORE...
Monday, August 22, 2011

Masimo Sued Over Patent

Irvine-based Masimo, the maker of pulse oximetry and other medical monitoring devices, has been sued for patent infringement by competitor Essential Medical Devices, Inc.. According to a filing in the Delaware District Court Friday, Essenti...

READ MORE...
Thursday, August 18, 2011

Sonendo Raises $5.9M

Laguna Hills-based Sonendo, a developer of dental surgery equipment, has raised $5.9M in a funding round, according to a regulatory filing by the firm this week. According to the filing, the $5.9M is part of an ongoing $6.4M equity round. N...

READ MORE...
Wednesday, August 17, 2011

TCA Funds PharmaSecure

The Tech Coast Angels, Southern California's biggest and most active angel investing group, appears to be backing a developer of prescription drug validation systems, based in Lebanon, N.H. According to a regulatory filing from PharmaSecure...

READ MORE...
Wednesday, August 17, 2011

Quality Systems Buys CQI Solutions

Irvine-based Quality Systems, a developer of electronic health records and other health-related IT products, said Wednesday that it has agreed to acquire CQI Solutions, a provider of surgery information systems. Financial terms of the acqui...

READ MORE...
Monday, August 8, 2011

Acutus Medical Raises $1M

San Diego-based Acutus Medical, a developer of medical devices for treating cardiac arrhythmia, said today that it has received $1M in a funding round. The round came form Index Ventures and un-named private investors. Acutus Medical said i...

READ MORE...
Monday, August 8, 2011

Avanir Pharmaceuticals Names Research VP

Aliso Viejo-based Avanir Pharmaceuticals said today that it has named Dr. Joao Siffert as its Senior Vice President Research and Development. Siffert was previously VP and Chief Medical Officer at Ceregene, and has also served at Avera Phar...

READ MORE...
Thursday, August 4, 2011

Vessix Vascular Takes $23M

Laguna Hills-based Vessix Vascular, a developer of catheter technology, said this week that it has raised $23M in a Series B financing round. The round was led by Edmond de Rothschild Investment Partners (EdRIP), and also included Orbimed A...

READ MORE...
Thursday, August 4, 2011

KFx Medical Files Patent Suit Against Competitor

San Diego-based KFx Medical, the venture-backed developer of medical devices used for orthopedic surgery, said this week that it has launched a patent infringement suit against a competitor, Arthrex. KFx medical alleges that Arthrex is infr...

READ MORE...
Wednesday, August 3, 2011

Cynvenio Biosystems Bolsters Board

Westlake Village-based Cynvenio Biosystems, a developer of medical diagnostics technology, said Wednesday that it has bolstered its board of directors with two appointments. According to Cynvenio, Amit Munshi and Simon Raab have joined the ...

READ MORE...
Tuesday, August 2, 2011

Ellipse Technologies Gains $17.6M

Irvine-based Ellipse Technologies, a developer of minimally invasive treatments for spinal deformities, said Tuesday that it has raised $17.6M in a Series C financing round. The round came form HBM BioVentures and BioStar Ventures, along wi...

READ MORE...
Monday, August 1, 2011

CareFusion Completes Acquisition of Rowa

San Diego-based CareFusion, the developer of medical devices, said today that it has completed its acquisition of German firm Rowa, a firm which develops robotics medical storage and retrieval systems for pharmacies. The deal was worth $150...

READ MORE...
Thursday, July 28, 2011

Nexus Biosystems Acquired For $79M

Poway-based Nexus Biosystems, a developer of automated compound and sample management equipment for the life sciences industry, has been acquired by Brooks Automation in a deal worth $79M, the firms said earlier this week. According to Broo...

READ MORE...
Thursday, July 21, 2011

Amira Pharmaceuticals Acquired By Bristol-Myers Squibb

San Diego-based Amira Pharmaceuticals, a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb, the firms said late Thursday. Bristol-Myers Squibb said...

READ MORE...
Wednesday, July 20, 2011

Awarepoint Claims Record Quarter

San Diego-based Awarepoint Corporation, the developer of real-time location systems for the hospital market, claimed today that it had a record quarter, booking over forty-six hospitals and health systems. The firm said the number of bookin...

READ MORE...
Tuesday, July 19, 2011

Allergan Buys Vicept Therapeutics

Irvine-based Allergan said this morning that it has acquired Vicept Therapeutics, a developer of a compound for treating the erythema of rosacea. According to Allergan, it will pay $75M in cash up front, plus up to $200M in earnout dependen...

READ MORE...
Monday, July 18, 2011

Amgen Resolves Patent Suit With Teva

Thousand Oaks-based Amgen said Friday afternoon that it has resolved a patent litigation suite with Teva. The firm said that the United States District Court in Pennsylvania has issued a final judgement and permanent injunction against Teva...

READ MORE...
Thursday, July 14, 2011

Naviscan Bolsters Board

San Diego-based Naviscan, the developer of 3D medical imaging technology, said today that it has added Andre Cheng, M.D., Ph.D., to its board of directors. Cheng has previously served as VP of Medical Affairs and Reimbursement at Acclarent,...

READ MORE...
Monday, July 11, 2011

Kite Pharma Names Scientific Officer

Los Angeles-based Kite Pharma, a biopharmaceuticals firm focused on cancer treatments, announced this morning that it has appointed Adrian Bot, M.D., Ph.D., as its Chief Scientific Officer. Dr. Bot joins the company from MannKind Corp., whe...

READ MORE...
Wednesday, July 6, 2011

Amgen On Final Space Shuttle Mission

Thousand oaks-based biotech giant Amgen said Tuesday that the firm is taking part in a preclinical test on the final, NASA Space Shuttle mission scheduled to launch Friday. According to Amgen, it is in a collaboration with UCB and NASA Ames...

READ MORE...
Wednesday, July 6, 2011

ResMed Buys Irish Firm

San Diego-based ResMed, a developer of medical equipment for treating sleep disorders, said today that it has acquired Irish medical technology firm BiancaMed Ltd.. Financial terms of the buy were not disclosed. BiancaMed is a developer of ...

READ MORE...
Tuesday, July 5, 2011

CareFusion Buys German Firm

San Diego-based CareFusion, the developer of infusion pumps and other medical products, reported today that it is acquiring Rowa, a German firm focused on robotic medical storage and retrieval systems. The deal was worth approximately $150M...

READ MORE...
Thursday, June 30, 2011

Tenex Health Raises $5M

Lake Forest-based Tenex Health, a developer of minimally invasive for treating tendon injuries, said today that it has raised $5M in a series A financing round. The funding was led by VCI Partners. Tenex said the new funding comes on top of...

READ MORE...
Tuesday, June 28, 2011

Experian Buys Medical Present Value

Costa Mesa-based Experian, the provider of credit information and related services, said today that it has acquired venture-backed Medical Present Value, a provider of revenue cycle management software to physicians. Experian said it would ...

READ MORE...
Monday, June 27, 2011

Ivantis Scores $17M For Glaucoma Treatments

Irvine-based Ivantis, a developer of medical devices for the treatment of glaucoma, announced today that it has raised $17M in a new, second round of funding. The round came from New Enterprise Associates and Delphi Ventures. Ivantis said i...

READ MORE...
Monday, June 27, 2011

OSI Systems Gets $3M Contract

Hawthorne-based OSI Systems, the developer of specialized electronics products for the security and healthcare industry, reported today that it has won a $3M contract from a New Jersey health system customer. The award went to its healthcar...

READ MORE...
Thursday, June 23, 2011

Clovis Oncology, With SoCal Backers, Files For IPO

In another, Southern California linked IPO, a Colorado anti-cancer firm. Clovis Oncology, has filed for a debut on the NASDAQ Global Market. Clovis Oncology is backed by Southern California investors Domain Associates and Versant Ventures, ...

READ MORE...
Wednesday, June 22, 2011

Amgen Gives Teachers $10,000 For Teaching Excellence

Thousand Oaks-based Amgen said today that it has awarded 34 science teachers with $10,000 each, in its 19th annual Amgen Award for Science Teaching Excellence. The firm awards the grants each year for "extraordinary" science teachers throug...

READ MORE...
Monday, June 13, 2011

Somaxon Gets $5M In PIPE

San Diego-based Somaxon Pharmaceuticals, a specialty pharmaceuticals firm working on insomnia on other drugs, said today that it has raised $5M in a private placement. The firm said it raised the $5M from Paladin Labs, Inc., and comes in co...

READ MORE...
Friday, June 10, 2011

Ambit Biosciences Raises $30M

San Diego-based Ambit Biosciences, which is developing cancer treatments, announced this morning that it has raised $30M in Series D-2 round of funding. The funding was led by Apposite Capital LLP, and also included prior investors Perseus-...

READ MORE...
Thursday, June 9, 2011

Epiomed Therapeutics Gets Series A

Irvine-based Epiomed Therapeutics, a developer of small-molecule, anti-emetic and anti-motion sickness compounds, said this week that it raised a Series A funding round. The firm said the round came from NDI Capital. Financial details of th...

READ MORE...
Thursday, June 9, 2011

Access Scientific Raises $10M

San Diego-based Access Scientific, a developer of vascular access technology, said today that it has completed a $10M, financing round. The round was led by CAC, and also included the firm's prior investors. The firm said the funding will ...

READ MORE...
Tuesday, June 7, 2011

Ambit Drops IPO Ambitions

San Diego-based Ambit Biosciences has dropped its IPO plans, according to the firm in a filing with the Securities and Exchange Commission Tuesday afternoon. According to the withdrawal request from Ambit, the firm decided that "terms curre...

READ MORE...
Tuesday, June 7, 2011

Billionaire Soon Shiong Funds Healthcare Systems Developer

Los Angeles billionaire entrepreneur Patrick Soon Shiong has made an investment in a healthcare technology firm Net.Orange, Net.Orange said today. The Texas firm provides a suite of web-based applications for the healthcare industry. Financ...

READ MORE...
Friday, June 3, 2011

Otonomy Ups Funding By $14.2M

San Diego-based Otonomy, a firm developing products to treat disorders of the inner and middle ear, looks to have pulled in $14.2M more in a tranched financing which was originally announced last August, according to a regulatory filing by ...

READ MORE...
Thursday, May 26, 2011

Interview with Jake Winebaum, Brighter

Jake Winebaum is a veteran of the Southern California technology industry, having run and sold a number of successful, Southern California startups. His last success was Business.com, which he sold to R.R. Donnelly, and he also was behind e...

READ MORE...
Tuesday, May 24, 2011

Prometheus Laboratories Acquired by Nestle

San Diego-based Prometheus Laboratories, a specialty pharmaceuticals and diagnostics firm, has been acquired by Nestle Health Sciences S.A., a subsidiary of Nestle S.A. Financial terms of the deal were not disclosed. The firms said that the...

READ MORE...
Monday, May 23, 2011

OSI Systems Gets $1.6M Contract

Hawthorne-based OSI Systems, a manufacturer of specialized electronic systems, reported today that it has scored a $1.6M contract. The firm said its Spacelabs Healthcare unit received the order from a South Carolina hospital, for a line of ...

READ MORE...
Friday, May 20, 2011

Aperio Adds To Board

Vista-based Aperio, which develops digital pathology equipment, said Thursday that it has named Thomas Bologna to its board of directors. Bologna is President and CEO of Orchid Cellmark, a provider of DNA identity testing services. Bologna ...

READ MORE...
Thursday, May 19, 2011

AutoGenomics Pulls IPO

Vista-based AutoGenomics, a developer of molecular diagnostics hardware, has pulled its IPO, the firm said in a filing Wednesday evening. The firm said it has "elected not to pursue the sale of securities" but did not give a reason for the ...

READ MORE...
Wednesday, May 18, 2011

Cameron Health Raises $107M

San Clemente-based Cameron Health, which is developing subcutaneous implantable defibrillators, said today that it has raised $107M in an equity financing round. The round was led by Alloy Ventures and Delphi Ventures. the firm said the fun...

READ MORE...
Tuesday, May 17, 2011

CytRx Sells Assets To Orphazyme

Los Angeles-based biopharmaceuticals firm CytRx said late last night that it has sold off the firm's molecular chaperone assets, to Denmark-based Orphazyme ApS. The deal is worth as much as $120M, if all development and commercialization mi...

READ MORE...
Wednesday, May 11, 2011

mobileStorm Turns Eyes Towards Healthcare

Los Angeles-based mobileStorm, the mobile and email messaging and marketing firm headed by Jared Reitzin, said Wednesday that it has launched a new, healthcare focused offering, and signed Humana as a beta client. The firm said its new "mob...

READ MORE...
Wednesday, May 11, 2011

Halozyme Therapeutics In $83M Licensing Deal

San Diego-based Halozyme Therapeutics, a developer of products for the insulin, cancer, dermatology and drug delivery markets, said today along with ViroPharma Incorporate that it is in a $83M licensing deal. The two said that Halozyme has ...

READ MORE...
Tuesday, May 10, 2011

Anti-AgingGames.com Launches Brain Fitness Site

Los Angeles-based Anti-AgingGames.com, a new startup offering up brain fitness games, has launched today, aiming at healthy people looking to help their memory, concentration, and focus. The site--whose games were designed by Atari founder ...

READ MORE...
Wednesday, May 4, 2011

NeuroVigil Gets Funding

La Jolla-based NeuroVigil, a firm developing non-invasive wireless brain recording technology and advanced computational analysis techniques, has raised a first round of funding, the firm said this week. Amount of the funding, and source, w...

READ MORE...
Tuesday, May 3, 2011

TCA Backs Cancer Testing Firm

The Tech Coast Angels, the largest and most active angel investment group in Southern California, is backing a firm developing testing for cervical cancer. According to fellow investor the Sand Hill Angels, OncoHealth Corporation has raised...

READ MORE...
Monday, May 2, 2011

Life Technologies Adds Board Member

Carlsbad-based Life Technologies, the developer of life sciences analysis equipment, said last week that it has named Dr. Ora Hirsch Pescovitz to its board of directors. Pescovitz is Executive Vice President for Medical Affairs and Health S...

READ MORE...
Wednesday, April 20, 2011

TRACON Pharmaceuticals Raises $14M

San Diego-based TRACON Pharmaceuticals, a firm developing cancer therapeutics, said this morning that it has raised $14M in a first tranche closing of a venture round. The round was led by JAFCO and Nextech Invest, and also included Arcus V...

READ MORE...
Tuesday, April 19, 2011

Sangart Raises $50M

San Diego-based Sangart, a firm developing products to prevent and treat ischemia and to stabilize the hemoglobin of sickle cell disease patients, said Tuesday that it has raised $50M in a Series G equity financing round. The round was led ...

READ MORE...
Tuesday, April 19, 2011

Awarepoint Acquires Competitor

San Diego-based Awarepoint, the developer of real time location systems for hospitals, said this morning that it has acquired Patient Care Technology Systems (PCTS). Financial terms of the acquisition were not disclosed. PCTS, based in Char...

READ MORE...
Monday, April 18, 2011

CoDa Therapeutics Adds $19M

San Diego-based CoDA Therapeutics, a developer of chronic wound healing biopharmaceuticals, announced this morning that it has raised $19.2M in a series B financing round. The round came from Domain Associates, GBS Venture Partners and BioP...

READ MORE...
Monday, April 18, 2011

Regulus Therapeutics Names Chief Scientific Officer

La Jolla-based Regulus Therapeutics, a biopharmaceuticals firm developing microRNA-based medicines, said this morning that it has named Neil W. Gibson as its Chief Scientific Officer. Gibson joins the firm from PFizer, and previously has se...

READ MORE...
Thursday, April 14, 2011

Conatus Pharmaceuticals Adds $7.5M

San Diego-based Conatus Pharmaceuticals, a biopharmaceuticals firm working on treatments for hepatitis C, said this week that it has closed on an additional $7.5M in its Series B funding round. The round came from MPM Capital. The new fundi...

READ MORE...
Monday, April 11, 2011

MabVax Therapeutics Gets SBIR Grant

San Diego-based MabVax Therapeutics, a biotechnology firm developing cancer treatments based on vaccine and antibody based therapies, said this morning that it has received $1.8M in a Phase 2, Small Business Innovation Research award. The a...

READ MORE...
Wednesday, April 6, 2011

Arrowhead Research Boosts Investment In Ablaris

Pasadena-based Arrowhead Research said Wednesday that it has boosted its stake in Ablaris Therapeutics, a firm developing treatments for obesity. According to Arrowhead Research, it invested $1.3M in a second close of a Series A financing r...

READ MORE...
Thursday, March 31, 2011

Magnetecs Names CFO

Inglewood-based Magnetecs, a designer of robotic catherization control systems for minimally invasive surgery, announced today that it has named Clive Zickel as the firm's new Chief Financial Officer. Zickel has previously served at JPMorga...

READ MORE...
Wednesday, March 30, 2011

Inspiration Biopharmaceuticals Raises Funding To $247M

Laguna Nigel-based Inspiration Biopharmaceuticals, a developer of treatments for hemophilia, has raised its latest funding to $247.6M, according to a regulatory filing by the firm today. Details on the funding have not been announced by the...

READ MORE...
Tuesday, March 29, 2011

Arena Pharmaceuticals Raises $35.5M in PIPE

San Diego-based Arena Pharmaceuticals, a publicly held developer of pharmaceuticals based on G protein-coupled receptors (GPCRs), announced this morning that it has raised $35.5M in a Series C convertible preferred stock financing. The fund...

READ MORE...
Friday, March 18, 2011

GenMark Diagnostics Appoints CFO

Carlsbad-based GenMark Diagnostics, a developer of molecular diagnostic systems, said Thursday that Paul Ross has been appointed as its Chief Financial Officer. Ross joins from Teledata Technology Solutions, and also has been at Meade Instr...

READ MORE...
Wednesday, March 16, 2011

Amylin Suspends Clinical Trial

San Diego-based Amylin Pharmaceuticals and partner Takeda Pharmaceutical Company reported this morning that they have suspended clinical activities on a Phase 2 study involving its obesity treatment. The firm said the study was voluntarily ...

READ MORE...
Tuesday, March 15, 2011

TriLink Gets SBIR

San Diego-based TriLink BioTechnologies, a biotech startup working on technology for improving PCR processes, said this morning that it has received a $100,000 Phase I, SBIR Grant from the National Institutes of Health. The firm said the fu...

READ MORE...
Thursday, March 10, 2011

Astute Medical Raises $13M

San Diego-based Astute Medical, a firm working on developing diagnostic test using protein biomarkers, said this week that it has raised $13M in a financing round. The round was a Series B extension. The funding came from Domain Associates,...

READ MORE...
Wednesday, March 9, 2011

Kite Pharma Raises $15M

Los Angeles-based Kite Pharma, a biopharmaceuticals firm developing treatments for cancer, said this morning that it has raised $15M in an initial round of funding. The funding was led by TPG Capital. As part of the funding, David Bonderman...

READ MORE...
Tuesday, March 8, 2011

Anabios Gets Angel Backing

Bonita, California-based Anabios, a stealth mode firm working on drug testing services for pain drugs, has scored an angel investment round from the Tech Coast Angels. The funding came from the TCA's new ACE Fund, the angel group's more for...

READ MORE...
Thursday, March 3, 2011

Pharmaron Finds $40M

Irvine-based Pharmaron, a provider of R&D services to the pharmaceutical and biotech industry, said last week that it has raised $40M in a Series C funding round. The round came from DCM, Legend Capital, GL Capital Group, and others. The fi...

READ MORE...
Tuesday, March 1, 2011

Uptake Medical Bolsters Board

Irvine-based Uptake Medical, a developer of non-surgical treatments for lung disease, said today that it has named Scott Huennekens to its board. Huennekens is President and CEO of Volcano Corporation, and also has served at Digirad Corpora...

READ MORE...
Monday, February 28, 2011

JMI Equity Invests In PointClickCare

San Diego- and Baltimore-based private equity firm JMI Equity has invested in PointClickCare, a developer of electronic health records software for the long-term care industry. Financial terms of the deal were not disclosed. PointClickCare ...

READ MORE...
Wednesday, February 23, 2011

Biomatrica Gets Investment From In-Q-Tel

San Diego-based Biomatrica, a developer of technology for storing biological samples at room temperature, announced this morning that it has scored an investment from In-Q-Tel, the investment arm of the U.S. intelligence community. Size of ...

READ MORE...
Friday, February 18, 2011

Calcimedia Gets $6M

La Jolla-based CalciMedica, a developer of small molecule drugs for the treatment of inflammatory and autoimmune diseases, said Thursday that it has raised $6M in a tranche of financing, after initiating a Phase I clinical trial of a treatm...

READ MORE...
Thursday, February 17, 2011

Orexigen Therapeutics Loses CFO

San Diego-based Orexigen Therapeutics announced this morning that its CFO, Graham Cooper, is resigning from the firm. The company said that Cooper is resigning for personal reasons, and partially because he has been commuting from the San F...

READ MORE...
Monday, February 14, 2011

Conatus Pharmaceuticals Raises $20M

San Diego-based Conatus Pharmaceuticals said Friday afternoon that it has closed a $20M, Series B funding round. The firm, which is developing treatments for Hepatitis C, said the funding was led by AgeChem Venture Fund, and also included A...

READ MORE...
Wednesday, February 9, 2011

Orexigen Therapeutics Cuts 40 Percent

San Diego-based Orexigen Therapeutics, which is developing biopharmaceuticals focused on treating obesity, said Wednesday afternoon that it is cutting 40 percent of its staff, or 23 employees. According to Orexigen, the move comes as a resu...

READ MORE...
Tuesday, February 8, 2011

Somaxon Pharmaceuticals Gets Line of Credit, Expands Sales Force

San Diego-based Somaxon Pharmaceuticals said this morning tha tit has scored a $15M, revolving line of credit from Comerica Bank, and also engaged a contract sales force firm. Somaxon said it has tied with Publicis Touchpoint Solutions to r...

READ MORE...
Monday, February 7, 2011

Beckman Coulter Acquired By Danaher For $6.8 Billion

Orange County-based Beckman Coulter, a maker of biomedical testing equipment, said today that it is in a merger agreement with Danaher, where Danaher will buy the firm for $6.8 billion. The deal is worth $83.50 per share in cash, which the ...

READ MORE...
Monday, February 7, 2011

ReVision Optics Names CEO

Lake Forest-based ReVision Optics, which is developing an implantable microlens for treating vision problems, said today that it has named John t. Kilcoyne as its CEO and President. Kilcoyne was most recently Chairman and CEO of Micrus Endo...

READ MORE...
Thursday, February 3, 2011

Glaukos Raises $29.5M

Laguna Hills-based Glaukos, which is developing a medical device for the treatment of glaucoma, has raised $29.5M in a Series E round, the firm confirmed Thursday. According to Richard Harrison, the firm's CFO, the funding was led by Merite...

READ MORE...
Thursday, February 3, 2011

CareFusion Sells Distribution Business For $130M

San Diego-based CareFusion, which develops medical products such as pumps, ventilators, patient identification systems, and more, said this morning that it is selling its CareFusion International Surgical Products (ISP) business to Medline,...

READ MORE...
Thursday, February 3, 2011

Somaxon Pharmaceuticals Names VP

San Diego-based Somaxon Pharmaceuticals announced today that it has appointed Robert Cutler as Vice President Business Development. Cutler was most recently at Biogen Idec, having served as Senior Director Business Development, as well as A...

READ MORE...
Wednesday, February 2, 2011

Patrick Soon-Shiong Buys Vitality Corp.

Patrick Soon-Shiong, the Los Angeles area biotech billionaire, has acquired Vitality Corp., a Cambridge, Massachusetts maker of "smart pills." Financial terms of the acquisition were not disclosed. According to Vitality, the acquisition wil...

READ MORE...
Tuesday, February 1, 2011

VertiFlex Raises $14M For Spinal Implants

San Clemente-based VertiFlex, a developer of medical devices for the treatment of spine disorders, said this afternoon that it has raised $14M in a equity placement. The funding came from Aberdare Ventures, Alta Partners, New Enterprise Ass...

READ MORE...
Monday, January 31, 2011

BAROnova Gets $5.2M

Goleta-based BAROnova, a developer of medical devices to treat obesity, has raised another $5.2M in funding, according to numbers released earlier this month in the PricewaterhouseCoopers/NVCA MoneyTree report. The funding has not yet been ...

READ MORE...
Wednesday, January 26, 2011

Ligand Buys CyDex Pharmaceuticals

San Diego-based Ligand Pharmaceuticals said Wednesday afternoon that it has acquired CyDex Pharmaceuticals, a Kansas-based drug reformulation firm. Ligand said it will pay $31.2M in upfront cash, $4.3M at the one year anniversary of closing...

READ MORE...
Monday, January 24, 2011

Amgen Acquires Firm For $1 Billion

Thousand Oaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex, a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. Amgen said it will pay up to $1 billion for the company,...

READ MORE...
Monday, January 24, 2011

Genoptix Acquired By Novartis For $470M

San Diego-based Genoptix, a publicly held provider of laboratory services to the hematology and oncology market, said this morning that it is in a definitive merger agreement to be acquired by Novartis. According to Genoptix, the deal is wo...

READ MORE...
Thursday, January 20, 2011

TCA Funds Cognition Therapeutics

The Tech Coast Angels, the largest angel investment group in Southern California, is part of a syndicate funding Pittsburgh-based Cognition Therapeutics, a drug discovery firm focused on Alzheimer's. According to Cognition, it raised $2.5M ...

READ MORE...
Wednesday, January 19, 2011

Amgen Sells Fremont Facility

Thousand Oaks-based Amgen said Tuesday afternoon along with Boehringer Ingelheim, that the firm has agreed to sell rights in and substantially all of the assets of its Fremont, Calfiornia development and manufacturing facility. According to...

READ MORE...
Wednesday, January 19, 2011

Illumina Expands in Latin America

San Diego-based Illumina, which manufactures genetic sequencing tools for the life sciences industry, said late Tuesday that it has opened up a new office in Sao Paolo, Brazil, to focus on business across Latin America. Illumina said the of...

READ MORE...
Friday, January 7, 2011

ADVENTRX Pharmaceuticals Raises $22.5M, Plans Acquisition

San Diego-based ADVENTRX Pharmaceuticals said this morning that it has raised $22.5M in funding, via a registered direct offering to RA Capital Management and other investors. According to the publicly traded firm, the new funding will go t...

READ MORE...
Thursday, January 6, 2011

Amgen, Xencor In Development Deal

Thousand Oaks-based Amgen, and Monrovia-based Xencor said Thursday that the two firms are in a co-development dual around a new novel antibody for treating autoimmune diseases. According to the two, Amgen has gained an option to an exclusiv...

READ MORE...
Tuesday, January 4, 2011

Qualcomm Gets Design Win In Blood Glucose Meter

San Diego-based Qualcomm said today that the firm's wireless machine-to-machine modules have been designed into a blood glucose meter product from Telcare Incorporated. According to Qualcomm its Internet of Everything Module (IEM) has been ...

READ MORE...
Thursday, December 23, 2010

Aperio Names CFO

Vista-based Aperio, a provider of digital pathology products, said this week that it has named Patrick Yount as its Chief Financial Officer. Yount joins the firm from Univita Health, and has served at Axia Health Management, Biosensors Inte...

READ MORE...
Tuesday, December 21, 2010

OSI Systems Gets $3M Order

Hawthorne-based OSI Systems, a developer and manufacturer of specialized electronic systems, said today that it has received a $3M order from a Washington state hospital. The firm said its Spacelabs Healthcare division received the $3M orde...

READ MORE...
Monday, December 20, 2010

Capricor Gets $2M

Los Angels-based Capricor, a firm developing stem cell technology to regenerate damaged heart tissue, announced Friday that it has raised $2M in a funding round. The round came from Broadview Ventures and individual investors. According to ...

READ MORE...
Monday, December 20, 2010

Optimer Pharmaceuticals Names VP

San Diego-based Optimer Pharmaceuticals said today that it has named Gregory Papaz as its Senior Vice President of Commercial Operations. Papaz was most recently at Genentech, and als ohas worked at Roche Pharma, Sanofi-Aventis, and Marion ...

READ MORE...
Friday, December 17, 2010

Amgen Gives $1.8M To Teach For America

Thousand Oaks-based Amgen, via its nonprofit foundation, the Amgen Foundation, said Friday that it is giving $1.8M to the Teach For America effort. According to the two, the funding will go towards increasing the number of math and science ...

READ MORE...
Thursday, December 16, 2010

Specialists On Call Finds $11.73M

Westlake Village-based Specialists On Call, a firm developing a service to provide physician specialists to urban, suburban, and other hospitals via videoconferencing, has raised around $11.73M in a series of fundings, according to regulato...

READ MORE...
Thursday, December 16, 2010

Gen-Probe Buys GTI Diagnostics

San Diego-based Gen-Probe has acquired GTI Diagnostics, a specialty diagnostics firm focused on the transplantation, blood bank and specialty coagulation markets, the firm said Wednesday. The deal was worth $53M in cash. GTI was owned by pr...

READ MORE...
Tuesday, December 14, 2010

Endologix Completes Nellix Buy

Irvine-based Endologix said today that it has completed its acquisition of Nellix, a developer of a medical device for the treatment of Abdominal Aortic Anerysms (AAAs). The acquisition had been originally announced in october. Endologix wi...

READ MORE...
Monday, December 13, 2010

SPK Capital Funds Pharmacy Services Firm

Los Angeles-based SPK Capital, an investment firm, has funded San Francisco-based Pipeline Healthcare, Pipeline said last week. Pipeline said SPK Capital led a $2.5M, Series A funding round for the firm. Pipeline Healthcare is a provider of...

READ MORE...
Friday, December 10, 2010

Prometheus Laboratories, UCLA In Research Deal

San Diego-based Prometheus Laboratories, a developer of specialty pharmaceuticals, and the Regents of the University of California, Los Angeles campus, said Thursday night that they are in a exclusive research agreement. The two said that U...

READ MORE...
Wednesday, December 8, 2010

Sofie Biosciences Gets $2M

Culver City-based Sofie Biosciences, a firm developing agents and devices for molecular imaging, said today that it has raised $2M in funding. The round came from Cycad Group and other investors. Sofie Biosciences technology is being applie...

READ MORE...
Tuesday, December 7, 2010

BioIQ Simplifies Wellness Service

Santa Barbara-based BioIQ, the diagnostic testing and screening service provider headed by Justin Bellante, said Tuesday that it has simplified access to personal health records on the site. The firm--which offers up home test kits and scre...

READ MORE...
Monday, December 6, 2010

Awarepoint Raises $9M

San Diego-based Awarepoint, a developer of enterprise, real-time location systems for the hospital market, has raised $9M in a financing round, the firm has announced. According to Awarepoint, the funding came from Cardinal Partners, Jafco ...

READ MORE...
Wednesday, December 1, 2010

Prolacta Bioscience Renews With Breast Milk Group

Monrovia-based Prolacta Bioscience, the venture backed firm which is extracting nutritional fortification from human breast milk, used to help premature and other ill infants, said Wednesday that it has renewed an agreement with the Interna...

READ MORE...
Wednesday, December 1, 2010

Awarepoint Names CEO

San Diego-based Awarepoint, a developer of real-time, asset and patient tracking products for hospitals, said today that it has named Jay Deady as the company's new President and CEO. Deady was most recently EVP of Client Solutions for Ecli...

READ MORE...
Tuesday, November 30, 2010

Histogen Raises $10M

San Diego-based Histogen, a developer of regenerative medicine products, announced today that it has raised $10M in a Series A financing round. The financing came from private investors, including Secure Medical, Leonard Lavin, Lordship Ven...

READ MORE...
Tuesday, November 30, 2010

Total Immersion Applies Technology To Surgery

Los Angeles-based Total Immersion, the developer of augmented reality software tools, reports today that it has added Los Angeles-based Vantage Surgical Systems as a partner. According to Total Immersion, Vantage is looking to use its augme...

READ MORE...
Monday, November 29, 2010

Awarepoint Raises $3.2M

San Diego-based Awarepoint, a developer of real time, location monitoring systems for hospitals, has raised another $3.2M in capital, according to a recent regulatory filing by the firm. The filing indicates current investors Venrock, JAFCO...

READ MORE...
Friday, November 19, 2010

Amgen Gets FDA Approval On Bone Drug

Thousand Oaks-based Amgen said Thursday that it has received U.S. Food and Drug Admnistration (FDA) approval on its denosumab treatment for reducing fractures and other bone problems in cancer patients. The new drug will be sold under the n...

READ MORE...
Tuesday, November 16, 2010

BeneChill Finds $600K

San Diego-based BeneChill, a firm developing medical devices for treatment of cerebral ischemia, has raised $600,000 as part of $1.2M in debt funding, according to a regulatory filing by the firm this week. Source of the new funding was not...

READ MORE...
Thursday, November 11, 2010

Aires Pharmaceuticals Raises $20M, Inks Exclusive With Novartis

San Diego-based Aires Pharmaceuticals, a developer of treatments for pulmonary arterial hypertension, said this morning that it has raised $20M in a Series B funding round. The round was led by MPM Capital, and also included prior investor ...

READ MORE...
Thursday, November 11, 2010

Ceregene Scores $11.5M

San Diego-based biopharmaceuticals firm Ceregene announced this morning that it has raised $11.5M in a Series D funding round. The round was co-led by Hamilton Bioventures and Alta Partners, and also included MPM Capital and Investor Growth...

READ MORE...
Monday, November 8, 2010

Ambit Files For IPO

San Diego-based Ambit Biosciences, a firm discovering, developing and commercializing targeted small molecule therapeutics for treating cancer, has filed for an IPO, saying it is looking to raise up to $86.25M on the Nasdaq Global Market. T...

READ MORE...
Monday, November 8, 2010

Ambit Expands Board, Names Execs

San Diego-based Ambit Biosciences, a developer of small molecule treatments for cancer, said today that it has named Faheem Hasnain as its Chairman of the board, added Alan Fuhrman as its Chief Financial Officer, and promoted Chritopher Mor...

READ MORE...
Friday, November 5, 2010

Caldera Medical Gets Grant

Agoura Hills-based Caldera Medical, a developer of medical devices for the gynecology, urology and urogynecology markets, said this week that it has received two grants worth a total of $488,958 from the U.S. Department of the Treasury. Acc...

READ MORE...
Thursday, November 4, 2010

Zogenix Sets Pricing Range, Offering Size In IPO

San Diego-based Zogenix has updated its S-1, saying this morning the firm intends to offer 6 million shares of its common stock on the Nasdaq Global Market as ZGNX. The firm also said it currently estimates the firm's initial offering price...

READ MORE...
Thursday, November 4, 2010

International Technidyne Acquired By Warburg Pincus, Merges With Nexus Dx

San Diego-based International Technidyne Corporation (ITC), a provider of blood testing devices, has been acquired by private equity firm Warburg Pincus, and also merged with venture backed San Diego firm Nexus Dx. According to ITC, a subsi...

READ MORE...
Tuesday, November 2, 2010

PathCentral Gets $10M More

Irvine-based PathCentral, a provider of pathology services and software to community pathologists, said Tuesday that it has raised $10M in a Series B funding round. The round was led by Okapi Venture Capital, Arboretum Ventures, and Baird V...

READ MORE...
Tuesday, November 2, 2010

GenMark Diagnostics In Licensing Deal

Carlsbad-based GenMark Diagnostics, a developer of molecular diagnostic testing systems, said this morning that it has acquired a non-exclusive license to technology from Innogentics. The firm said the licesne covers Innogenetics' Hepatitis...

READ MORE...
Thursday, October 28, 2010

Endologix Buys Nellix, Gets $15M Investment

Irvine-based Endologix, a developer of minimally invasive treatments for aortic disorders, said this morning that it has agreed to acquire Nellix, a developer of medical devices for treating abdominal aortic aneurysms (AAAs). Endologix said...

READ MORE...
Thursday, October 28, 2010

Regulus Therapeutics Gets $10M From Sanofi-Aventis

La Jolla-based Regulus Therapeutics reports today that it has received $10M in an equity investment from drug maker Sanofi-Aventis. The firm said the investment came as part of its strategic alliance with Sanofi-Aventis, which was signed Ju...

READ MORE...
Wednesday, October 27, 2010

Phenomix Shuts Down, Says Report

San Diego-based Phenomix, a developer of diabetes drugs, has shut down, according to reports. The firm--which was developing drugs to help treat diabetes--apparently has laid off most of its staff, and is looking for a buyer for the assets....

READ MORE...
Wednesday, October 27, 2010

KYTHERA Expands Board

Calabasas-based KYTHERA Biopharmaceuticals said this morning that it has added Francois Kress, the President and CEO of Prada, to its board of directors. KYTHERA, which develops products for the aesthetic medicine market, said that Kress ha...

READ MORE...
Wednesday, October 27, 2010

Response Genetics Loses COO

Los Angeles-based Response Genetics, a developer of molecular diagnostics tests for cancer, said Tuesday that it has lost its Chief Operating Officer, Michael B. McNulty. The reason for McNulty's departure was not announced. The firm said t...

READ MORE...
Tuesday, October 26, 2010

aTyr Pharma Nabs $23M

San Diego-based aTyr Pharma, a developer of biotherapeutics aimed at the blood, immune, and metabolism disorder areas, announced today that it has raised $23M in a Series C equity financing round. The round was led by Domain Associates, and...

READ MORE...
Friday, October 22, 2010

Clarient Acquired By GE Healthcare For $580M

Aliso Viejo-based Clarient, a developer of cancer diagnostic tools, is being acquired by GE Healthcare in a deal worth $580M. According to GE Healthcare, which is a unit of General Electric, it will pay $5.00 per common share or $20.00 per ...

READ MORE...
Thursday, October 21, 2010

Minnow Medical Gets $4.7M

Laguna Hills-based Minnow Medical, a developer of treatments for peripheral vascular disease therapy, said said Wednesday that it has raised $4.7M in a combination of equity and convertible debt. According to the firm, it sold $3.2M in pref...

READ MORE...
Monday, October 18, 2010

CLRS Technology Acquired By Solta Medical

Costa Mesa-based CLRS Technology, a developer of personal care products for treating acne, has been acquired. According to acquiring firm Solta Medical, it is acquiring CLRS for the payment of approximately $1.1M of debt, plus potential fut...

READ MORE...
Saturday, October 16, 2010

Cogent's Ming Hsieh Gives Another $50M To USC

The University of Southern California announced Friday, in conjunction with the inauguration of new president C. L. Max Nikias, that Ming Hsieh, the founder of Monrovia-based COgent, has donated $50M to endow a new instute focused on nano-m...

READ MORE...
Thursday, October 14, 2010

Pathway Genomics Raises Additional Funding

San Diego-based Pathway Genomics, a provider of genetic testing services, has raised additional funding, according to the firm's legal counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Amount, details, and source of the new fundi...

READ MORE...
Tuesday, October 12, 2010

Halozyme Therapeutics Chops 25 Percent

San Diego-based Halozyme Therapeutics, a firm developing biopharmaceuticals for the endocrinology, oncology, dermatology and drug delivery markets, said late Monday that it has cut its workforce by approximately 25 percent, as it says it is...

READ MORE...
Friday, October 8, 2010

Ligand Names New Board Member

San Diego-based Ligand Pharmaceuticals, a developer of a broad line of pharmaceuticals, said today that it has named Sunil Patel to its board of directors. Patel is Senior Vice President of Corporate Development for OncoMed Pharmaceuticals,...

READ MORE...
Thursday, October 7, 2010

Synthetic Genomics, J. Craig Venter Spin Out New Vaccine Startup

La Jolla-based Synthetic Genomics and the J. Craig Venter Institute, the nonprofit genetic research organization of genetic sequencing pioneer J. Craig Venter, said today that they have formed a new company in San Diego, Synthetic Genomics ...

READ MORE...
Thursday, October 7, 2010

Ligand Sells Screening Technology

San Diego-based Ligand Pharmaceuticals announced today that it has agreed to sell its combinatorial compound library and screening technology, in a deal worth $1.8M. According to Ligand, it is selling the technology to Venenum Biodesign, LL...

READ MORE...
Tuesday, October 5, 2010

LivHOME Targets Expansion Via Franchising

Los Angeles-based LivHOME, a venture backed provider of in-home care for seniors, said today that it has launched a franchising program. The firm--which is venture backed by Scale Venture Partners, Tullis Dickerson, and Kilne Hawkes--said t...

READ MORE...
Wednesday, September 29, 2010

Opthonix Sees $5.39M More

Vista-based Opthonix, a developer of wavefront guided, high definition vision eyeglasses, has raised $5.39M as part of an ongoing, $12.1M financing, according to a regulatory filing from the firm earlier this week. Details on the funding ha...

READ MORE...
Monday, September 27, 2010

Valeant Shareholders Approve Biovail Buyout, Despite Objections

Shareholders of Aliso Viejo-based Valeant Pharmaceuticals and Canadian firm Biovail have approved Valeant's acquisition by Biovail, despite objections from Biovail founder Eugene Melnyk and a a number of California state lawmakers. The deal...

READ MORE...
Monday, September 27, 2010

QAD Signs Nexus Dx

Santa Barbara-based QAD, the developer of enterprise resource planning software, said this morning that San Diego-based life sciences firm Nexus Dx has adopted its software. According to QAD, Nexus Dx is using QAD Enterprise Applications, i...

READ MORE...
Friday, September 24, 2010

Cylene Pharmaceuticals Gets $12M

San Diego-based Cylene Pharmaceuticals reported today that it has raised $12M in a financing round, from its existing investors, as it kicks off a Phase I clinical trial. The developer of treatments for multiple myeloma said the funding cam...

READ MORE...
Thursday, September 23, 2010

Cytomx Gets $30M, But Plans Move North

Santa Barbara-based CytomX Therapeutics, a biotechnology firm developing antibodies, said this morning that it has raised $30M in a Series B funding round. The round was led by Third Rock Ventures, and also included the Roche Venture Fund. ...

READ MORE...
Wednesday, September 22, 2010

A-Life Medical Acquired By UnitedHealth

San Diego-based A-Life Medical, a firm which developed software to help physicians to properly code the billing of medical procedures, has been acquired by a unit of UnitedHealth Group, the firms said Tuesday. According to Ingenix, the Unit...

READ MORE...
Wednesday, September 22, 2010

Valeant Plans Cash Payout, Following Biovail Merger

Aliso Viejo-based Valeant Pharmaceuticals, the specialty pharmaceuticals firm that is in the midst of a merger with Biovail, said today that it is planning a one time, special cash dividend of $16.77 per share, in conjunction with the merge...

READ MORE...
Wednesday, September 15, 2010

Interview with Scott Sangster, Health In Reach

Yesterday, there were a lots of startups who launched at the DEMO Fall event in Silicon Valley. One of the local firms that launched was Los Angeles-based Health In Reach (www.healthinreach.com). HealthInReach was founded by Scott Sangste...

READ MORE...
Tuesday, September 14, 2010

Health In Reach Launches Medical Scheduling Service

Los Angeles-based Health In Reach, a new startup founded by Scott Sangster, has launched its new service today at the DEMO Fall conference. Health In Reach is focused on helping patients find doctors, schedule appointments, and receive upfr...

READ MORE...
Monday, September 13, 2010

Kareo Gets $9.5M

Irvine-based Kareo, a developer of web-based medical billing software, announced today that it has raised $9.5M in an investment round. According to Kareo, the funding came from OpenView Venture Partners. The firm said the new funding will ...

READ MORE...
Wednesday, September 8, 2010

Valeant Sees Deeper Job Cuts

Aliso Viejo-based Valeant Pharmaceuticals is planning deeper cuts, after the firm's merger with Biovail, according to an email released by the firm via a regulatory filing Tuesday. According to Valeant, it now expects to cut 25 percent of i...

READ MORE...
Wednesday, September 8, 2010

NEXUS Completes REMP Sample Management Buy

Poway-based NEXUS Biosystems, a developer of automated sample management systems for the pharmaceuticals and biotech industry, said today that it has completed its acquisition of REMP AG of Switzerland, a developer of sample management syst...

READ MORE...
Tuesday, September 7, 2010

Zogenix Files For IPO

San Diego-based Zogenix, a developer of needle-free, delivery systems for the treatment of acute migraines and cluster headaches, has filed for a $90M IPO. The IPO is being underwritten by Wells Fargo Securities, Leerink Swann, Oppenheimer ...

READ MORE...
Tuesday, September 7, 2010

Somaxon In Commercial Availability

San Diego-based pharmaceuticals firm Somaxon Pharmaceuticals reports this morning that it is now in commercial availability of its Silenor compound in the United States. The firm said it has now implemented wholesale and retail stocking of ...

READ MORE...
Wednesday, September 1, 2010

Accumetrics Closes On $24M In Funding

San Diego-based Accumetrics, a developer of medical devices used to measure antiplatelet therapy, a technique used to prevent heart attack and stroke, said this morning that it has closed on a $24M funding round. The firm said the funding c...

READ MORE...
Tuesday, August 31, 2010

CEBIX Raises $14.0M

La Jolla-based Cebix, a developer of treatments for type 1 diabetic neuropathy, has raised $14.0M in a new funding round, according to a regulatory filing by the firm today. Details on the funding have not been announced by the company, how...

READ MORE...
Tuesday, August 31, 2010

DexCom Board Member Departs

San Diego-based DexCom, a developer of continuous glucose monitoring systems, said Monday afternoon that Donald A. Lucas has resigned from the firm's board of directors. Lucas is Founding Managing Member at RWI Group, which was an investor ...

READ MORE...
Monday, August 30, 2010

Otonomy Raises $38.5M

San Diego-based Otonomy, a biopharmaceuticals firm developing products to treat disorders of the inner and middle ear, announced today that it has raised $38.5M in a Series B financing. The round was led by Novo Ventures and RiverVest Ventu...

READ MORE...
Friday, August 27, 2010

Finistere Ventures Targets New Fund

San Diego-based venture capital firm Finistere Ventures, which is focused on early stage medical devices and biotechnology investments, is in the midst of raising a new fund, Finistere Ventures II, according to VentureWire this week. No oth...

READ MORE...
Tuesday, August 24, 2010

GreatCall Expands Into Medication Reminders

Looking to capitalize on the firm's customer demographics, San Diego-based GreatCall, the operator of the Jitterbug easy-to-use cell phone, said today that it has rolled out a new "Medication Reminder" service. The company, which is venture...

READ MORE...
Thursday, August 19, 2010

Enterprise Partners Re-Ups On Complete Genomics

San Diego-based venture capital firm Enterprise Partners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics, Complete Genomics said today. The round was led by Sands Capital, and also included Es...

READ MORE...
Tuesday, August 17, 2010

Life Technologies Buys Ion Torrent

Carlsbad-based Life Technologies, a developer of DNA sequencing technology, said Tuesday afternoon that it has agreed to buy Ion Torrent in a $375M deal. According to the firm, the cash and stock deal also includes up to $350M in additional...

READ MORE...
Tuesday, August 17, 2010

Cibus Global Finds $1.1M

San Diego-based Cibus Global, a developer of technology for engineering agricultural crops, has raised $1.16M in funding, according to a regulatory filing by the firm Tuesday. The funding appears to be part of an ongoing, $2.6M fundraising ...

READ MORE...
Monday, August 16, 2010

REVA Medical Looks To Australia For IPO

San Diego-based REVA Medical, a developer of stents used for treating coronary artery disease, has filed for an IPO in Australia. According to REVA, it is looking to raise up to $63M in an offering on the Australian Securities Exchange. REV...

READ MORE...
Thursday, August 12, 2010

Toshiba Names Business Unit Exec

Tustin-based Toshiba America Medical Systems, the marketing, distribution, and services arm of Toshiba's diagnostic imaging systems group, said today that it has named Stuart Clarkson as Director of its MR Business Unit. Toshiba said Clarks...

READ MORE...
Wednesday, August 11, 2010

CareFusion Cuts 700 Employees

San Diego-based CareFusion, a manufacturer of medical devices including pumps, patient identification systems, ventilators, surgical instruments, and more, said last night that it is cutting 700 jobs in a company-wide restructuring. The fir...

READ MORE...
Tuesday, August 10, 2010

Aspyra Acquired By Orion Healthcare Ventures

Westlake Village-based Aspyra said Monday that it has been acquired by Orion Healthcare Ventures LLC. The firm, which develops healthcare information technology products, did not disclose financial details of the acquisition. Orion Healthca...

READ MORE...
Tuesday, August 10, 2010

MabVax Gets $1.1M In STTR Grant

San Diego-based MabVax Therapeutics, a biotechnology firm focused on vaccine and antibody therapies for treating cancer, said today that it has received a $1.1M, Phase 2 Small Business Technology Transfer Program Award (STTR) from the Natio...

READ MORE...
Tuesday, August 10, 2010

XIFIN Names CFO

San Diego-based XIFIN, a developer of revenue cycle management software-as-a-service for the healthcare industry, said Monday that it has named Craig Kussman as Chief Financial Officer at the firm. Kussman has previously served at Breach Se...

READ MORE...
Thursday, August 5, 2010

Life Technologies, UCSD Tie On Genomic Analysis Effort

Carslbad-based Life Technologies, a developer of genomic analysis technology, and the University of California at San Diego's Moores Cancer Center, said this morning that the two are collaborating on a research effort. According to the two,...

READ MORE...
Wednesday, August 4, 2010

Concerro Names COO

San Diego-based Concerro, a developer of hospital workforce management software, said Tuesday that it has named Cindy Watson as Chief Operating Officer of the firm. Watson was most recently Vice President of Client Services for the firm. W...

READ MORE...
Tuesday, August 3, 2010

Althea Technologies Gets $17M In Venture Debt

San Diego-based Althea Technologies, a provider of contract development and manufacturing for the life sciences market, has raised $17M in debt funding, according to financing provider Hercules Technology Growth Capital. Use for the funding...

READ MORE...
Tuesday, August 3, 2010

Trius Therapeutics To Hit Markets Today In IPO

San Diego-based Trius Therapeutics is set to hit the markets today, after pricing its IPO last night. Trius will trade on the NASDAQ Global Market under the symbol TSRX. Trius, a biopharmaceuticals firm developing antibiotics, priced its IP...

READ MORE...
Monday, August 2, 2010

Trius Therapeutics Chops IPO Offering Price

San Diego-based Trius Therapautics has slashed its IPO offering price, saying today in a filing with the SEC that it will offer 10,000,000 shares of its common stock at $5.00 per share. The firm, which will list on the Nasdaq Global Market ...

READ MORE...
Monday, August 2, 2010

Conatus Pharmaceuticals Buys Idun Pharmaceuticals

San Diego-based Conatus Pharmaceuticals said Friday that it has acquired the Idun Pharmaceuticals subsidiary of Pfizer. Financial terms of the buy were not disclosed. According to Conatus Pharmaceuticals, it is focused on developing drugs f...

READ MORE...
Tuesday, July 27, 2010

Illumina Buys Helixis

San Diego-based Illumina said today it has launched a new, real-time PCR system for the genetic analysis market, and also revealed that it acquired Carlsbad-based Helixis, a developer of those real-time PCR systems. The deal was worth $70M ...

READ MORE...
Monday, July 26, 2010

BioIQ Ups Funding By $1.0M

Santa Barbara-based BioIQ, the provider of online wellness testing and related services for employees and their employers, has upped its latest round of funding to just over $1.0M, according to a regulatory filing from the firm today. Detai...

READ MORE...
Friday, July 23, 2010

Amgen Adds To Board

Thousand Oaks-based biotech giant Amgen said Thursday that it has named Ronald D. Sugar to the firm's board of directors. Sugar is the former Chairman of Northrop Grumman Corp, having served as Chairman and CEO of the defense firm from 2003...

READ MORE...
Friday, July 16, 2010

NEXUS Biosystems Buys Swiss Firm

Poway-based NEXUS Biosystems, a developer of automated sample management systems for the biopharmaceuticals industry, said Thursday that it has signed an agreement to acquire REMP AG, a Swiss-based firm which provides sample management syst...

READ MORE...
Friday, July 16, 2010

Amgen Names New CFO

Thousand Oaks-based biotech giant Amgen announced this morning that it has appointed Jonathan M. Peacock as Chief Financial Officer. Peacock replaces Michael A. Kelly, who has been acting CFO since May. According to Amgen, Peacock joins fro...

READ MORE...
Friday, July 16, 2010

Illumina Names VP

San Diego-based Illumina announced this morning that it has appointed Melina Cimler as Vp Quality and Regulatory Affairs. Cimler joins the firm from PandiaDx Consulting, and has also served at Beckman Coulter, Abbot Molecular, and Gen-Probe...

READ MORE...
Tuesday, July 13, 2010

Zogenix Gets $50M in Debt, Equity

San Diego-based Zogenix announced today that it has just raised $35M in debt, and $15M in equity funding. The developer of biopharmaceuticals said that the $35M in debt came from Oxford Finance Corporation and Silicon Valley Bank, and was s...

READ MORE...
Monday, July 12, 2010

Irvine Scientific Opens Second Facility In Japan

Santa Ana-based Irvine Scientific, a developer of medical devices for the cell culture and biopharmaceutical industry, said this morning that it has opened up a second facility, in Tokyo, Japan. The firm said the new facility will manufactu...

READ MORE...
Thursday, July 8, 2010

Ceres Details Financing Round

Thousand Oaks-based Ceres, a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. The funding came from Artal Luxembourg, Ambergate Trust, Gimv, and other undisclosed ...

READ MORE...
Wednesday, July 7, 2010

Uptake Medical Raises $17.5M

Seattle- and Irvine-based Uptake Medical, a developer of medical technologies for the treatment of lung disease, said today that it has completed a Series B financing round worth $17.5M. Uptake said the round was led by Maverick Capital, an...

READ MORE...
Wednesday, July 7, 2010

Illumina Expands Board

San Diego-based Illumina, a developer of life sciences tools and sequencers, said this morning that it has named Gerald Moller, Ph.D., to its board. Moller is an advisor at investment firm HBM Bio Ventures AG. Moller has previously served a...

READ MORE...
Tuesday, July 6, 2010

LenSx Acquired By Alcon

Aliso Viejo-based LenSx Lasers, a developer of laser technology used for cataract surgery, has been acquired by Alcon, Alcon said late Tuesday. According to Alcon, it will pay $361.5M in cash for LenSx shareholders, plus up to $382.5M in co...

READ MORE...
Friday, July 2, 2010

Illumina Names VP

San Diego-based Illumina announced this morning that it has named Nicholas J. Naclerio, Ph.D., as Senior Vice President, Corporate Development at the firm. Naclerio was the co-founder and executive chairman of Quanterix, and also has served...

READ MORE...
Wednesday, June 30, 2010

TargeGen Acquired By Sanofi-aventis

San Diego-based TargeGen, a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday....

READ MORE...
Wednesday, June 30, 2010

Abraxis BioScience Acquired For $2.9 Billion

Los Angeles-based Abraxis BioScience, a developer of cancer treatments, is being acquired by Celegene Corporation in a deal worth $2.9 billion. According to Celegene, it will pay $58.00 in cash and 0.2617 shares of its common stock for Abra...

READ MORE...
Tuesday, June 29, 2010

AqueSys Gets $35M

Irvine-based AqueSys, a developer of medical devices for the treatment of glaucoma, said today that it has raised $35M in a Series C funding round. The round was led by Longitude Capital and Rho Ventures, and also included Accuitive Medical...

READ MORE...
Monday, June 28, 2010

Xencor In License With MorphoSys

Monrovia-based Xencor, the biopharmaceuticals firm headed by Dr. Bassil Dahiyat, has inked a licensing deal with German pharmaceuticals firm MorphoSys, Morphosys said over the weekend. Accordin to MorphoSys, it has gained an worldwide licen...

READ MORE...
Wednesday, June 23, 2010

Nereus Pharmaceuticals Rounds Up $20M More

San Diego-based Nereus Pharmaceuticals, a firm developing drugs for the treatment of lung cancer, said Tuesday that it has raised another $20M in funding and commitments from its venture backers. The new funding round was led by HBM Biovent...

READ MORE...
Wednesday, June 23, 2010

Spectrum Pharmaceuticals Names Chief Commercial Officer

Irvine-based Spectrum Pharmaceuticals, a biopharmaceuticals firm focused on oncology and hematology, said today that it has named James E. Shields as its Chief Commercial Officer. Shields was most recently with Teva Pharmaceuticals Industri...

READ MORE...
Tuesday, June 22, 2010

DexCom Names COO, CTO

San Diego-based DexCom, a developer of continuous glucose monitoring systems, said today that it has named Steven R. Pacelli as its Chief Operating Officer, and Jorge Valdes as Chief Technology Officer. Pacelli has been Chief Administrative...

READ MORE...
Monday, June 21, 2010

Valeant Merges With Biovail

Aliso Viejo-based pharmaceuticals firm Valeant said today that it has agree to merge with Biovail, a Toronto-based pharmaceuticals developer. According to the firms, the deal calls for Valeant stockholders to receive $16.77 in cash per shar...

READ MORE...
Thursday, June 17, 2010

Gen-Probe Invests $50M In Pacific Biosciences

San Diego-based scientific instruments maker Gen-Probe has invested $50M in a Northern California firm developing DNA sequencing technology, Pacific Biosciences. According to the two firms, Gen-Probe made the investment as part of a larger ...

READ MORE...
Thursday, June 17, 2010

Cyntellect Names CEO

San Diego-based Cyntellect, a life sciences firm developing stem cell and other biopharmaceuticals products, said today that it has named Saiid Zarrabian as the firm's CEO. Zarrabian replaces Fred Koller, who becomes Chief Technology Office...

READ MORE...
Tuesday, June 15, 2010

Prolacta Ties With Susan G. Komen for the Cure

Monrovia, California-based Prolacta Bioscience, the venture backed firm developing human milk fortifiers for premature infants, announced this morning that it will be donating funds to the Susan G. Komen for the Cure as part of its milk don...

READ MORE...
Monday, June 14, 2010

Cytori Gets $20M In Loan Facility

San Diego-based Cytori Therapeutics, a developer of medical devices and instruments for the cosmetic and reconstructive surgery market, announced today that it has received $20M in a loan facility. The facility came from GE Capital, Healthc...

READ MORE...
Monday, June 14, 2010

MP Biomedicals Buys New Zealand Firm

Santa Ana-based MP Biomedicals, a diversified manufacturer of life sciences products, said this morning that it has signed a definitive agreement to acquire New Zealand firm ICPbio International LTD, in an asset deal. ICPbio is a manufactur...

READ MORE...
Friday, June 11, 2010

AqueSys Snags $7.5M

Irvine-based AqueSys, a medical device firm which is working on a proprietary surgical device for the treatment of glaucoma, has raised $7.5M of a $35M funding round, according to a regulatory filing by the firm today. Source of the new fun...

READ MORE...
Friday, June 11, 2010

Otonomy Raises $10M

San Diego-based Otonomy, which is developing treatments for Meniere's disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. According to Otonomy, the funding will go towards supporti...

READ MORE...
Wednesday, June 9, 2010

Otonomy Takes $10.5M

San Diego-based Otonomy, a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M fundraising effort, according to a regulatory filing by the firm. Source...

READ MORE...
Monday, June 7, 2010

Firm With Ties To UCI Gets Backing Of Iacocca Family

A Seattle-area firm, Kineta, with ties to two University of California, Irvine professors has scored funding support from the Iacocca Family Foundation, created by Lee A. Iacocca, the company said today. Kineta said that the Iacocca Family ...

READ MORE...
Thursday, June 3, 2010

Arena Pharmaceuticals Raises $35.5M In PIPE

San Diego-based Arena Pharmaceuticals, a firm developing biopharmaceuticals, including a compound targeted at weight loss and weight management, said today that it is raising $35.5M in an equity investment from Deerfield Management. Publicl...

READ MORE...
Wednesday, June 2, 2010

Life Technologies Invests in Synthentic Genomics

Carlsbad-based Life Technologies said Wednesday that it has made an equity investment in Synthetic Genomics, a firm commercializing synthetic genomic advances. Terms of the investment were not announced. Synthetic Genomics develops technol...

READ MORE...
Wednesday, June 2, 2010

Amgen Gets FDA Approval On Prolia

Thousand Oaks-based Amgen said Tuesday evening that it has received U.S. Food and Drug Administration (FDA) approval on its pRolia treatment of osteoporosis for postmenopausal women. The firm said the approval was based on its Phase 3 study...

READ MORE...
Tuesday, June 1, 2010

Altura Medical Scores $20M

San Clemente-based Altura Medical announced this morning that it has raised $20M in a Series A financing round. The firm said the funding was led by New Leaf Venture Partners, and also included Advanced Technology Ventures and SV Life Scien...

READ MORE...
Friday, May 28, 2010

Life Technologies Buys Majority Stake In Geneart

Carlsbad-based Life Technologies announced this morning that it has acquired a majority stake in Geneart AG, a synthetic biology company. The firm said it now owns approximately 74 percent of Geneart, after purchasing approximately 554,000 ...

READ MORE...
Friday, May 28, 2010

GenMark Chops IPO Offering Price

Pasadena-based Genmark Diagnostics, a maker of molecular diagnostics equipment, lowered its initial public offering price to between $6.00 and $7.00 per share yesterday, down from an earlier anticipated initial public offering price of betw...

READ MORE...
Thursday, May 27, 2010

Valeant Completes Aton Pharma Buy

Aliso Viejo-based Valeant Pharmaceuticals said today that it has completed its acquisition of Aton Pharma, a specialty pharmaceuticals firm focused on ophthalmology and other drugs. The deal was worth $318M. Aton Pharma was based in lawrenc...

READ MORE...
Tuesday, May 25, 2010

ReVision Optics Raises $35M

Lake Forest-based ReVision Optics, a firm developing implantable lenses for correcting vision, announced Tuesday that it has raised $35M. The round was led by ProQuest Investments, and also included Domain Associates, Canaan Partners, and I...

READ MORE...
Tuesday, May 18, 2010

ReVision Optics Sees $35M

Lake Forest-based ReVision Optics, a developer of implantable lenses for treating presbyopia, has received $35.0M in a new round of venture funding, according to a regulatory filing by the firm Tuesday. Details on the funding have not yet b...

READ MORE...
Tuesday, May 18, 2010

CareFusion Completes Medegen Buy

San Diego-based CareFusion, a provider of medical devices, said Monday that it has completed its $225M cash acquisition of Medegen, a developer of needleless access connectors for delivering intravenous medication to patients. The acquisiti...

READ MORE...
Monday, May 17, 2010

Halozyme Warns Baxter On Manufacturing Issues

San Diego-based Halozyme Therapeutics said over the weekend that it has delivered notice to Baxter Healthcare, that Baxter is in breach due to failure to provide its HYLENEX (hyaluronidase human injection) product per the firm's development...

READ MORE...
Thursday, May 13, 2010

Enclarity Gets Investment From Emdeon

Aliso Viejo-based Enclarity, a developer of healthcare information solutions, recently received an investment from Nashville, Tennessee-based Emdeon. Financial terms of the investment were not announced, however, Emdeon said that the minori...

READ MORE...
Thursday, May 13, 2010

Sequent Medical Raises $15.6M

Aliso Viejo-based Sequent Medical, a firm focused on medical devices for treating neurovascular disease, said Thursday that it has raised $15.6M in a Series B funding round. The funding was led by Domain Associates, and also included Versan...

READ MORE...
Tuesday, May 11, 2010

Astute Medical Finds $26.5M

San Diego-based Astute Medical, a developer of biomarker-based medical diagnostics products, has raised $26.5M in a Series B funding round, the firm said yesterday. The round was co-led by Domain Associates and Delphi Ventures. According to...

READ MORE...
Tuesday, May 4, 2010

Livestrong Looks To USC For Chief Medical Advisor

Santa Monica-based LIVESTRONG.COM, the online health information site run by Demand Media and the Lance Armstrong Foundation, said today that it has named Dr. Leslie Anne Saxon as its Chief Medical Advisor. Saxon is Professor of Medicine, C...

READ MORE...
Monday, May 3, 2010

Canon Communications Buys Pharmaceuticals Blog Pharmalot

Los Angeles-based Canon Communications, a publisher and trade show operator serving the pharmaceutical industry, said Monday that it has acquired Pharmalot, a blog focused on news and information in the pharmaceutical industry. Financial te...

READ MORE...
Monday, May 3, 2010

ADVENTRX Pharmaceuticals Gets $19.2M

San Diego-based ADVENTRX Pharmaceuticals, a publicly held developer of cancer treatments, said today that it is in a private placement where it will receive $19.2M in a Series F convertible preferred stock round. Source of the new funding w...

READ MORE...
Monday, May 3, 2010

InTouch Health Gets $10M, Eyes Public Markets

Santa Barbara-based InTouch Technologies, a developer of remote presence systems used for the healthcare industry, announced today that it has raised $10M in a private placement. The round came from Beringea, via its InvestMichigan! Growth ...

READ MORE...
Monday, May 3, 2010

Althea Technologies Buys Altus Pharmaceuticals

San Diego-based Althea Technologies, a contract development and manufacturing firm for the biopharmaceuticals industry, said today that it has acquired the assets and IP portfolio of Altus Pharmaceuticals. Financial terms of the deal were n...

READ MORE...
Friday, April 30, 2010

Illumina Names Two VPs

San Diego-based Illumina, a developer of gene sequencing tools, said today that it has named Elizabeth Brady as the firm's Vice President, Global Supply Chain, and Emily S. Winn-Deen, Ph.D., as its Vice President, Diagnostics Development. B...

READ MORE...
Thursday, April 29, 2010

Schrodinger Gets Investment From Bill Gates

Schrodinger, a firm focused on computational drug design for the pharmaceuticals and biotechnology research industry, announced today that Bill Gates--through his investment firm, Cascade Investment--has invested in the company. The firm, w...

READ MORE...
Tuesday, April 27, 2010

Amgen Names President, COO

Thousand Oaks-based Amgen announced this morning that it has named Robert A. Bradway as the firm's President and Chief Operating Officer. Bradway has been at Amgen since 2006, and was most recently Executive Vice President and Chief Financi...

READ MORE...
Tuesday, April 27, 2010

KYTHERA Biopharmaceuticals Names VP

Los Angeles-based Kythera Biopharmaceuticals, which is developing aesthetic medicine products, said today that it has named Pierre J.G. Corin as the firm's Vice President, Global Clinical Operations. Corin joins the firm from Allergan Medic...

READ MORE...
Thursday, April 22, 2010

Aragon Pharmaceuticals Raises $22M

San Diego-based Aragon Pharmaceuticals, a developer of treatments for hormonally driven cancers, said today that it has raised $22M in a Series B funding. The funding came from Aisling Capital, OrbiMed Advisors, and the Column Group. As par...

READ MORE...
Wednesday, April 21, 2010

Valeant Buys Brazilian Pharmaceuticals Firm

Aliso Viejo-based Valeant Pharmaceuticals announced today that it has entered into a binding agreement to acquire a pharmaceuticals firm located in Brazil, in a deal worth approximately $56M (97 million Brazilian reals). According to Valean...

READ MORE...
Tuesday, April 20, 2010

CardioPolymers Adds $1.35M

Laguna Hills-based CardioPolymers, a developer of an implantable device for treating congestive heart failure, has added $1.35M to its venture funding, according to numbers from the latest PricewaterhouseCoopers/NVCA quarterly venture capit...

READ MORE...
Monday, April 19, 2010

Sotera Wireless Raises $10.75M

San Diego-based Sotera Wireless, a developer of patient monitoring technology, announced Monday afternoon that it has raised $10.75M in a strategic investment round. The round was led by West Family Holdings, LLC, and also included prior in...

READ MORE...
Tuesday, April 13, 2010

AltheaDx Raises $6M

San Diego-based AltheaDx, a developer of molecular diagnostics products, has raised $6M in a Series A round, the firm revealed today. The firm said the round was led by Telegraph Hill Partners. AltheaDx is focused on developing diagnostic t...

READ MORE...
Monday, April 12, 2010

Sotera Wireless Lands $10.7M

San Diego-based Sotera Wireless, a developer of wireless vital signs management product, has raised $10.7M as part of an ongoing, $15.0M funding round, accoridng to a regulatory filing today. Source of the new funding was not disclosed. The...

READ MORE...
Friday, April 9, 2010

Amplyx Pharmaceuticals Gets $1.5M

San Diego-based Amplyx Pharmaceuticals announced Thursday that the firm has raised $1.5M in a Series A funding round. According to the firm, the round came from Golden Seeds, a nationwide angel group investing in women-led companies, with p...

READ MORE...
Friday, April 9, 2010

NexMed Adds Execs

San Diego-based NexMed, a specialty contract research organization, announced earlier this week that it has named Terry Ladd as Vice President of Business Development at its Bio-Quant subsidiary, and Richard Martin as Vice President of Chem...

READ MORE...
Thursday, April 8, 2010

Fate Therapeutics Acquires Verio Therapeutics

San Diego-based Fate Therapeutics, a developer of stem cell therapeutics, announced this morning that it is in a definitive agreement to acquire Canadian biotechnology firm Verio Therapeutics. Financial terms of the acquisition were not dis...

READ MORE...
Monday, April 5, 2010

Accelrys, Symyx In Merger

San Diego-based Accelerys and Santa Clara-based Symyx announced this morning that the two are in a all-stock merger to create a new, scientific information software firm. The firms said that Symyx shareholders will receive 0.7802 shares of ...

READ MORE...
Monday, April 5, 2010

CareFusion Acquires Medegen For $225M

San Diego-based CareFusion, a firm that develops a wide range of medical devices, said today that it is paying $225M in cash for Ontario, California-based Medegen. Medegen develops needleless access valves and disposable IV sets that are us...

READ MORE...
Tuesday, March 30, 2010

Reverse Medical Raises $14M

Irvine-based Reverse Medical Corporation, a developer of microcatheters for treating neurovascular disorders, announced today that it has raised $14M in a Series B funding round. The firm said that the new funding came from Wexford Capital,...

READ MORE...
Monday, March 29, 2010

Cynvenio Biosystems Names VPs

Westlake Village-based Cynvenio Biosystems announed this morning that the firm has appointed two new VPs. According to Cynvenio, it has added David J. Sauvageau as the firm's Vice President, Engineering and Product Development, and Dr. Paul...

READ MORE...
Monday, March 29, 2010

Response Genetics Loses CFO

Los Angeles-based Response Genetics, a firm developing molecular diagnostic tests for cancer, announced this morning that its Chief Financial Officer, Thomas Stankovich, has resigned. The firm said that Stankovich resigned to "pursue other ...

READ MORE...
Thursday, March 25, 2010

Cyntellect Raises $3.0M

San Diego-based Cyntellect, a developer of cytometry equipment, has raised $3.0M in a new funding round, according to a regulatory filing from the firm earlier this week. Details on the funding have not been disclosed by the company. Cyntel...

READ MORE...
Thursday, March 25, 2010

Genomatica Raises $15M

San Diego-based Genomatica, a developer of chemical processes based on bio-manufacturing, has raised $15M in a Series C funding round, the firm announced today. According to the firm, the new funding was led by TPG Biotech, and also include...

READ MORE...
Monday, March 22, 2010

Gc-Free Raises $700K

Vista-based Gc-Free, a firm developing diagnostic tools to predict risks of colon, prostate, breast and other cancers, has raised $700,000 in an equity funding, according to a regulatory filing by the firm today. Source of the funding was n...

READ MORE...
Friday, March 19, 2010

Elcelyx Therapeutics Gets $1.2M

San Diego-based Elecelyx Therapeutics, a stealth mode biotech firm, has raised $1.2M in a funding round, which includes Morgenthaler Ventures, according to a regulatory filing this week. Details on the funding have not been announced by the...

READ MORE...
Friday, March 19, 2010

Valeant Buys Brazilian Firm

Aliso Viejo-based Valeant Pharmaceuticals announced today that it is in an agreement to buy a Brazilian manufaturer of branded, generic and over the counter pharmaceuticals. According to Valeant, the deal is worth approximately $28M. Valean...

READ MORE...
Friday, March 19, 2010

Genmark Diagnostics Files For IPO

Pasadena-based Genmark Diagnostics, a developer of a diagnostic biomarker detection system, has filed for an IPO, saying it is looking to raised up to $46.0M in an IPO on the NASDAQ Global Market. The firm said it is looking to trade as GNM...

READ MORE...
Monday, March 8, 2010

Isis Gets $6M From Bristol-Myers Squibb

Carlsbad-based Isis Pharmaceuticals, a firm developing antisense drugs for treating cardiovascular, metabolic and severe neurodegenerative diseases, and cancer, said this morning it has earned $6M in a milestone payment from Bristol-Myers S...

READ MORE...
Thursday, March 4, 2010

Enigma Diagnostics Sets Up Shop In San Diego

Oxford, England-based Enigma Diagnostics, a molecular diagnostics firm, said today that it has opened up a new, regional headquarters in San Diego. Enigma said the new, 17,000 sq. ft. office is in the Sorrento Valley, where it will house sa...

READ MORE...
Wednesday, March 3, 2010

La Jolla Pharmaceutical Dropped From Nasdaq

San Diego-based La Jolla Pharmaceuticals, the failed biopharmaceuticals firm which was previously developing treating lupus renal disease, reported today that it has received notification from the Nasdaq that it will be delisted from the ma...

READ MORE...
Monday, March 1, 2010

Valeant Links With Spear Pharmaceuticals

Aliso Viejo-based Valeant Pharmaceuticals said today that it has entered into an agreement with Spear Pharmaceuticals, where the firm will commercialize a cream used to reduce wrinkles and fade irregular pigmentation due to sun damage. Vale...

READ MORE...
Thursday, February 25, 2010

Trius Therapeutics Sets IPO Pricing Range

San Diego-based Trius Therapeutics, which is looking to IPO on the Nasdaq as TSRX, indicated in a filing today that it is looking to price its IPO at between $12.00 and $14.00 per share. The firm's IPO is being underwritten by Credit Suiss...

READ MORE...
Tuesday, February 23, 2010

Toshiba America Medical Names Marketing VP

Tustin-based Toshiba America Medical Systems, a manufacturer of diagnostic imaging systems for the healthcare market, said today that it has named Doug Ryan as Vice President, Marketing and Strategic Development, heading up the firm's strat...

READ MORE...
Monday, February 22, 2010

Quidel Completes Diagnostic Hybrids Acquisition

San Diego-based Quidel, a developer of medical diagnostic tests, said Friday that it has completed its $130M acquisition of Diagnostic Hybrids. Diagnostic Hybrids was located in Athens, Ohio, and develops in-vitro diagnostic assays used by ...

READ MORE...
Thursday, February 18, 2010

TriTech Software Buys Health Care Technology Firm

San Diego-based TriTech Software Systems, a developer of public safety and other software for law enforcement, fire and emergency management services agencies, said Thursday that it has entered into an agreement to acquire Ortivus North Ame...

READ MORE...
Wednesday, February 17, 2010

Tioga Pharmaceuticals Riases $18M

San Diego-based Tioga Pharmaceuticals said today that it has raised $18M in a new equity funding. The funding came from Forward Ventures, New Leaf Venture Partners, BB Biotech Ventures, and Genesys Capital Partners. According to Tioga, the ...

READ MORE...
Friday, February 12, 2010

NexMed Gets $2.7M In Private Placement

San Diego-based NexMed, a clinical research organization focused on in vitro and in vivo pharmacology services, said earlier this week that it raised $2.3M in a private placement. Name of the investors were not disclosed. The firm said the ...

READ MORE...
Thursday, February 11, 2010

Quality Systems Buys Opus Healthcare Solutions

Irvine-based Quality Systems, which develops healthcare information systems, said today that it is in an agreement to acquire Opus Healthcare Solutions, a provider of web-based, clinical information systems. Financial details of the buy wer...

READ MORE...
Wednesday, February 10, 2010

UCLA Looks To Tap Social Networks In Teen Health Effort

The UCLA School of Public Health is looking to tap into the power of social networks, in an attempt to encourage adolescents from 13 to 17 to take better care of their health. According to health care insurer Health Net and UCLA, the two ar...

READ MORE...
Tuesday, February 9, 2010

Xencor Names Baracchini Business Head

Monrovia-based Xencor, a developer of antibody discovery technology, said this morning that it has named Edgardo Baracchini, Ph.D., as Chief Business Officer at the company. Baracchini joins the firm from Metabasis Therapeutics, where he wa...

READ MORE...
Monday, February 8, 2010

PatientSafe Nabs $30M

San Diego-based PatientSafe Solutions, a developer of software and bar code systems used for management of patient and workflow management in hospitals, has reported raised $30M in a new round of funding. The funding was first reported by V...

READ MORE...
Monday, February 8, 2010

OrthAlign Gets $5.16M

Laguna Beach-based OrthAlign, a developer of medical devices for computer assisted surgery, has raised $5.16M in a Series A-2 funding round. Source of the funding was not announced by the firm, however, the firm has previously raised capita...

READ MORE...
Monday, February 8, 2010

Tragara Pharmaceuticals Snags $5M

San Diego-based Tragara Pharmaceuticals, a developer of biopharmaceuticals aimed at cancer and inflammation treatments, has raised another $5M in a funding round, according to a regulatory filing by the firm last week. The filing indicates...

READ MORE...
Monday, February 1, 2010

Life Technologies Completes Mass Spectrometry Business Sale

Carlsbad-based Life Technologies, a manufacturer of scientific equipment to the life sciences industry, has completed its sale of its mass spectrometry business to Danaher in a deal worth $450M in cash, the firm announced this morning. The...

READ MORE...
Thursday, January 28, 2010

Abraxis Plans Spinoff, Names Execs

Los Angeles-based Abraxis BioScience confirmed this morning that it is still planning on a spinoff of its Abraxis Health division this year, and has named a number of executives as part of the effort. According to Abraxis, it has named Bruc...

READ MORE...
Wednesday, January 27, 2010

Neomend Raises $30M

Irvine-based Neomend, a developer of sealants for the surgical market, announced this morning that it has raised $30M in a Series D funding round. Neomend said the round was led by Clarus Ventures, which contributed $17M of the total round....

READ MORE...
Thursday, January 21, 2010

Elevation Pharmaceuticals Gains $30M

San Diego-based Elevation Pharmaceuticals, a biopharmaceuticals firm developing treatments for repiratory diseases, said Thursday that it has closed on $30M of Series A funding. The funding came from Canaan Partners, TPG Growth, Care Capita...

READ MORE...
Wednesday, January 20, 2010

US Healthworks Gains $175M

Valencia-based U.S. HealthWorks, an operator of occupational health care centers, said today that it has raised $175M in a combination of debt and equity. The firm said the funding will go towards its growth and acquisition strategy. The fu...

READ MORE...
Friday, January 15, 2010

Amgen Donates $2M To Haiti Earthquake Relief

Thousand Oaks-based Amgen said Thursday that it is donating $2M to Haiti relief efforts, as well as encourage its staff to contribute their own funds to organizations aiding in relief and rebuilding efforts in the country. According to Amge...

READ MORE...
Thursday, January 14, 2010

Aliva Pharmaceuticals Raises $12.87M

Pasadena-based Aliva Pharmaceuticals, a firm developing animal systems for predicting human drug profiles, has raised $12.87M in funding, according to a recent regulatory filing by the firm. Source of the new funding was not disclosed. Acco...

READ MORE...
Tuesday, January 12, 2010

SEDLine Gets Investment, Acquires Hospira Unit

Irvine-based SEDLine said today that it has acquired Hospira's brain function monitoring business, and scored an equity investment from Masimo. Financial details of the acquisition were not disclosed by the firm. According to SEDline, the f...

READ MORE...
Tuesday, January 12, 2010

VentiRx Gets $25M In Series A Extension

San Diego-based biopharmaceuticals firm VentiRx Pharmaceuticals said today that the firm has raised $25M in a Series A extension round. The firm, which is developing treatments for cancer, respiratory, and inflammatory disease, said the rou...

READ MORE...
Monday, January 11, 2010

Cynvenio Biosystems Gets Nearly $2M

Westlake Village-based Cynvenio Biosystems, a developer of high speed, bioseparation instruments for the life sciences market, has raised $1.96M in a Series B funding round, according to a regulatory filing by the firm today. Source of the ...

READ MORE...
Monday, January 11, 2010

Advanced Cardiac Therapeutics Raises $5M

Laguna Beach-based Advanced Cardiac Therapeutics, which develops advanced cardiac ablation systems, said this morning that it has raised $5M in a Series B funding. According to the firm, the funding was led by NBGI Ventures. The firm said t...

READ MORE...
Monday, January 11, 2010

Tandem Diabetes Nabs $31M

San Diego-based Tandem Diabetes, a developer of insulin pumps, has raised another $31.0M in funding, bring its current funding round to $52.3M, according to a regulatory filing by the firm lsat week. Source of the new funding was not disclo...

READ MORE...
Monday, January 11, 2010

Zynx Health Ties With MEDITECH

Los Angeles-based Zynx Health, a provider of clinical decision support systems for the healthcare industry, announced this morning that it has tied with IT healthcare provider MEDITECH, to offer a package addressing the American Recovery an...

READ MORE...
Monday, January 11, 2010

Quidel Buys Diagnostic Hybrids

San Diego-based Quidel, a developer of diagnostic tests, said today that it is in a definitive agreement to acquired Diagnostic Hybrids, a manufacturer of in-vitro diagnostic assays, in a deal worth approximately $130M in cash. According to...

READ MORE...
Friday, January 8, 2010

Inovio Taps Merck For Chief Medical Officer

San Diego-based Inovio Biomedical said this week that it has tapped a Merck veteran for its new Chief Medical Officer. According to Inovio, it has hired on mark L. Bagarazzi, M.D>, as Chief Medical Officer heading up worldwide clinical deve...

READ MORE...
Friday, January 8, 2010

Traversa Names Research VP

San Diego-based Traversa Therapeutics, a biopharmaceuticals firm developing RNA interference (RNAi) technology, said earlier this week that it has named Curt W. Bradshaw as Vice President of Research and Development. Bradshaw joins the firm...

READ MORE...
Thursday, January 7, 2010

Marlin Equity Partners Buys Life Sciences Software Firm

Los Angeles-based private equity firm Marlin Equity Partners has acquired Pennsylvania-based Liquent, a developer of software and services for the life sciences industry, from Thomson Reuters. Financial details of the deal were not disclose...

READ MORE...
Wednesday, January 6, 2010

Christie Acquires Luminetx

Cypress-based Christie Digital Systems, a developer of digital display systems, said Wednesday morning that it has acquired substantially all of the assets of Luminetx, a developer of medical devices used for detecting and mapping veins in ...

READ MORE...
Monday, December 21, 2009

Ambit Deal With Astellas Pharma Worth As Much As $350M

San Diego-based Ambit Biosciences inked a deal Friday with Astellas Pharma Inc., where Astellas will pay the firm $40M in cash, and up to $350M in pre-commercialization milestones, in a joint partnership to develop and commercialize Ambit's...

READ MORE...
Wednesday, December 16, 2009

Xencor Gets Milestone Payment

Monrovia-based Xencor, a developer of antibody engineering technology, reported today that the firm has received a milestone payment from Pfizer, as part of the firm's antibody technology license agreement with Pfizer. Amount of the payment...

READ MORE...
Tuesday, December 15, 2009

Amgen Licenses Rights For Diabetes Drug

Thousand Oaks-based Amgen and Colorado-based Array BioPharma announced Monday evening that Amgen is licensing the exclusive worldwide rights to Array's compounds for treating Type 2 diabetes, in a deal worth $60M plus additional contingent ...

READ MORE...
Monday, December 14, 2009

Calixa Therapeutics Acquired By Cubist Pharmaceuticals, In Big Win For Domain

San Diego-based Calixa Therapeutics, a biopharmaceuticals firm developing antibiotics to treat multi-drug resistant organisms, has been acquired by Cubist Pharmaceuticals, a Massachusetts-based biotherapeutics firm. The deal was worth $92.5...

READ MORE...
Thursday, December 10, 2009

Pfenex Spins Out From Dow Chemical With $24M

San Diego-based Pfenix, a new startup focused on biotechnology technology for producing proteins, has spun out of Dow Chemical Company, Pfenex said this week. As part of the spinout, the firm has received $24M in a Series A funding round. T...

READ MORE...
Tuesday, December 8, 2009

EVOFEM Gains $25M

San Diego-based EVOFEM, a firm developing feminine hygiene products, said today that it has raised $25M in a private equity investment. Name of the investor was not disclosed. EVOFEM--which was formerly known as Instead Healthcare--is devel...

READ MORE...
Monday, December 7, 2009

Zogenix Ups Series B To $71M

San Diego-based Zogenix, a pharmaceuticals firm developing neuroscience disorders and pain treatments, said Monday that it has closed on $35M in a second tranche of Series B funding, bringing the firm's Series B to a total of $71M. The firm...

READ MORE...
Monday, December 7, 2009

Nexus Biosystems Acquires Aurora Biotechnologies

Poway-based NEXUS Biosystems, a developer of automated sample management systems for the biotech industry, announced this morning that it has acquired Carlsbad-based Aurora Biotechnologies, a developer of microplate products used for sample...

READ MORE...
Monday, December 7, 2009

Somaxon Gets Rejection From FDA

San Diego-based Somaxon Pharmaceuticals, a developer of a drug for the treatment of insomnia, reported this morning that it has received a response from the U.S. Food and Drug Administration on its NAD for Silenor, the firm's treatment of i...

READ MORE...
Monday, December 7, 2009

Xencor Names Chairman

Monrovia-based Xencor, a developer of biotherapeutics, said today that it has named Bruce Carter, Ph.D., most recently the Chief Executive Officer of ZymoGenetics, as Chairman of the firm's board of directors. Carter has also served as Corp...

READ MORE...
Thursday, December 3, 2009

Salk Insitute Adds VC To Board

La Jolla-based Salk Institute for Biological Studies, known for its life science research, disclosed this morning that the firm has added venture capitalists Fred Dotzler to its board of trustees. The institute said that Dotzler, co-founder...

READ MORE...
Monday, November 30, 2009

Xencor Licenses Technology To Centocor

Monrovia-based Xencor, a developer of biotherapeutics technology to improve antibodies, said this morning that it has licensed its Fc engineering technology to Centocor Research & Development, Inc. Financial details of the license were not ...

READ MORE...
Tuesday, November 17, 2009

NextImage Medical Gains $5M

San Diego-based NextImage Medical, a provider of radiology services to the worker's comp market, said Tuesday that it has raised $5M in a Series A funding round. The round was led by Chrysalis Ventures. NextImage said the funding will go to...

READ MORE...
Monday, November 16, 2009

Fate Therapeutics Raises $30M

La Jolla-based Fate Therapeutics is reporting this morning that it has raised $30M in a Series B financing round. The firm, which develops stem cell therapies, said the funding was led by OVP Venture Partners, and included Astellas Venture ...

READ MORE...
Thursday, November 12, 2009

Cyntellect Raises $15.5M

San Diego-based Cyntellect, a developer of products for the biotech industry, has raised $15.5M, according to a regulatory filing from the firm this week. The funding is part of an ongoing, $18.6M fundraising effort, and includes both equit...

READ MORE...
Wednesday, November 11, 2009

Altair Therapeutics Raises $17M

San Diego-based Altair Therapeutics said Wednesday afternoon that it has raised $17M in a financing round. According to the firm, the round was led by Domain Associates, and also included AgeChem Venture Fund; Thomas, McNerney & Partners; F...

READ MORE...
Tuesday, November 10, 2009

Life Technologies Buys BioTrove

Carlsbad-based Life Technologies said today that it has signed a definitive agreement to acquire BioTrove, a developer of a high throughput gene expression and genotyping analysis system. Financial details of the acquisition were not disclo...

READ MORE...
Monday, November 9, 2009

Advanced Bionics Acquired By Sonova

Valencia-based Advanced Bionics, a manufacturer of cochlear implants, said Monday that it has entered into a definitive merger agreement with Sonova Holdings AG. Financial details of the acquisition were not announced. According to Advance...

READ MORE...
Monday, November 9, 2009

Trius Therapeutics Files For IPO

San Diego-based Trius Therapeutics has filed for an IPO, saying Friday that it is looking to raise $86.25M in an offering on the Nasdaq Global Market. According to the firm's filing, it has applied to trade under the symbol TSRX. The IPO is...

READ MORE...
Thursday, November 5, 2009

Abraxis Health Expands In Arizona

Los Angeles-based Abraxis Health, the personalized healthcare division of Abraxis BioScience, said this morning that it is expanding in Arizona, and will open up a new biopharmaceuticals manufacturing plant in Phoenix. Abraxis said the plan...

READ MORE...
Tuesday, November 3, 2009

Accenx Acquired By Initiate Systems

Irvine-based Accenx Technologies, a provider of health information exchange software, has been acquired by Initiate Systems, a data management firm based in Chicago. Financial terms of the deal were not released. According to Initiate, the ...

READ MORE...
Friday, October 30, 2009

Amgen Sued By New York, 14 Other States

Thousand Oaks-based biotech giant Amgen is the subject of a lawsuit being filed by New York Attorney General Andrew M. Cuomo, along with 14 other states, claiming that the biotech firm created a kickback scheme to boost drug sales. Accordin...

READ MORE...
Friday, October 30, 2009

Verdezyne Raises $2.96M

Carlsbad-based Verdezyne, which is developing technology to improve the fermentation process for biofuels, has raised $2.96M as part of a funding round, according to a regulatory filing from the firm Thursday afternoon. According to the fil...

READ MORE...
Friday, October 30, 2009

Abraxis Founder Pledges $100M To Reopoen MLK Jr. Hospital

Patrick Soon-Shiong, the billionaire founder of Abraxis Bioscience, has committed $100M in underwriting guarantees to reopen Martin Luther King, Jr. hospital (MLK), his foundation announced this week. According to the Chan Soon-Shiong Famil...

READ MORE...
Thursday, October 29, 2009

One Recovery Raises $1.49M

Del Mar-based One Recovery, an online community site providing support for people recovering from addiction, has raised $1.49M in a funding round, according to a filing from the firm this week. According to the filing, the funding comes as ...

READ MORE...
Wednesday, October 28, 2009

Helixis Bumps Funding To $7.3M

Carlsbad-based Helixis, a developer of nucleic acid analysis tools, has upped its recent funding round to $7.3M, according to a filing from the firm this week. The funding is a continuation of a $10.0M venture round which the firm has been ...

READ MORE...
Wednesday, October 28, 2009

Aspyra To Delist Stock

Westlake Village-based Aspyra said Tuesday afternoon that the firm is voluntarily delisting its common stock from the AMEX. The firm, which is listed at APY, said it intends to deslist due to limited trading in its common stock, the costs o...

READ MORE...
Tuesday, October 27, 2009

Ligand Buys Metabasis

San Diego-based biopharmaceuticals firms Ligand Pharmaceuticals and Metabasis Therapeutics announced this morning that Ligand is acquiring Metabasis, in a deal worth $3.2M in cash plus rights to receive payments from any royalties or licens...

READ MORE...
Monday, October 26, 2009

Ceres Gets $4.9M Grant From DOE

Thousand Oaks-based Ceres, a developer of energy crops for the biofuels energy, has landed $4,989,144 in a grant from the Department of Energy, as part of a $151M effort to fund energy breakthroughs. According to the DOE, the funding--part ...

READ MORE...
Monday, October 26, 2009

Allergan Wins Patent Suit

Irvine-based Allergan is reporting this morning that it has won a patent infringement case against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd., Apotex, Inc. and Apotex Corp. in the US District Court for the District of Delaware. Allerga...

READ MORE...
Friday, October 23, 2009

Kythera Gets $10M More

Calabasas-based Kythera Biopharmaceuticals, a developer of aesthetic medicine products, has added $10M more in new funding. The new funding came to light in this week's PricewaterhouseCoopers/NVCA MoneyTree report. No details on the funding...

READ MORE...
Wednesday, October 21, 2009

Pathology Inc. Gets Debt Funding

Torrance-based Pathology Inc., a provider of pathology and molecular diagnostics services, has scored both a term loan and revolving line of credit from ORIX Venture Finance, ORIX said Wednesday. Terms and amount of the funding were not dis...

READ MORE...
Wednesday, October 21, 2009

Orqis Medical Assets Go On The Block

The physical assets of Lake Forest-based Orqis Medical, a venture backed firm which was developing treatments for congestive heart failure, are slated to go up for auction next week, according to auctioneer CowanAlexander. According to Cowa...

READ MORE...
Wednesday, October 21, 2009

U.S. Dermatology Gets Investment

Irvine-based U.S. Dermatology Medical Management, a provider of healthcare services for skin cancer treatment and other dermatological conditions, has scored an investment from Los Angeles-based Vicente Capital Partners, Vicente said today....

READ MORE...
Tuesday, October 20, 2009

Vertos Medical Raises $15.5M

Aliso Viejo-based Vertos Medical, a developer of medical devices for treating lumbar spinal stenosis, announced this morning that it has raised $15.5M in a Series D funding. The round was led by new investor ONSET Ventures, with participati...

READ MORE...
Monday, October 19, 2009

Amgen Gets Delay On Osteoporosis Treatment

The Food and Drug Adminstration has delayed an approval of Thousand Oaks-based Amgen's osteoporosis denosumab, the firm said Monday, in order to seek more information. According to Amgen, the FDA has requested that the firm include further ...

READ MORE...
Monday, October 19, 2009

Veredezyne Gets $1.7M Grant

Carlsbad-based Veredezyne--which was formerly known as CODA Genomics--said today that it has received a $1.7M grant from the National Institute of Allergy And Infectious Diseases (NIAID). The firm said the grant, which lasts for 1.5 years, ...

READ MORE...
Wednesday, October 7, 2009

Gen-Probe Buys Molecular Testing Firm

San Diego-based Gen-Probe said Tuesday that it has signed a definitive agreement to acquire Prodesse, a provider of molecular testing for influenza and other infection diseases. The deal is worth $60M in cash, with provision to increase the...

READ MORE...
Wednesday, October 7, 2009

Cyntellect Expands In Europe

San Diego-based Cyntellect, a developer of scientific equipment for the life science and stem cell research market, reported today that it has opened up a new European headquarters in the U.K. The firm said the firm now has a team of sales,...

READ MORE...
Tuesday, October 6, 2009

Accumetrics Raises $16.5M

San Diego-based Accumetrics said today that it has raised $16.5M in new capital. The funding round came from Arnerich Massena, BBT Fund/Apothecary Capital, Essex Woodlands Health Ventures, Kaiser Permanente Ventures and RiverVest Venture Pa...

READ MORE...
Thursday, October 1, 2009

Nexus DX Raises $15M

San Diego-based Nexus DX, a stealth mode, biotech firm, has raised $9.0M in a venture round, according to a regulatory filing from the firm this week. Details on the funding have not been announced. Kleiner Perkins Caufield & Byers as well ...

READ MORE...
Thursday, September 24, 2009

Life Technologies, Illumina In Patent Spat

San Diego-based Illumina said today that it has been served with a complaint alleging patent infringement, from Carlsbad-based Life Technologies. According to Illumina, it is being sued by Life Technologies, Applied Biosystems, a Russian re...

READ MORE...
Wednesday, September 23, 2009

Zogenix Gets $51M In Series B

San Diego-based Zogenix, a pharmaceutical firm developing treatments for neuroscience disorders and pain, said Wednesday that it has completed a $51M, Series B preferred stock financing. The firm said that the round was led by Clarus Ventur...

READ MORE...
Tuesday, September 22, 2009

Gamma Medica-Ideas Raises $24M

Northridge-based Gamma Medica-Ideas, a developer of digital molecular imaging systems, said Tuesday that it has raised $24M in financing. The firm said the round, the first institutional funding for the firm, was made up of $14M in equity, ...

READ MORE...
Monday, September 21, 2009

Quality Systems Names COO, Director

Irvine-based Quality Systems, a provider of IT products for the healthcare market, reported this morning that it has appointed Philip N. Kaplan as the firm's Chief Operating Officer, and added Craig A. Barbarosh to its board. Kaplan was mos...

READ MORE...
Friday, September 11, 2009

Celladon Gains $21.8M

La Jolla-based Celladon, a developer of treatments for heart failure and other cardiovascular diseases, has raised $21.8M out of a $24.6M funding round, according to a filing from the firm today. Details on the new funding round were not di...

READ MORE...
Tuesday, September 8, 2009

ValenTx Raises $22M In Series B

Carpinteria-based ValenTx, a developer of medical devices for addressing morbid obesity, announced today that it has raised $22M in a Series B financing round. The round was led by SV Life Sciences, and also included Covidien Ventures, Sapi...

READ MORE...
Wednesday, September 2, 2009

Visiogen Acquired By Abbott For $400M

Irvine-based Visiogen, a developer of intraocular lens technology for treating cataract patients, is being acquired by Abbott in a deal worth $400M. According to Abbott, it will pay $400M in cash for VisioGen, whose intraocular lens technol...

READ MORE...
Wednesday, September 2, 2009

Mabvax Finds $500K

San Diego-based Mabvax Pharmaceuticals, which is developing vaccines and human antibodies targeted at treating cancer, has gained $500,000 out of a $4M funding round, according to a regulatory filing from the firm. Mabvax had previously rai...

READ MORE...
Wednesday, September 2, 2009

Life Technologies Sells JV For $450M

Carlsbad-based Life Technologies, a developer of biotechnology tools, announced this morning that it has entered into a definitive agreement to sell its ownership stake in its mass spectrometry joint venture, to Danaher for $450M. Danaher i...

READ MORE...
Tuesday, September 1, 2009

Animal Cell Therapies Scores $1.1M

San Diego-based Animal Cell Therapies, a biotech firm developing stem cell treatments for animals, has raised $1.1M in a funding round, according to a regulatory filing by the firm Monday. No details on the funding have been released. The f...

READ MORE...
Tuesday, September 1, 2009

Aubrey Gets $3.87M

Carlsbad-based Aubrey, a startup developing wound care products that promote wound healing and burn care, has raised $3.87M in a $6.0M venture round, according to a regulatory filing from the firm Monday. Details on the funding have not bee...

READ MORE...
Tuesday, September 1, 2009

Metabasis Therapeutics Loses CEO

San Diego-based Metabasis Therapeutics reported this morning that the firm's President, CEO, and Chief Scientific Officer, Mark Erion, is leaving the firm. According to Metabasis, Erion is leaving the firm for Merck, to become Vice Presiden...

READ MORE...
Monday, August 31, 2009

Medsphere Raises $12M

Carlsbad-based Medsphere Systems, a developer of electronic health record software, announced Monday afternoon that the firm has raised $12M in a financing round. The round came from Azure Capital Partners, Epic Ventures, Thomas Weisel Vent...

READ MORE...
Thursday, August 27, 2009

ValenTX Raises $20.28M

Carpinteria-based ValenTX, a developer of treatments for obesity, has raised $20.28M in an equity funding round, according to a regulatory filing by the firm Thursday. Details on the funding have not been released by the company. ValenTx ha...

READ MORE...
Monday, August 24, 2009

Ligand Buys Drug Development Firm

San Diego-based Ligand Pharmaceuticals reported Monday that it has acquired Connecticut-based Neurogen, a developer of small-molecule drugs to improve the lives of patients suffering from psychiatric and neurological disorders. Ligand said ...

READ MORE...
Friday, August 21, 2009

Medicinova Buys Avigen

San Diego-based MediciNova, a biotech firm developing small-molecule therapeutics, said Friday that it has reached an agreement with Alameda-based Avigen to merge with the firm. Medicinova said Avigen shareholders would receive either $1.24...

READ MORE...
Wednesday, August 19, 2009

Palkion Raises $2.5M

San Diego-based Palkion, a developer of oral drugs for treating anemia, has raised $2.5M in a funding round, according to a regulatory filing from the firm Monday. Details on the funding have not been released. The firm is backed by ProQues...

READ MORE...
Friday, August 14, 2009

Datrix Acquired By Medical Devices Firm

Escondido-based Datrix, a developer of portable devices for heart monitoring, has been acquired by medical devices firm IntriCon Corporation for approximately $2.5M. St. Paul, Minnesota-based IntriCon said the deal includes $1.225M in cash,...

READ MORE...
Monday, August 10, 2009

Domain Associates Raises $500M Venture Fund

Venture capital firm Domain Associates, which is based in San Diego and New Jersey, said Monday that it has closed a $500M fund focused on the life sciences industry. The firm said the fund, Domain Partners VIII, L.P., will continue to focu...

READ MORE...
Friday, August 7, 2009

ChemNavigator Acquired By Sigma-Aldrich

San Diego-based ChemNavigator, a developer of informatics tools for the pharmaceutical industry, has been acquired by scientific equipment firm Sigma-Aldrich. Financial terms of the buy were not disclosed. According to Sigma-Aldrich, the bu...

READ MORE...
Thursday, August 6, 2009

Spectrum Pharmaceuticals Buys Remaining Rights To Compound

Irvine-based Spectrum Pharmaceuticals has acquired the remaining rights to RenaZorb, the firm's nanotechnology compound being used for treating hyperphosphatemia in patients with chronic kidney disease. The firm said it is paying $750,000 i...

READ MORE...
Tuesday, August 4, 2009

Freedom Meditech Gets Additional Financing

San Diego-based Freedom Meditech, a developer of medical devices for measuring blood sugar in the diabetic, said today that it has raised a second tranche of funding in its Series A funding. Amount of the funding was not disclosed, however,...

READ MORE...
Monday, August 3, 2009

Celerus Diagnostics Ramps Automation Efforts

Carpinteria-based Celerus Diagnostics, a developer of scientific equipment for the pathology lab market, said today that it plans to introduce a totally automated immunohistochemistry (IHC) staining system to the market next year. The firm ...

READ MORE...
Monday, August 3, 2009

Beckman Coulter Buys Olympus' Diagnostics Business

Fullerton-based scientific equipment firm Beckman Coulter announced today that it has acquired the lab-based diagnostics business of Olympus, in a deal worth approximately 76 billion Japanese yen in cash, or approximately $780M. Beckman, wh...

READ MORE...
Thursday, July 30, 2009

Cortex Pharmaceuticals Gets $2.0M In PIPE

Irvine-based Cortex Pharmaceuticals, which is developing treatments for sleep apnea, reported this morning that it has received $2.0M in a Series F, convertible preferred stock financing from an unnamed, single institutional investor. The f...

READ MORE...
Wednesday, July 29, 2009

Replenish Raises $10.25M

Pasadena-based Replenish Inc. has quietly raised $10.25M in venture funding, according to a regulatory filing by the firm this week. No details on the firm have been disclosed, however, the firm describes itself as working on a "flexible dr...

READ MORE...
Tuesday, July 28, 2009

aTyr Pharma Gets $12M

San Diego-based aTyr Pharma, which is developing biopharmaceuticals focused on inflammation, autoimmune, hematopoietic and metabolic disorders, disclosed Tuesday that it has raised $12M in an additional funding round. The firm said the fund...

READ MORE...
Friday, July 24, 2009

Epic Sciences Raises $2.5M

San Diego-based Epic Sciences, a stealth mode startup which appears related to the Scripps Research Institute, has quietly raised $2.5M in a funding round. Epic is developing analytical laboratory instruments. The funding for the firm was d...

READ MORE...
Wednesday, July 22, 2009

Lithera Raises $10M

San Diego-based Lithera, which is developing injectable treatments for fat tissue reduction, has raised $10M in a funding round. Source of the funding was not announced by the firm. Lithera, which was formerly known as Lipothera, is backed ...

READ MORE...
Monday, July 20, 2009

BeneChill Pulls In $13.5M

San Diego's BeneChill, a firm developing medical devices for rapid, non-invasive cooling of patients for the treatment of cardiac arrest, stroke, or head injury, said Monday that it has raised $13.5M in a Series C financing round. The round...

READ MORE...
Monday, July 20, 2009

Numira Biosciences Gets $3.2M

Irvine-based Numira Biosciences, a contract research organization focused on high resolution imaging, has raised $3.2M in a funding round, according to a recent regulatory filing by the firm. No details on the funding have been announced by...

READ MORE...
Tuesday, July 14, 2009

StemCyte Gains $1M In Debt

Covina-based StemCyte, a venture-backed operator of an umbilical cord blood bank, has scored $1M in a debt funding round, according to debt financing firm Agility Capital. Agility said that the senior secured growth capital loan closed in J...

READ MORE...
Friday, July 10, 2009

DexCom Expands Board

San Diego-based DexCom, which develops continuous glucose monitoring systems for the hospital industry, said this week that it has named Eric Topol, M.D., to its board. Topol is the Director of the Scripps Translational Science Institute. D...

READ MORE...
Thursday, July 9, 2009

USC Spinout Gains From $3.5M Award

A spinout of the University of Southern California, Pivotal Biosciences, is benefiting from the approval of a $3.5M drug development project that was just approved by the National Cancer Institute, for developing a treatment for metastatic...

READ MORE...
Thursday, July 9, 2009

Intellikine Raises $51M

La Jolla-based Intellikine, a developer of small molecule drugs for the treatment of cancer, inflammation, and autoimmune diseases, said Wednesday that it has raised $51M in a financing round for the firm. The round was led by Novartis Biov...

READ MORE...
Tuesday, July 7, 2009

Pegasus Biologics Acquired By Synovis

Irvine-based Pegasus Biologics, a venture backed developer of collagen-based bioimplants for orthopedic, spine, and neurosurgery, has been acquired by Synovis Life Technologies, Inc. Synovis said that it has signed a definitive purchase agr...

READ MORE...
Tuesday, July 7, 2009

Somaxon Gets $6M In PIPE

San Diego-based Somaxon Pharmaceuticals reports today that the publicly held firm has received a $6M, private equity financing. The firm said that the funding came from its existing venture investors, including MPM Capital, Montreux Equity ...

READ MORE...
Tuesday, June 30, 2009

Life Technologies To Sell Business Unit

Carlsbad-based Life Technologies, a developer of biotechnology tools and products, reported today that it is selling its SQL*LIMS laboratory information management software business to LabVantage Solutions, Inc. Financial terms of the dives...

READ MORE...
Monday, June 29, 2009

Ambit Biosciences Gets $6.4M In Debt

San Diego-based Ambit Biosciences, a developer of small molecule profiling tools being used for biopharmaceuticals development, has raised $6.5M in an ongoing, debt round, according to a filing from the firm today. Details on the debt round...

READ MORE...
Friday, June 19, 2009

Sorrento Therapeutics Gets $2.3M

San Diego-based Sorrento Therapeutics, a new biotechnology startup, has raised $2.3M in an equity funding round, according to a regulatory filing by the firm yesterday. Source of the funding was not disclosed. The firm is headed by Antonius...

READ MORE...
Wednesday, June 17, 2009

Halozyme Therapeutics Names VP

San Diego-based Halozyme Therapeutics reported today that the firm has named H. Michael Shepard, Ph.D., as the firm's new Vice President of Discovery Research. According to Halozyme, Shepard was most recently at Receptor Biologix, where he ...

READ MORE...
Tuesday, June 16, 2009

Accelrys Names New CEO

San Diego-based life sciences and scientific software developer Accelrys reported Monday that Scipio "Max" Carnecchia has joined the company as chief executive officer and president, effective immediately. Carnecchia has also been appointed...

READ MORE...
Monday, June 15, 2009

Inovio Biomedical, Cardigant Medical In Licensing Deal

San Diego-based Inovio Biomedical and Long Beach-based Cardigant Medical announced this morning that the two firms are in a commercial license, where Cardigant Medical will use Inovio's technology to develop intravascular catheters. Financi...

READ MORE...
Thursday, June 11, 2009

Protabit, Monsanto Launch Startup

Pasadena-based Protabit, a brand new startup based on research from Caltech, and chemical giant Monsanto disclosed this morning that the two firms have entered into a two-year collaboration, to develop new tools for protein design and optim...

READ MORE...
Wednesday, June 10, 2009

Illumina Gets Into Personal Genome Sequencing

San Diego-based Illumina, which makes gene sequencing and other related life sciences equipment, said Wednesday afternoon that the firm is getting into the personal genome sequencing market. According to Illumina, it will offer complete cov...

READ MORE...
Wednesday, June 10, 2009

VivoMetrics Announces New LifeShirt

Ventura-based VivoMetrics, which develops patient monitoring devices, said this week that it has completed a prototype of the firm's next generation LifeShirt product, which is used for remote monitoring of patient vital signs. According to...

READ MORE...
Wednesday, June 10, 2009

Aperio Sues Olympus, Hamamatsu

Vista-based Aperio Technologies, which develops digital pathology products for the healthcare and life sciences industries, is reporting that it has filed a patent infringement lawsuit against Olympus America, Inc., Hamamatsu Corporation an...

READ MORE...
Tuesday, June 9, 2009

CardioDynamics Acquired For $10M

San Diego-based CardioDynamics, a maker of cardiography products used for non-invasive assessment of cardiac output, is being acquired for $10M by SonoSite. According to Sonosite, it will pay $1.35 per share in cash for publicly held Cardi...

READ MORE...
Tuesday, June 9, 2009

TrueVision Systems Adds $1.2M

Santa Barbara-based TrueVision Systems, a developer of 3D visualization technology used for microsurgery, said this week that it has raised $1.2M in a convertible financing round, part of an effort which will raise $2M for the firm. TrueVis...

READ MORE...
Tuesday, June 9, 2009

aFraxis Gets $750K

San Diego-based aFraxis, a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday. Details on the funding have not been announce...

READ MORE...
Friday, June 5, 2009

Alphatec Spine Gains $10M In PIPE

Carlsbad-based Alphatec Holdings, the parent firm of medical device firm Alphatec Spine, announced Friday that the firm has raised $10M in a private placement. According to the company, the funding came from Healthpoint Capital Partners II,...

READ MORE...
Monday, June 1, 2009

Applied Biosystems Ships Mass Spectrometry Tools

Carlsbad-based Applied Biosystems announced Monday that the firm has shipped a number of new, mass spectrometry tools aimed at the laboratory market. According to the firm, which is a division of Life Technologies, the new tools are targete...

READ MORE...
Wednesday, May 27, 2009

Metabasis Therapeutics Lops 85 Percent , Looks For Buyer

San Diego-based Metabasis Therapeutics, which is developing treatments for metabolic diseases, said Wednesday that it will cut approximately 85 percent, or 45 of its employees. According to the firm, the move was necessary because of "diffi...

READ MORE...
Tuesday, May 26, 2009

Ophthonix Gains $25.9M In Series AA

Vista-based Ophthonix, which is developing high definition vision correction products, announced Tuesday afternoon that it has raised $25.9M in what it is calling a "Series AA" funding round. According to the firm, investors in the new roun...

READ MORE...
Tuesday, May 26, 2009

Spectrum Pharmaceuticals Wins $4.3M In Arbitration

Irvine-based biotechnology firm Spectrum Pharmaceuticals reports that it has won $4.3M in an arbitration over a dispute with Cell Therapeutics, over liabilities over joint venture expenses. According to the firm, $3.5M of the amount was ord...

READ MORE...
Friday, May 22, 2009

Abraxis Names VP

Los Angeles-based Abraxis BioScience, a biotech firm focused on treatments for cancer, said Friday that it has hired on Marty J. Duvall as the firm's Senior Vice President, Global Marketing and International Commercial Operations. Duvall jo...

READ MORE...
Thursday, May 21, 2009

NeoMend Finds $2.7M

Irvine-based NeoMend, which is developing wound healing products, disclosed this week via a regulatory filing that it has raised $2.7M out of a $3.5M funding round for the company, consisting of a convertible note along with warrants conver...

READ MORE...
Thursday, May 21, 2009

Aragon Pharmaceuticals Gets $8M

La Jolla-based Aragon Pharmaceuticals reported Wednesday that it has raised $8M in a Series A financing. The firm, which is focused on small molecule therapeutics for treating hormone-resistant cancers, said that the financing was led by Th...

READ MORE...
Wednesday, May 20, 2009

Victory Pharma Acquired By Sciele Pharma

San Diego-based specialty pharmaceuticals firm Victory Pharma has been acquired by Atlanta-based Sciele Pharma, Sciele said this week. According to Schiele, it will pay $150M to acquire Victory Pharma, which is focused on acquiring, develop...

READ MORE...
Thursday, May 14, 2009

Metabasis Therapeutics Running Short On Runway, Looks For Capital

San Diego-based Metabasis Therapeutics, which develops biopharmaceuticals for treating metabolic diseases, said today as part of its quarterly results that it is hoping to raise capital in Q2 to fund the firm's operations. The firm--which s...

READ MORE...
Thursday, May 14, 2009

Anaphore Takes $13M

La Jolla-based Anaphore, a developer of protein therapeutics, announced today that it has raised an additional $13M in the firm's Series A preferred stock financing. According to the firm, the new funding brings the total round size to $38M...

READ MORE...
Friday, May 8, 2009

Medsphere Hires New CFO

Carlsbad-based Medsphere Systems, a venture-backed developer of open source electronic health records software, said Friday that it has named Irv Lichtenwald as its Chief Financial Officer. Lichtenwald previously served as CFO For Advent So...

READ MORE...
Tuesday, May 5, 2009

Illumina Sues Affymetrix

San Diego-based Illumina, a developer of life sciences and genetic analysis systems, disclosed Tuesday that it has filed a patent infringement suit against competitor Affymetrix. According to Illumina, the suit--filed in the United States D...

READ MORE...
Monday, April 27, 2009

Visiogen Gains $40M In Funding

Irvine-based Visiogen is reporting this morning that it has raised $40M in a financing round for its intraocular lens technology. The firm said the funding was led by Novartis Venture Fund, and also included investments from Technology Part...

READ MORE...
Friday, April 24, 2009

InTouch Health Names VP

Santa Barbara-based InTouch Health, a developer of telepresence robots for the healthcare market, said this week that it has named Gerry Popolow as the firm's Vice President of Clinical Services and Account Management. Popolow has served as...

READ MORE...
Thursday, April 23, 2009

X Prize Foundation Puts DNA Mapping Up For Bid On eBay

Playa Vista-based X Prize Foundation is taking an unusual approach to fund its nonprofit efforts, and is auctioning off a complete gene sequencing to the highest bidder on eBay. The auction--which starts at $68,000--will give the winner a c...

READ MORE...
Thursday, April 23, 2009

NuVasive Agrees to Acquire Cervitech for up to $80M

San Diego-based NuVasive, a manufacturer of products used in the surgical treatment of spine disorders, announced Wednesday that it has agreed to acquire Cervitech, a New Jersey-based firm developing a cervical disc replacement device. NuVa...

READ MORE...
Tuesday, April 21, 2009

Abraxis Invests In Biotech Firm

Los Angeles-based Abraxis BioScience, a biotechnology firm focused on treatments for cancer and other illnesses, is the lead investor in a Maryland-firm developing technology for tissue protein analysis. According to Rockville, Maryland-bas...

READ MORE...
Friday, April 17, 2009

Vision Solutions Gains Medical Win

Irvine-based Vision Solutions reported yesterday that the firm has signed on healthcare provider The Jackson Clinic as a customer. Financial impact of the win was not disclosed. Vision Solutions said that The Jackson Clinic is using the fir...

READ MORE...
Tuesday, April 14, 2009

Obagi Medical Bails On Pharmacy Sales

Long Beach-based Obagi Medical Products, which develops aesthetic and therapeutic skin care products, said Monday afternoon that the firm will stop selling its SoluCLENZ Rx Gel in pharmacies. The firm said that the company will instead focu...

READ MORE...
Monday, April 13, 2009

TriZetto Signs Health Plan

Newport Beach-baed TriZetto Group, a developer of health care management software, said Monday that the firm has added the CareMore Health Plan as a customer. Financial impact of the deal was no disclosed. CareMore Health Plan is a provider...

READ MORE...
Monday, April 13, 2009

Invitrogen Releases Equipment

Carlsbad-based Invitrogen, a manufacturer of diagnostic equipment for the life sciences industry, announced this morning that it has released a new product. According to Invitrogen, its new GIBCO OPTmizer T-cell Expansion SFM is targeted at...

READ MORE...
Friday, April 10, 2009

X Prize Foundation To Set $10M Health Care Competition Rules

The X PRIZE Foundation, the Playa Vista-based nonprofit using multimillion dollar prizes to drive innovation, said Thursday that the firm will announce the initial prize parameters for its $10M+, Healthcare X PRIZE next week. According to t...

READ MORE...
Thursday, April 9, 2009

La Jolla Pharmaceuticals Gets Dreaded "Going Concern" Opinion

San Diego-based La Jolla Pharmaceuticals, a publicly traded specialty pharmaceuticals firm, has received a dreaded "going concern" opinion from its auditor, Ernst & Young. The opinion--when an auditor decides that the firm being audited has...

READ MORE...
Tuesday, April 7, 2009

Inovio Biomedical Adds Director

San Diego-based Inovio Biomedical Corporation said yesterday that the firm has appointd Ng Tee Khiang to the firm's board. Khiang is co-founder, partner, and director of a number of firms, including Evia Capital Partners Pte. Ltd. and Evia ...

READ MORE...
Tuesday, April 7, 2009

Cianna Medical Finds $10M

Aliso Viejo-based Cianna Medical is reporting today that the firm has completed a Series B funding round worth more than $10M. The firm, which is developing treatments for early stage breast cancer, said the funding comes from Emergent Medi...

READ MORE...
Thursday, April 2, 2009

LensX Lasers Raises $22M

Aliso Viejo-based LensX Lasers, a maker of cataract surgery devices, has raised $22.36M in a funding round, according to a recent regulatory filing. According to the filing, the funding came on March 19th, and included investors Versant Ven...

READ MORE...
Thursday, April 2, 2009

Aspyra Reorganizes, Delays 10-K

Calabasas-based Asprya, a provider of clinical information management systems for the healthcare market, said today that it has reorganized its management team. According to the firm, Bruce Miller, Chief Technology Officer of the firm and o...

READ MORE...
Thursday, April 2, 2009

Traversa Therapeutics Lands $5M In Second Round

La Jolla-based Travera Therapeutics, which is developing biopharmaceuticals based on RNA interference (RNAi) technology, said Thursday that it has raised $5M in a Series B financing round. The round was led by Morningside Venture Investment...

READ MORE...
Thursday, April 2, 2009

TorreyPines Therapeutics Lops Employees, Looks For Buyer

La Jolla-based TorreyPines Therapeutics, a biopharmaceuticals firm focused on small molecule compounds, said this week that it has reduced its work force to just three employees. The firm said the move came as it looks to evaluate strategic...

READ MORE...
Wednesday, April 1, 2009

Ambrx Gains $10M

La Jolla-based Ambrx, which is developing protein and antibody drugs, said in a regulatory filing today that it has raised $10M. No details of the funding round have been disclosed. Ambrx has previously raised capital from 5AM Ventures, Mav...

READ MORE...
Tuesday, March 31, 2009

Quidel Cuts 10 Percent

San Diego-based Quidel, a developer of diagnostic tests for the healthcare industry, said Tuesday that it has cut approximately 10 percent of its work force, or 31 employees, in a corporate restructuring. According to Quidel, it made the cu...

READ MORE...
Thursday, March 26, 2009

Somaxon Gets Nasdaq Warning

San Diego-based Somaxon Pharmaceuticals, a specialty pharmaceuticals firm in the central nervous system therapeutic area, said Thursday afternoon that the firm has received a warning from the Nasdaq Stock Market. The warning--which is a pre...

READ MORE...
Wednesday, March 25, 2009

Pure Bioscience In India Distribution Deal

San Dieog-based PURE Bioscience, a developer of an antimicrobial disinfectant, said Wednesday that it has licensed a distributor for its products in India. According to PURE Bioscience, the firm's products will be distributed under the bran...

READ MORE...
Monday, March 23, 2009

Adventrx Reaches End Of Line, Looks For Buyer

San Diego-based Adventrx Pharmaceuticals, which was developing pharmaceuticals to improve existing cancer treatments, said late Friday that it will discontinue "substantially all" of its development activities and business operations. The f...

READ MORE...
Monday, March 23, 2009

Relsys International Acquired By Oracle

Irvine-based Relsys International, a developer of drug safety and risk management software for the health care industry, has been acquired by software giant Oracle. Oracle said this morning that it has agreed to acquire Relsys, which will b...

READ MORE...
Friday, March 20, 2009

Advantar Laboratories In Deal With NextPharma

San Diego-based Advantar Laboratories, a provider of contract laboratory services to the drug development industry, has signed an agreement with UK-based firm NextPharma Technologies, a pharmaceutical product development, contract manufactu...

READ MORE...
Thursday, March 19, 2009

Cortex Pharmaceuticals Lops Half Of Workers

Irvine-based Cortex Pharmaceuticals, a developer of biopharmaceuticals for treating psychiatric disorders, neurological diseases and brain-mediated breathing disorders, said Thursday that it has cut half of its staff as part of a restructur...

READ MORE...
Tuesday, March 17, 2009

Innovative Micro Targets Life Sciences

Santa Barbara-based Innovative Micro Technology, a maker of micro-electromechanical (MEMS) systems, announced today that the firm has created a new division focused on life sciences. The firm said the new division will focus on developing m...

READ MORE...
Tuesday, March 17, 2009

InstaMed Gains $6M

InstaMed, which operates a network for healthcare payment processing, said Tuesday that the firm has raised $6M in a growth equity financing. The firm, which has operations in Newport Beach and is headquartered in Philadelphia, said the rou...

READ MORE...
Monday, March 16, 2009

Zynx Health Upgrades Software

Los Angeles-based Zynx Health, a developer of health care decision support software, said this morning that the firm has upgraded its AuthorSpace software. According to the firm, the new version of the software adds such features as PDF exp...

READ MORE...
Friday, March 13, 2009

NeoMatrix Gains $15M In Funding

Irvine-based NeoMatrix, a developer of a noninvasive breast cancer screening device, said Friday that it has completed a C2 funding round, worth $15M. Investors in the round were not disclosed. According to the firm, the round was oversubsc...

READ MORE...
Friday, March 13, 2009

Sangart Gets $50M

San Diego-based Sangart, a biopharmaceuticals firm focused on the commercialization of oxygen therapeutics, said Thursday that it has raised $50M in a Series F funding round. Names of investors were not disclosed, however, the firm said the...

READ MORE...
Thursday, March 12, 2009

Fate Therapeutics Names Chief Scientific Officer

La Jolla-based Fate Therapeutics, a firm developing stem cell technology, said today that it has named Ken Batchelor, Ph.D., as the firm's Chief Scientific Officer. Batchelor joins the firm GlaxoSmithKline, where he was most recently Senior...

READ MORE...
Monday, March 9, 2009

Victory Pharma Raises $45M

San Diego-based Victory Pharma has raised $45M in an equity financing round, the firm said Monday. The round was led by Essex Woodlands Health Ventures, and also included prior investor Ampersand Ventures. According to Victory Pharma, Scott...

READ MORE...
Wednesday, March 4, 2009

Regulus Therapeutics Raises $20M

Carlsbad-based Regulus Therapeutics, a biopharmaceuticals firm focused on microRNA-based therapeutics, announced this morning that it has raised $20M in a Series A funding round. The investment came from Alnylam Pharmaceuticals and Isis Pha...

READ MORE...
Monday, March 2, 2009

Xencor In License Deal With Pfizer

Monrovia, California-based Xencor, which is developing antibodies to treat such things as Hodgkin lymphoma and inflammatory disease, said this morning that it has inked a technology license and evaluation agreement with Pfizer. According to...

READ MORE...
Monday, March 2, 2009

Metabasis Names CFO

San Diego-based Metabasis Therapeutics has hired on a new Vice President and Chief Financial Officer, the firm disclosed today. Metabasis, which is developing biopharmaceuticals for treating metabolic and other diseases, said that it has na...

READ MORE...
Friday, February 27, 2009

Helixis Adds Illumina's Flatley To Board

Carlsbad-based Helixis, which develops tools for nucleic acid analysis, said Thursday that it has added Illumnia CEO Jay Flatley to the firm's board of directors. The company, which is venture backed by Domain Associates and Okapi Venture C...

READ MORE...
Wednesday, February 25, 2009

Xifin Hires CFO, Marketing VP

San Diego-based XIFIN, a publisher of hosted revenue cycle management software for diagnostic laboratories, reported Tuesday that it has added two members to its executive staff. The company said it has hired Steve Zaniboni as chief financi...

READ MORE...
Monday, February 23, 2009

CoreValve Acquired By Medtronic For $700M

Irvine-based CoreValve, a venture-backed developer of an aortic valve replacement market, has been acquired by Medtronic in a $700M deal, Medtronic said this morning. According to Medtronic, it will pay $700M plus additional contingent paym...

READ MORE...
Friday, February 20, 2009

La Jolla Pharmaceuticals Lays Off Staff, Looks To Sell Firm

San Diego-based La Jolla Pharmaceutical Company has laid of a "substantial" number of the firm's personnel, and is looking to either shut down the business or sell the company, the firm said Thursday, after a failure of the firm's Phase 3 t...

READ MORE...
Wednesday, February 18, 2009

Kythera Biopharmaceuticals Lands $10M

Los Angeles-based Kythera Biopharmaceuticals, which is developing products for the aesthetic medicine market, disclosed this morning that it has received $10M as part of the firm's Series C funding round. According to Kythera, the round inc...

READ MORE...
Tuesday, February 17, 2009

Cadence Pharmaceuticals Raises $86.6M In PIPE

San Diego-based Cadence Pharmaceuticals, which licenses, develops, and commercializes biopharmaceuticals, said Tuesday that it has reached an agreement to raise approximately $86.6M from a group of venture capital investors. The publicly he...

READ MORE...
Thursday, February 12, 2009

Celerus Diagnostics Gets $5M

Carpinteria-based Celerus Diagnostics, which is developing products focused on providing rapid cancer diagnostics, announced today that it has raised $5M in a Series C funding round. Investors in the new round were not disclosed. According ...

READ MORE...
Tuesday, February 10, 2009

Mpex Pharmaceuticals Gains $27.5M

San Diego-based Mpex Pharmaceuticals said Tuesday that the firm has raised $27.5M in a Series D financing round. The firm, which is developing antibiotics, said that the round was led by Investor Growth Capital. Other investors in the firm ...

READ MORE...
Friday, February 6, 2009

SynergEyes Sees $13.3M

Carlsbad-based SynergEyes, a developer of hybrid contact lenses, announced Friday that the firm has raised $13.3M in a Series C funding round. SynergEyes said that the round was led by De Novo Ventures, and also included Bio-Star Private Eq...

READ MORE...
Monday, February 2, 2009

Hollis-Eden Pharmaceuticals Lops A Third Of Company

San Diego-based Hollis-Eden Pharamceuticals, a developer of biopharmaceuticals, said Monday that the firm is cutting its workforce by approximately 33 percent, or 20 employees. According to the firm, the "aggressive" cost cutting plan is du...

READ MORE...
Thursday, January 29, 2009

Aquea Scientific Gets $10.95M

Ventura-based Aquea Scientific, which develops a UVA/UVB sunscreen which can be washed on or applied in the shower, has quietly raised $10.955M in funding. The funding was first disclosed in the PricewaterhouseCOopers/NVCA MoneyTree venture...

READ MORE...
Monday, January 26, 2009

Sequenom Buys SensiGen

San Diego-based Sequenom, a developer of genetic analysis products, said Monday afternoon that it has acquired SensiGen LLC, a biotechnology firm based in Ann Arbor, Michigan. Sequenom said it paid $8.7M for SensiGen, including earn-out mil...

READ MORE...
Thursday, January 22, 2009

Axikin Pharmaceuticals Gets $3M

San Diego-based Axikin Pharmaceuticals, a new startup focused on small molecule therapeutics for respiratory and inflammatory disease, announced Thursday that it has raised $3M in a Series A funding. The company, which is a spinout of Actim...

READ MORE...
Wednesday, January 21, 2009

Nanogen Looks For New Suitor

San Diego-based Nanogen, a developer of molecular diagnostics products, said today that it has received permission to investigate alternatives to a previously announced merger with the Elitech Group. Nanogen had originally announced its mer...

READ MORE...
Tuesday, January 20, 2009

Metabasis Therapeutics Lops 43 Percent

San Diego-based Metabasis Therapeutics, a biopharmaceuticals development firm, just announced this morning that it is cutting 38 employees, or approximately 43 percent of its employees as part of a corporate restructuring. Metabasis said th...

READ MORE...
Tuesday, January 20, 2009

Abraxis Bioscience Spins Out Personalized Medicine Firm

Los Angeles-based Abraxis Biosciences disclosed this morning that the firm's board has approved a plan to create a new company, Abraxis Health, Inc., which will focus on biomarkers and personalized medicine. According to Abraxis, the new fi...

READ MORE...
Wednesday, January 14, 2009

Sequenom In Hostile Bid For Competitor

San Diego-based Sequenom, a developer of genetic analysis products, is making a hostile bid for a competitor, EXACT Sciences Corporation, shortly after an offer was rejected by Exact's board. Sequenom said this morning that it has offered ...

READ MORE...
Monday, January 12, 2009

Ablation Frontiers Acquired By Medtronic

Carlsbad-based Ablation Frontiers, a venture-backed provider of products for the treatment of atrial fibrillation, has been acquired by Medtronic for $225M. According to Medtronic, it will pay $225M plus additional, unspecified contingent p...

READ MORE...
Monday, January 12, 2009

Illumina Signs University Customer

San Diego-based Illumina, a developer of life science analysis tools, said Monday that the firm's products have been selected by Duke University Medical Center. According to Illumina, researchers at the school will use its Genome Analyzer t...

READ MORE...
Wednesday, January 7, 2009

Anaphore Takes $25M In Series A

La Jolla-based Anaphore has raised $25M in a Series A financing, the firm said Wednesday, in a funding led by 5AM Ventures, Versant Ventures, and Apposite Capital. The firm, which is developing biopharmaceuticals for treating immune-mediate...

READ MORE...
Wednesday, January 7, 2009

OrthAlign Raises $7.2M

Laguna Beach-based OrthAlign said Wednesday that the firm has raised $7.2M in a Series A funding round, in what looks to be the first announced Southern California venture deal in 2009. The funding was led by Research Corporation Technologi...

READ MORE...
Monday, January 5, 2009

Illumina Hires Operations VP

San Diego-based Illumina has hired on a new Senior Vice President of Operations, Bill Bonnar, the firm disclosed this morning. The firm, which develops life science products and services for the genomics market, said that Bonnar joins the c...

READ MORE...
Tuesday, December 16, 2008

Dexcom Hires Executive

San Diego-based DexCom has appointed a new Chief Administrative Officer, the firm disclosed this morning, saying it had hired Steven R. Pacelli. The firm, which designs glucose monitoring systems for the healthcare industry, said that Pacel...

READ MORE...
Friday, December 12, 2008

Healthshoppr Launches Health Booking Site

Los Angeles-based Healthshoppr, a startup developing an online appointment booking and ratings site for the healthcare market, launched its beta site Thursday. The site has launched starting with the wellness market, offering bookings of ma...

READ MORE...
Tuesday, December 9, 2008

Medsphere In Education Deal

Carlsbad-based Medsphere is behind a new effort to help medical students learn about healthcare IT and clinical informatics, the firm disclosed this morning, and is supplying its products to the University of Oklahoma College of Nursing. Me...

READ MORE...
Monday, December 8, 2008

BioIQ Gets Win At Alere

Santa Barbara-based BioIQ, a provider of web-based, consumer health testing services, said last week that it has inked a deal to provide its services to Alere, a provider of health and wellness serviecs. According to BioIQ, the firms will w...

READ MORE...
Tuesday, November 25, 2008

Vical Cuts 20 Percent

San Diego-based Vical Incorporated, a biopharmaceuticals firm focused on immunotherapeutics for cancer and DNA vaccines for infectious diseases, said Friday that it has cut 29 employees, or approximately 20 percent of the firm. According to...

READ MORE...
Tuesday, November 25, 2008

Awarepoint Raises $13.3M

San Diego-based Awarepoint, a developer of systems for tracking assets and patients in hospitals, has raised $13.3M in a Series D funding. The firm said the round was led by Cardinal partners, and also included Venrock and prior investor Av...

READ MORE...
Tuesday, November 25, 2008

Abraxis BioScience Buys Back Rights

Los Angeles-based Abraxis BioScience, a biotechnology firm focused on compounds for treating cancer, said this morning that it has reached an agreement with AstraZeneca UK Limited to re-acquire rights to market the firm's ABRAXANE treatment...

READ MORE...
Friday, November 21, 2008

Aspyra Names CEO

Calabasas-based Aspyra, a provider of clinical information systems for the healthcare industry, has appointed Rodney Schutt as the firm's CEO. Schutt joins Aspyra from Luminetx, where he was Chief Operating Officer. Schutt has also served a...

READ MORE...
Tuesday, November 18, 2008

Zacharon Pharmaceuticals Raises $3.5M

San Diego-based Zacharon Pharmaceutical said today that it has raised $3.5M in a Series A financing for the firm's biopharmaceuticals technology. According to the firm, the financing came from Avalon Ventures LLC. The firm also said it has ...

READ MORE...
Friday, November 14, 2008

Valeant Pharmaceuticals Buys Australian Firm

Aliso Viejo-based Valeant Pharmaceuticals said today that it has acquired an Australian specialty pharmaceuticals firm, DermaTech Pty Ltd. Valeant said it paid approximately AU$19M ($12.5M US) for DermaTech, which develops products for the ...

READ MORE...
Thursday, November 13, 2008

Ardea Biosciences Gets $8M Loan

San Diego-based Ardea Biosciences, which is developing small-molecule therapeutics for the treatment of HIV, gout, cancer and inflammatory diseases, announced Thursday that the firm has scored an $8M growth capital loan from Oxford Finance ...

READ MORE...
Tuesday, November 11, 2008

CODA Genomics Becomes Verdezyne

Laguna Hills-based CODA Genomics, which is developing technology for engineering proteins, metabolic pathways and microorganisms for the life sciences, chemical, and biofuels market, said Tuesday that it is renaming itself Verdezyne, Inc. T...

READ MORE...
Wednesday, November 5, 2008

Precision Dynamics Buys TimeMed Labeling Systems

San Fernando-based Precision Dynamics Corporation, a provider of identification and labeling products for the hospital and healthcare market, has acquired TimeMed Labeling Systems, which creates specialty healthcare labels, the firms said T...

READ MORE...
Friday, October 31, 2008

Pegasus Biologics Names VP

Irvine-based Pegasus Biologics, which develops products for the soft tissue repair and wound care management market, said earlier this week that it has named Rob Cripe as its Vice President of Marketing and Product Development. Cripe joins ...

READ MORE...
Friday, October 24, 2008

Phenomix Gets $75M In Deal With Forest Labs

San Diego-based biopharmaceuticals firm Phenomix will receive $75M in an upfront payment, and up to $340M total, in a deal with Forest Laboratories, Inc., the firms said Thursday. According to the companies, they are in a definitive collabo...

READ MORE...
Friday, October 24, 2008

NaviMedix Acquires TopLine Solutions

San Diego-based NaviMedix said earlier this week that it has acquired TopLine Solutions, a provider of healthcare payment and collection services. Financial terms of the acquisition were not disclosed. NaviMedix operates a web-based network...

READ MORE...
Thursday, October 23, 2008

Phenomix Drops IPO Bid

San Diego-based Phenomix Corporation, a biopharmaceuticals firm focused on small molecule drugs, has dropped its IPO bid, according to a filing by the company with the SEC this morning. Phenomix said that it has applied to withdraw its IPO,...

READ MORE...
Tuesday, October 21, 2008

Vivometrics Gets $19.9M

Ventura-based Vivometrics, maker of medical monitoring technology, has raised $19.917M in funding, according to numbers released by this week's PricewaterhouseCoopers/NVCA venture capital report. Details of the funding were not disclosed. V...

READ MORE...
Tuesday, October 21, 2008

SkinMedica Scores Debt Financing

Carlsbad-based SkinMedica, a developer of cosmeceuticals for the dermatology field, has scored $27.5M in debt from two lenders. According to GE Healthcare Financial Services and BlueCrest Capital Finance, they have provided $27.5M in a seni...

READ MORE...
Friday, October 17, 2008

X Prize Foundation Targets Tuberculosis, Gets Gates Grant

The X Prize Foundation announced Thursday that it has received a grant from the Bill & Melinda Gates Foundation to develop a prize focused on the effective diagnosis of tuberculosis in the developing world. Amount of the grant was not discl...

READ MORE...
Friday, October 17, 2008

Cytori Gets $15M Loan

San Diego-based Cytori Therapeutics disclosed earlier this week that it has scored a $15M loan facility from GE Healthcare Financial Services and Silicon Valley Bank. The firm, which develops products for the regenerative medicine market, s...

READ MORE...
Thursday, October 16, 2008

Valeant Pharmaceuticals Completes Coria Laboratories Buy

Aliso Viejo-based Valeant Pharmaceuticals International said Thursday that it has completed its acquisition of Coria Laboratories Ltd. The deal was worth $95M. Valeant had originally announced the acquisition of Coria Laboratories from its ...

READ MORE...
Wednesday, October 15, 2008

Endologix Gets Unsolicited Offer To Buy Firm

Irvine-based Endologix, which develops medical devices for the minimally invasive treatment of abdominal aortic aneurysms, said Wednesday that it has received an unsolicited offer for the company from private equity firm Elliot Associates. ...

READ MORE...
Friday, October 10, 2008

CoreValve Expands Board

CoreValve Inc., a designer and manufacturer of artificial replacement components for the human heart, reported earlier this week that it has appointed Frank Fischer to its board of directors. The Irvine, Calif.-based company described Fisch...

READ MORE...
Thursday, October 9, 2008

AMO Cuts Estimates, Blames Economy

Santa Ana-based Advanced Medical Optics is seeing an impact on it sales due to the economy, the firm disclosed this morning, saying it would lower its 2008 revenue guidance and EPS. According to AMO, it is now forecasting $1.17 billion to $...

READ MORE...
Tuesday, October 7, 2008

Nexeon MedSystems Gets $24M

Nexeon MedSystems, a newly formed company focused on developing stents and other medical devices, announced this morning that the firm has raised $24M in funding from SurModics, Inc., Guidant Corporation, and other private investors. The fi...

READ MORE...
Tuesday, October 7, 2008

AMO Gets Approval On Medical Device

Santa Ana-based Advanced Medical Optics said this morning that it has received FDA approval on a medical device for opthalmic surgery. According to AMO, the U.S. Food and Drug Administration has granted premarket approval to the firm's Heal...

READ MORE...
Thursday, September 25, 2008

Ligand Acquires Pharmacopeia

San Diego-based pharmaceuticals firm Ligand Pharmaceuticals said Thursday morning that it has entered into a definitive merger agreement to acquire Pharmacopeia. The deal is worth $70M. According to the firm, the deal is a stock-for-stock e...

READ MORE...
Tuesday, September 23, 2008

Sequenom Acquires Diagnostics Lab

San Diego-based Sequenom, a provider of genetic analysis products, said Tuesday that it has agreed to acquire the Center for Molecular Medicine (CMM), a clinical diagnostics laboratory based in Grand Rapids, Michigan. According to Sequenom,...

READ MORE...
Monday, September 22, 2008

Tech Coast Angels Invests In Biopharmaceuticals Firm

The Tech Coast Angels said this morning that the group has made an investment in Amplyx Pharmaceuticals, a drug development firm developing small molecule drugs. According to the Tech Coast Angels, it invested $289,000 in a Series A round f...

READ MORE...
Monday, September 22, 2008

Freedom Meditech Gets Investment

Freedom Meditech, a firm developing proprietary non-invasive ocular glucose measurement device for people with diabetes, has scored $380,000 in a equity investment. The round was disclosed by JumpStartup, an early stage venture acceleration...

READ MORE...
Monday, September 22, 2008

Endologix Hires VP

Irvine-based Endologix, which develops medical devices for the minimally invasive treatment of aneurysms, said this morning that it has hired Gary I. Sorsher as the firm's Vice President of Quality. According to Endologix, Sorsher joins the...

READ MORE...
Friday, September 19, 2008

Sofinnova Ventures Hires EIR In San Diego

Venture capital firm Sofinnova Ventures has hired on an Executive-in-Residence based in San Diego, the firm said Thursday. Sofinnova, which invests in early stage life sciences and IT firms, said it has appointed Lars Ekman, M.D., Ph.D. to ...

READ MORE...
Thursday, September 4, 2008

Microfabrica Scores $22.5M

Van Nuys-based Microfabrica, which micro-fabricates three dimensional micro-devices, said Thursday that the firm has raised $22.5M in a Series B funding. The round was co-led by Versant Ventures and Interwest Partners, and also included pri...

READ MORE...
Thursday, August 28, 2008

BioIQ Rolls Out Wellness Testing Enhancements

Santa Barbara-based BioIQ, a startup providing web-linked health testing services, said this week that it has rolled out a new product targeted at corporate wellness testing. According to the firm, it has rolled out a new generation of the ...

READ MORE...
Tuesday, August 26, 2008

Ivera Snags License From Becton Dickinson

San Diego-based medical device firm Ivera Medical Corporation has snagged a patent license from Becton, Dickenson and Company, the firm said this morning. Ivera announced that it is in an exclusive license agreement with BD, for the worldwi...

READ MORE...
Thursday, August 14, 2008

Interview with Brent Reinke, Gold Coast Bio Center

Last week, the organizers behind the Gold Coast Bio Center, a life sciences incubator forming along the 101 technology corridor, held a meeting to talk about the group's efforts to tap into the wealth of experience in the area in the biotec...

READ MORE...
Thursday, August 7, 2008

Somaxon Pharmaceuticals Appoints CEO

San Diego-based Somaxon Pharmaceuticals said today that it has appointed Richard W. Pascoe as the firm's President and CEO. Pascoe will also serve as a director of the company. Pascoe was most recently at ARAID Pharmaceuticals, where he was...

READ MORE...
Tuesday, August 5, 2008

Valeant Sells European Operations

Aliso Viejo-based Valeant Pharmaceuticals International, which develops specialty pharmaceuticals, said Monday that it has agreed to sell the firm's business operations in Western Europe and Eastern Europe, including Russia. The firm said t...

READ MORE...
Thursday, July 31, 2008

Versant Ventures Closes Fourth Fund, Worth $500M

Versant Ventures, a Newport Beach- and Menlo Park-based venture capital fund, announced today that it has closed Versant Venture Capital IV, L.P. at $500M. The fund brings Versant's total under management to $1.6 billion, in the areas of bi...

READ MORE...
Friday, June 20, 2008

Biologics Process Development Acquired By Indian Firm

Poway-based Biologics Process Development Incorporated, a provider of contract laboratory services for the biotechnology industry, has been acquired by an Indian biopharmaceuticals firm, Intas Biopharmaceuticals Ltd. According to the firms,...

READ MORE...